2006, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, 2006

Aarsetoy H, Brugger-Andersen T, Hetland O, Grundt H, Nilsen DW. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb. Haemost. 95: 329-336 (2006).
Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. J. Lipid Res. 47: 366-374 (2006). *
Abad C, Gomariz RP, Waschek JA. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr. Top. Med. Chem. 6: 151-163 (2006).
Abadia-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C. CD48 controls T cell and antigen-presenting cell functions in experimental colitis. Gastroenterology 130: 424-434 (2006). *
Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch. Dermatol. Res. 298: 347-352 (2006). *
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701 (2006). *
Abbasciano V, Trevisani L, Di Todaro F, Guglielmini C, Marzola A, Sartori S, Salemi A. Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. An early case. Recenti Prog. Med. 97: 28-31 (2006).
Abbott CA, Yazbeck R, Geier MS, Demuth HU, Howarth GS. Dipeptidyl peptidases and inflammatory bowel disease. Adv. Exp. Med. Biol. 575: 155-162 (2006).
Abd El-Ghaffar HA, Aladle DA, Farahat SE, Abd El-Hady N. P-Glycoprotein (P-170) expression in acute leukemias. Hematology 11: 35-41 (2006).
Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology 44: 1063-1074 (2006). *
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Int. J. Immunogenet. 33: 155-161 (2006). *
Abdeen H, Heggarty S, Hawkins SA, Hutchinson M, McDonnell GV, Graham CA. Mapping candidate non-MHC susceptibility regions to multiple sclerosis. Genes Immun. 7: 494-502 (2006). *
Abdel Rahman H, Abdul Wahab A, Abdel Rahman MO, Mostafa OA. Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation. Acta Paediatr. 95: 1066-1069 (2006). *
Abdel-Naser MB, Wollina U, El Hefnawi MA, Habib MA, El Okby M. Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency. J. Drugs Dermatol. 5: 370-372 (2006).
Abdelbaqi M, Chidlow JH, Matthews KM, Pavlick KP, Barlow SC, Linscott AJ, Grisham MB, Fowler MR, Kevil CG. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins. Lab. Invest. 86: 380-390 (2006). *
Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4: 1162-1169 (2006).
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin. Exp. Immunol. 145: 63-70 (2006). *
Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG. Persistent expansion of CD4(+) effector memory T cells in Wegener's granulomatosis. Kidney Int. 70: 938-947 (2006). *
Abdulla D, Goralski KB, Renton KW. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat. Toxicol. Appl. Pharmacol. 216: 1-10 (2006). *
Abdullaev IF, Rudkouskaya A, Schools GP, Kimelberg HK, Mongin AA. Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in rat cultured astrocytes. J. Physiol. 572: 677-689 (2006). *
Abdullah HI, Pedraza PL, Hao S, Rodland KD, McGiff JC, Ferreri NR. NFAT regulates calcium sensing receptor-mediated TNF production. Am. J. Physiol. Renal Physiol. 290: F1110-F1117 (2006). *
Abe M. Complement activation and inflammation. Rinsho Byori 54: 744-756 (2006).
Abe M, Thomson AW. Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin. Immunol. 118: 300-306 (2006). *
Abe T, Takeuchi T, Miyasaka N, Hashimoto H, Kondo H, Ichikawa Y, Nagaya I. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. J. Rheumatol. 33: 37-44 (2006).
Abe-Dohmae S, Ueda K, Yokoyama S. ABCA7, a molecule with unknown function. FEBS Lett. 580: 1178-1182 (2006). *
Abebe F, Mustafa T, Nerland AH, Bjune GA. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin. Exp. Immunol. 143: 180-192 (2006). *
Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. n-3 Fatty acids inhibit vascular calcification via the p38-MAPK and peroxisome proliferator-activated receptor-gamma pathways. Circ. Res. 98: 727-729 (2006). *
Abedin M, Scheurich D, Reimold SC, Reimold AM. Acute coronary syndrome after infliximab infusion. Cardiol. Rev. 14: 50-52 (2006).
Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ. Epigenetic corruption of VDR signalling in malignancy. Anticancer Res. 26: 2557-2566 (2006).
Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Gunthert U, Kopf M. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis. Eur. J. Immunol. 36: 494-499 (2006). *
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S. Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum. Immunol. 67: 612-617 (2006).
Abel S, Yang Y, Waring JF. Development of an in vitro gene expression assay for predicting hepatotoxicity. ALTEX 23: S326-S331 (2006).
Abele R, Tampe R. Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett. 580: 1156-1163 (2006). *
Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis - cartilage destruction and the regulation of matrix metalloproteinases. Bull. Hosp. Jt. Dis. 64: 20-24 (2006).
Abenavoli L, Proietti I, Leggio L, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato G. Cutaneous manifestations in celiac disease. World J. Gastroenterol. 12: 843-852 (2006). *
Aberle J, Hopfer I, Beil FU, Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int. J. Obes. (Lond.) 30: 1709-1713 (2006).
Aberra FN. To be or not to be: infliximab during pregnancy? Inflamm. Bowel Dis. 12: 76-78 (2006). *
Aberra FN, Lichtenstein GR. Infliximab in ulcerative colitis. Gastroenterol. Clin. North Am. 35: 821-836 (2006).
Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, De Vente J, Groen AK, Wellington CL, Kuipers F, Mulder M. 24(S)-Hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281: 12799-12808 (2006). *
Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci. 79: 2364-2369 (2006). *
Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nat. Clin. Pract. Rheumatol. 2: 671-678 (2006). *
Aboian E, Winter DC, Metcalf DR, Wolff BG. Perineal hernia after proctectomy: prevalence, risks, and management. Dis. Colon Rectum 49: 1564-1568 (2006). *
Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun. Rev. 5: 331-337 (2006).
Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. (Berl.) 111: 539-547 (2006).
Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 12: 641-650 (2006). *
Abraham J, Earl HM, Pharoah PD, Caldas C. Pharmacogenetics of cancer chemotherapy. Biochim. Biophys. Acta 1766: 168-183 (2006). *
Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM. Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am. J. Surg. Pathol. 30: 1454-1461 (2006).
Abraldes JG, Pasarin M, Garcia-Pagan JC. Animal models of portal hypertension. World J. Gastroenterol. 12: 6577-6584 (2006). *
Abramovits W, Losornio M. Failure of two TNF-alpha blockers to influence the course of alopecia areata. Skinmed. 5: 177-181 (2006).
Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH. Utility in clinical practice of immunoglobulin A anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin. Gastroenterol. Hepatol. 4: 726-730 (2006).
Abramson SB, Attur M, Yazici Y. Prospects for disease modification in osteoarthritis. Nat. Clin. Pract. Rheumatol. 2: 304-312 (2006). *
Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv. Drug Deliv. Rev. 58: 212-225 (2006). *
Abreu MT. Serologies in Crohn's disease: can we change the gray zone to black and white? Gastroenterology 131: 664-667 (2006). *
Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, Yang H, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Adams JS, Targan SR. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J. Clin. Gastroenterol. 40: 55-63 (2006).
Abreu MT, Sparrow MP. Translational research in inflammatory bowel disease. Mt. Sinai J. Med. 73: 1067-1073 (2006). *
Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med. 3: e483 (2006). *
Absar S, Mason J, Anjum K, Haboubi N. A new combined form significantly improves accuracy of pathological diagnosis in inflammatory bowel disease in absence of the clinicopathological conference. Tech. Coloproctol. 10: 227-232 (2006). *
Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 130: S132-S137 (2006). *
AbuGhazaleh AA, Holmes LD, Jacobson BN, Kalscheur KF. Short communication: eicosatrienoic acid and docosatrienoic acid do not promote vaccenic acid accumulation in mixed ruminal cultures. J. Dairy Sci. 89: 4336-4339 (2006). *
Abuzaytoun R, Shahidi F. Oxidative stability of algal oils as affected by their minor components. J. Agric. Food Chem. 54: 8253-8260 (2006). *
Acar N, Bonhomme B, Joffre C, Bron AM, Creuzot-Garcher C, Bretillon L, Doly M, Chardigny JM. The retina is more susceptible than the brain and the liver to the incorporation of trans isomers of DHA in rats consuming trans isomers of alpha-linolenic acid. Reprod. Nutr. Dev. 46: 515-525 (2006). *
Achard-Joris M, Bourdineaud JP. Heterologous expression of bacterial and human multidrug resistance proteins protect Escherichia coli against mercury and zinc contamination. Biometals 19: 695-704 (2006). *
Achila D, Banci L, Bertini I, Bunce J, Ciofi-Baffoni S, Huffman DL. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake. Proc. Natl. Acad. Sci. U.S.A. 103: 5729-5734 (2006). *
Achiron A. Measuring disability progression in multiple sclerosis. J. Neurol. 253: vi31-vi36 (2006). *
Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am. J. Gastroenterol. 101: 572-580 (2006). *
Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch. Dermatol. 142: 371-376 (2006). *
Ackert-Bicknell C, Rosen C. The genetics of PPARG and the skeleton. PPAR Res. 2006: 93258 (2006). *
Adachi M, Inoko A, Hata M, Furuse K, Umeda K, Itoh M, Tsukita S. Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein. Mol. Cell. Biol. 26: 9003-9015 (2006). *
Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ. PPARgamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55: 1104-1113 (2006). *
Adachi T, Matsushita T, Ichihashi R, Hirashima K, Ito M, Inukai A, Yokozawa T, Nishida T, Murata M, Hayashi M, Katsumi A, Kojima T, Saito H, Naoe T. High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation. Int. J. Hematol. 83: 415-419 (2006).
Adachi T, Toishi T, Takashima E, Hara H. Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol. Pharm. Bull. 29: 2095-2098 (2006). *
Adak M, Gupta JK. Evaluation of anti-inflammatory activity of Calotropis gigantea (AKANDA) in various biological system. Nepal. Med. Coll. J. 8: 156-161 (2006).
Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Z. Gastroenterol. 44: 267-269 (2006).
Adam R, Sturrock RD, Gracie JA. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann. Rheum. Dis. 65: 1099-1101 (2006). *
Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver. Annals of Gastroenterology 19: 146-151 (2006). *
Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat. Rev. Immunol. 6: 244-251 (2006). *
Adams DR, Buckel T, Sceppa JA. Infliximab associated new-onset psoriasis. J. Drugs Dermatol. 5: 178-179 (2006).
Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 54: 980-985 (2006).
Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine 31: 2151-2161 (2006). *
Adamsen S, Olsen M, Jendresen MB, Holck S, Glenthoj A. Endobiliary brush biopsy: intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand. J. Gastroenterol. 41: 597-603 (2006). *
Adamson AW, Dreesen TD, Tekle M, Tang C, Cho HP, Clarke SD, Gettys TW. A newly discovered member of the fatty acid desaturase gene family: a non-coding, antisense RNA gene to Delta5-desaturase. Prostaglandins Leukot. Essent. Fatty Acids 75: 97-106 (2006). *
Adarichev VA, Glant TT. Experimental spondyloarthropathies: animal models of ankylosing spondylitis. Curr. Rheumatol. Rep. 8: 267-274 (2006).
Adarichev VA, Vermes C, Hanyecz A, Ludanyi K, Tunyogi-Csapo M, Finnegan A, Mikecz K, Glant TT. Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis. Autoimmunity 39: 663-673 (2006).
Adegbola O, Yang H, Zhuang H. Hepatobiliary scintigraphy monitoring patency of partial external biliary diversion in a patient with progressive familial intrahepatic cholestasis. Clin. Nucl. Med. 31: 622-623 (2006).
Ader F, Chatellier D, Le Berre R, Morand P, Fourrier F. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject. Med. Mal. Infect. 36: 396-398 (2006).
Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients. Crit. Care Med. 34: 2377-2385 (2006).
Adida A, Spener F. Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell. Biochim. Biophys. Acta 1761: 172-181 (2006). *
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49: 755-765 (2006). *
Adighibe O, Arepalli S, Duckworth J, Hardy J, Wavrant-De Vrieze F. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol. Aging 27: 1431-1434 (2006).
Adisen E, Gulekon A, Erdem O, Dursun A, Gurer M. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. J. Eur. Acad. Dermatol. Venereol. 20: 527-533 (2006). *
Adorini L, Daniel KC, Penna G. Vitamin D receptor agonists, cancer and the immune system: an intricate relationship. Curr. Top. Med. Chem. 6: 1297-1301 (2006).
Adriaansen J, Kuhlman RR, Holten JV, Kaynor C, Vervoordeldonk MJ, Tak PP. Intraarticular interferon-beta gene therapy ameliorates adjuvant arthritis in rats. Hum. Gene Ther. 17: 985-996 (2006).
Adriaansen J, Vervoordeldonk MJ, Tak PP. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology (Oxford) 45: 656-668 (2006). *
Adrych KJ, Marek IE, Kryszewski AJ. Adults celiac disease - the tip of the iceberg. Wiad. Lek. 59: 359-363 (2006).
Adsay NV. Role of MUC genes and mucins in pancreatic neoplasia. Am. J. Gastroenterol. 101: 2330-2332 (2006). *
Aeberli D, Leech M, Morand EF. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology (Oxford) 45: 937-943 (2006). *
Affolter VK, Moore PF. Feline progressive histiocytosis. Vet. Pathol. 43: 646-655 (2006). *
Afman L, Muller M. Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet. Assoc. 106: 569-576 (2006).
Aftab MN, Dee A, Helm TN. Erythema elevatum diutinum arising in the setting of dermatitis herpetiformis. Cutis 78: 129-132 (2006).
AGA Clinical Practice and Economics Committee. Position of the American Gastroenterological Association (AGA) Institute on computed tomographic colonography. Gastroenterology 131: 1627-1628 (2006). *
Agaba AE, Berry N, Agaba PO, Charaklias N, Wong LS. One stop rectal bleeding clinic: the Coventry experience. Int. Surg. 91: 288-290 (2006).
Agace WW. Tissue-tropic effector T cells: generation and targeting opportunities. Nat. Rev. Immunol. 6: 682-692 (2006). *
Agapov M. Balantidiasis in a patient with suspected Crohn's disease. Endoscopy 38: 655 (2006). *
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Clin. Exp. Immunol. 144: 67-75 (2006). *
Agarwal N, Sharma BC, Sarin SK. Endoscopic management of acute cholangitis in elderly patients. World J. Gastroenterol. 12: 6551-6555 (2006). *
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res. 26: 4457-4498 (2006).
Agarwal SK, Brenner MB. Role of adhesion molecules in synovial inflammation. Curr. Opin. Rheumatol. 18: 268-276 (2006).
Agerberth B, Gudmundsson GH. Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306: 67-90 (2006).
Aggarwal BB, Sethi G, Nair A, Ichikawa H. Nuclear factor-kB: a holy grail in cancer prevention and therapy. Current Signal Transduction Therapy 1: 25-52 (2006). *
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72: 1605-1621 (2006). *
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H. TNF blockade: an inflammatory issue. Ernst Schering Res. Found. Workshop 56: 161-186 (2006).
Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J. Rheumatol. 33: 1642-1645 (2006).
Aggarwal S, Kim SW, Cheon K, Tabassam FH, Yoon JH, Koo JS. Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol. Biol. Cell. 17: 566-575 (2006). *
Aggelidou E, Iordanidou P, Demetriades C, Piltsi O, Hadzopoulou-Cladaras M. Functional characterization of hepatocyte nuclear factor-4alpha dimerization interface mutants. FEBS J. 273: 1948-1958 (2006). *
Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, Kaki S, Sutsko R, Saslow JG, Stahl GE. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J. Perinatol. 26: 550-555 (2006).
Agirbasli M, Inanc N, Baykan OA, Direskeneli H. The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders. Clin. Exp. Rheumatol. 24: 580-583 (2006).
Agoston ES, Hatcher MA, Kensler TW, Posner GH. Vitamin D analogs as anti-carcinogenic agents. Anticancer Agents Med. Chem. 6: 53-71 (2006).
Agoumi S, Himdi B, Abidi K, Zeggwagh A, Abouqal R. Acute pancreatitis revealing a systemic lupus erythematous. Rev. Med. Interne. 27: 799-802 (2006).
Agrawal AA, Kapley A, Yeltiwar RK, Purohit HJ. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity. J. Periodontol. 77: 1515-1521 (2006).
Agrawal N, Chiang LK, Rifkin IR. Lupus nephritis. Semin. Nephrol. 26: 95-104 (2006).
Aguilera-Montilla N, Perez-Blas M, Paola Valeri A, Lopez-Santalla M, Rodriguez-Juan C, Mencia A, Castellano G, Luisa Manzano M, Casis B, Sanchez F, Manuel Martin-Villa J. Herpesvirus saimiri (HVS)-transformed T-cell lines: a method to study mucosal T cells in inflammatory bowel disease. Scand. J. Gastroenterol. 41: 1361-1363 (2006). *
Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 211: 75-84 (2006).
Aguirre S, Silber AM, Brito ME, Ribone ME, Lagier CM, Marcipar IS. Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. J. Clin. Microbiol. 44: 3768-3774 (2006). *
Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 318: 68-78 (2006). *
Ahdoot A, Kotler DP, Suh JS, Kutler C, Flamholz R. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York city. J. Clin. Gastroenterol. 40: 385-390 (2006).
Ahima RS. Obesity epidemic in need of answers. Gastroenterology 131: 991 (2006). *
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R. Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations. Anticancer Res. 26: 783-789 (2006).
Ahluwalia M, Gotlieb V, Damerla V, Saif MW. Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease. Yale J. Biol. Med. 79: 173-175 (2006). *
Ahmad A, Frank BB. Introduction: women's issues in gastroenterology and hepatology. Am. J. Gastroenterol. 101 Suppl. 3: S601 (2006). *
Ahmad K, Rogers S. Three years' experience with infliximab in recalcitrant psoriasis. Clin. Exp. Dermatol. 31: 630-633 (2006). *
Ahmad S, Tester RF, Corbett A, Karkalas J. Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis. Carbohydr. Res. 341: 2694-2701 (2006). *
Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J. Gastroenterol. 12: 3628-3635 (2006). *
Ahmed FE. Gene-gene, gene-environment and multiple interactions in colorectal cancer. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101 (2006). *
Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev. Mol. Diagn. 6: 345-363 (2006).
Ahmed I, Boulter MK, Lobo DN. The SLAPPA (significance of lower abdominal/periumbilical piercing as a predictor of acute appendicitis) audit. Sex Health 3: 195-196 (2006).
Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J. Am. Acad. Dermatol. 54: 55-60 (2006).
Ahmed M, Davies IH, Hood K, Jenkins HR. Incidence of paediatric inflammatory bowel disease in South Wales. Arch. Dis. Child. 91: 344-345 (2006).
Ahmed MH. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers. Scand. J. Gastroenterol. 41: 372 (2006). *
Ahmed MM, Berney SM, Wolf RE, Hearth-Holmes M, Hayat S, Mubashir E, Vanderheyde H, Chang WL, King JW. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am. J. Med. Sci. 331: 252-256 (2006).
Ahmed MM, Mubashir E, Wolf RE, Hayat S, Hall V, Shi R, Berney SM. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis. South. Med. J. 99: 1209-1215 (2006).
Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha. A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ. Res. 98: 490-498 (2006). *
Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA. PPARalpha gene variation and physical performance in Russian athletes. Eur. J. Appl. Physiol. 97: 103-108 (2006).
Ahn HS, Lee SK, Kim HJ, Jang JY, Joo KR, Dong SH, Kim BH, Lee JI, Chang YW, Chang R. Risk of postoperative infection in patients with inflammatory bowel disease. Korean J. Gastroenterol. 48: 306-312 (2006).
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27: 1876-1882 (2006). *
Ahn JH, Shin MS, Jung SH, Kang SK, Kim KR, Rhee SD, Jung WH, Yang SD, Kim SJ, Woo JR, Lee JH, Cheon HG, Kim SS. Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. J. Med. Chem. 49: 4781-4784 (2006). *
Ahn LB, Schroy PC 3rd. Statins and colorectal cancer risk: a new panacea? Gastroenterology 130: 278-280 (2006). *
Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J. Med. Virol. 78: 1564-1571 (2006). *
Ahn T, Houki N, Ohkura Y, Masui K, Fukui H, Shimada K, Yamasaki H, Nakamura-Uchiyama F, Yoshikawa M. Serologically diagnosed toxocariasis with hemophagocytic syndrome in a patient with primary biliary cirrhosis. Intern. Med. 45: 31-32 (2006). *
Aho TL, Sandholm J, Peltola KJ, Ito Y, Koskinen PJ. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell Biol. 7: 21 (2006). *
Ahuja J, Kampani K, Datta S, Wigdahl B, Flaig KE, Jain P. Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells. J. Neurovirol. 12: 47-59 (2006).
Ahuja V, Dieckgraefe B, Anant S. Molecular biology of the small intestine. Curr. Opin. Gastroenterol. 22: 90-94 (2006).
Ahya SN, Jose Soler M, Levitsky J, Batlle D. Acid-base and potassium disorders in liver disease. Semin. Nephrol. 26: 466-470 (2006).
Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect. Immun. 74: 4708-4714 (2006). *
Aida Y, Maeno M, Suzuki N, Namba A, Motohashi M, Matsumoto M, Makimura M, Matsumura H. The effect of IL-1beta on the expression of inflammatory cytokines and their receptors in human chondrocytes. Life Sci. 79: 764-771 (2006). *
Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology 147: 4463-4475 (2006). *
Aihara K, Azuma H, Matsumoto T. Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin. Calcium 16: 1173-1179 (2006).
Aimbire F, Albertini R, Pacheco MT, Castro-Faria-Neto HC, Leonardo PS, Iversen VV, Lopes-Martins RA, Bjordal JM. Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation. Photomed. Laser Surg. 24: 33-37 (2006).
Ainsworth DM, Wagner B, Franchini M, Grunig G, Erb HN, Tan JY. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am. J. Vet. Res. 67: 669-677 (2006).
Airaghi L, Tedeschi A. Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level. Acta Diabetol. 43: 43-45 (2006). *
Airas L, Mikkola J, Vainio JM, Elovaara I, Smith DJ. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J. Neuroimmunol. 177: 132-135 (2006).
Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Yoshizumi T, Taketomi A, Maehara Y, Tsuneyoshi M. Characteristic differences according to the cirrhotic pattern of advanced primary biliary cirrhosis: macronodular cirrhosis indicates slow progression. Hepatol. Res. 36: 188-194 (2006).
Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. Lactobacillus farciminis treatment suppresses stress-induced visceral hypersensitivity: a possible action through interaction with epithelial cells cytoskeleton contraction. Gut 55: 1090-1094 (2006). *
Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12: 178-180 (2006). *
Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu. Rev. Pharmacol. Toxicol. 46: 123-149 (2006). *
Aitken RJ, Wingate JK, DE Iuliis GN, Koppers AJ, McLaughlin EA. Cis-unsaturated fatty acids stimulate reactive oxygen species generation and lipid peroxidation in human spermatozoa. J. Clin. Endocrinol. Metab. 91: 4154-4163 (2006). *
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855 (2006). *
Ajaj W, Goyen M, Langhorst J, Ruehm SG, Gerken G, Lauenstein TC. MR colonography for the assessment of colonic anastomoses. J. Magn. Reson. Imaging 24: 101-107 (2006).
Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, Nakano M, Gejyo F. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 16: 294-299 (2006). *
Ajith C, Gupta S, Kanwar AJ. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome. J. Drugs Dermatol. 5: 262-266 (2006).
Ajuebor MN, Carey JA, Swain MG. CCR5 in T cell-mediated liver diseases: what's going on? J. Immunol. 177: 2039-2045 (2006). *
Akabas SR, Deckelbaum RJ. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am. J. Clin. Nutr. 83: 1536S-1538S (2006). *
Akagawa M, Ito S, Toyoda K, Ishii Y, Tatsuda E, Shibata T, Yamaguchi S, Kawai Y, Ishino K, Kishi Y, Adachi T, Tsubata T, Takasaki Y, Hattori N, Matsuda T, Uchida K. Bispecific Abs against modified protein and DNA with oxidized lipids. Proc. Natl. Acad. Sci. U.S.A. 103: 6160-6165 (2006). *
Akahoshi M, Nakashima H, Shirakawa T. Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus. Semin. Immunol. 18: 224-229 (2006). *
Akaogi J, Barker T, Kuroda Y, Nacionales DC, Yamasaki Y, Stevens BR, Reeves WH, Satoh M. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun. Rev. 5: 429-435 (2006).
Akaogi J, Nozaki T, Satoh M, Yamada H. Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr. Metab. Immune Disord. Drug Targets 6: 383-394 (2006).
Akar N, Hasipek M, Ozturk A, Akar E, Tekin M. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J. Nephrol. 19: 318-321 (2006).
Akar N, Ozturk A, Ozel D, Akar E, Ekim M. Is MEFV P706 polymorphism important in familial Mediterranean fever patients? J. Nephrol. 19: 119-120 (2006).
Akare S, Jean-Louis S, Chen W, Wood DJ, Powell AA, Martinez JD. Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence. Int. J. Cancer 119: 2958-2969 (2006). *
Akashi M, Tanaka A, Takikawa H. Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats. Hepatol. Res. 34: 193-198 (2006).
Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders. J. Infect. Chemother. 12: 233-240 (2006). *
Akay N, Boyvat A, Heper AO, Soykan I, Arica IE, Bektas M, Ensari A, Cokca F. Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease. Clin. Exp. Dermatol. 31: 384-386 (2006). *
Akaza T, El-Awar N, Nguyen A, Kitawaki J, Terasaki P. HLA class I epitopes: C-locus. Clin. Transpl. 2006: 95-102 (2006).
Akbari O. The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human. Allergy 61: 962-968 (2006). *
Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129 (2006). *
Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. Transplant. Proc. 38: 1290-1292 (2006). *
Akcakaya A, Sahin M, Coskun A, Demiray S. Comparison of mechanical bowel obstruction cases of intra-abdominal tumor and non-tumoral origin. World J. Surg. 30: 1295-1299 (2006). *
Akcam M, Yildiz M, Yilmaz A, Artan R. Bone mineral density in response to two different regimes in rickets. Indian Pediatr. 43: 423-427 (2006). *
Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A. The effect of total plasma exchange on fulminant hepatic failure. J. Clin. Apher. 21: 96-99 (2006).
Akerman L, Mimouni D, Trattner A, David M. Pemphigus vulgaris - an alternative for steroid treatment? Harefuah. 145: 493-494, 551 (2006).
Akg�l B, C�rten M, Haigis H, Rogosz I, Pfister H. Interferon regulatory factor 5.2 acts as a transcription repressor of epidermodysplasia verruciformis-associated human papillomaviruses. Arch. Virol. 151: 2461-2473 (2006). *
Akgul S, Erbil Y, Giris M, Alis H, Yanik BT, Olgac V, Toker GA. The effect of octreotide on pancreatic damage in TNBS-induced colitis. Surg. Innov. 13: 102-108 (2006).
Akiba Y, Ghayouri S, Takeuchi T, Mizumori M, Guth PH, Engel E, Swenson ER, Kaunitz JD. Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO(2) in rat duodenum. Gastroenterology 131: 142-152 (2006). *
Akinbami FO, Venugopalan P, Elnour IB, Nirmala V, Abiodun P, Azubuike JC. Pattern of chronic diarrhoea in children: a prospective analysis of causes, clinical features and outcome. Niger Postgrad. Med. J. 13: 53-56 (2006).
Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 311: 1-16 (2006).
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124: 783-801 (2006). *
Akiyama M. Pathomechanisms of harlequin ichthyosis and ABCA transporters in human diseases. Arch. Dermatol. 142: 914-918 (2006). *
Akiyama M, Sakai K, Sugiyama-Nakagiri Y, Yamanaka Y, McMillan JR, Sawamura D, Niizeki H, Miyagawa S, Shimizu H. Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity. J. Invest. Dermatol. 126: 1518-1523 (2006). *
Akkad DA, Godde R, Epplen JT. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J. Neurol. 253: 1365-1366 (2006). *
Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int. J. Immunogenet. 33: 59-61 (2006). *
Akkari R, Burbiel JC, Hockemeyer J, Muller CE. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Curr. Top. Med. Chem. 6: 1375-1399 (2006).
Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy. Best Pract. Res. Clin. Rheumatol. 20: 539-557 (2006).
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br. J. Dermatol. 155: 350-356 (2006). *
Akman SA, Arikan C, Sozen G, Ozturk C, Yagci RV. Infliximab treatment of pediatric refractory Crohn's disease: a case report. Turk. J. Gastroenterol. 17: 133-136 (2006). *
Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge AE, Gurvit H, Saruhan-Direskeneli G, Yazici H, Eraksoy M. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J. Neurol. 253: 928-934 (2006). *
Akobeng AK. Infliximab for induction and maintenance theraphy for ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 42: 589-590 (2006). *
Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast-feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch. Dis. Child. 91: 39-43 (2006).
Akomolafe A, Lunetta K, Erlich P, Cupples L, Baldwin C, Huyck M, Green R, Farrer L; MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin. Genet. 70: 49-56 (2006). *
Akritidis N, Papadopoulos A, Pappas G. Long-term follow-up of patients with adult-onset Still's disease. Scand. J. Rheumatol. 35: 395-397 (2006). *
Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 12: 293-298 (2006).
Aksoy Y, Aksoy H, Altinkaynak K, Aydin HR, Ozkan A. Sperm fatty acid composition in subfertile men. Prostaglandins Leukot. Essent. Fatty Acids 75: 75-79 (2006). *
Aktas O, Prozorovski T, Zipp F. Death ligands and autoimmune demyelination. Neuroscientist 12: 305-316 (2006). *
Al Hamoudi W, Lee SS. Cirrhotic cardiomyopathy. Ann. Hepatol. 5: 132-139 (2006). *
Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and Paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. Hum. Pathol. 37: 373-376 (2006).
Al Maini M, Carette S. Diagnosis of Wegener's granulomatosis in the ANCA era. J. Rheumatol. 33: 1923-1925 (2006).
Al Saieg N, Luzar MJ. Etanercept induced multiple sclerosis and transverse myelitis. J. Rheumatol. 33: 1202-1204 (2006).
Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells. Cytokine 36: 1-8 (2006).
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J. Hepatol. 45: 575-583 (2006). *
Al-Dosari MS, Knapp JE, Liu D. Activation of human CYP2C9 promoter and regulation by CAR and PXR in mouse liver. Mol. Pharm. 3: 322-328 (2006). *
Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. Singapore Med. J. 47: 147-151 (2006). *
Al-Hwiesh AK. Pyoderma gangrenosum in a renal transplant recipient: a case report. Saudi J. Kidney Dis. Transpl. 17: 559-563 (2006).
Al-Khalili L, Bouzakri K, Glund S, Lonnqvist F, Koistinen HA, Krook A. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol. Endocrinol. 20: 3364-3375 (2006). *
Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C. Expression of the interferon-induced Mx proteins in biliary atresia. J. Pediatr. Surg. 41: 1139-1143 (2006).
Al-Mayouf SM, Al-Sonbul A, Al Jumaah S, Al-Hemidan A. Sarcoidosis: a delayed or missed diagnosis in children. Ann. Saudi Med. 26: 220-223 (2006).
Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Al-Yahyaee SA, Grant CS. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9: 284-290 (2006). *
Al-Moundhri MS, Al-Thahli K, Al-Kindy S, Salam J, Rao L. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis. Saudi Med. J. 27: 1585-1587 (2006).
Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ. Dietary genistein stimulates anion secretion across female murine intestine. J. Nutr. 136: 2785-2790 (2006). *
Al-Saleh J, el-Eissawy S. The role of T helper cell subsets in pathogenesis of systemic lupus erythematosus and their relation to disease activity. Egypt. J. Immunol. 13: 41-48 (2006).
Al-Shukaili AK, Al-Jabri AA. Rheumatoid arthritis, cytokines and hypoxia. What is the link? Saudi Med. J. 27: 1642-1649 (2006).
Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients. Rheumatol. Int. 26: 1019-1024 (2006). *
Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin. Gastroenterol. Hepatol. 4: 315-319 (2006).
Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin. Gastroenterol. Hepatol. 4: 1322-1327 (2006).
Al-Wahadneh AM, Dahabreh MM. Familial mediterranean fever in children: a single centre experience in Jordan. East. Mediterr. Health J. 12: 818-823 (2006).
Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JO, Bach N. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology 43: 525-531 (2006). *
Ala-Laurila P, Kolesnikov AV, Crouch RK, Tsina E, Shukolyukov SA, Govardovskii VI, Koutalos Y, Wiggert B, Estevez ME, Cornwall MC. Visual cycle: dependence of retinol production and removal on photoproduct decay and cell morphology. J. Gen. Physiol. 128: 153-169 (2006). *
Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin. Immunol. 120: 310-318 (2006). *
Alaedini A, Latov N. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside. J. Neuroimmunol. 177: 167-172 (2006).
Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity. Autoimmun. Rev. 5: 167-179 (2006).
Alaibac M, Berti E, Chizzolini C, Fineschi S, Marzano AV, Pigozzi B, Riboldi E, Sozzani S, Kuhn A. Role of cellular immunity in the pathogenesis of autoimmune skin diseases. Clin. Exp. Rheumatol. 24: S14-S19 (2006).
Alam S, Khanna R, Sherwani R, Siraj I. Celiac disease: anti-endomysial antibody versus villous atrophy. Indian J. Gastroenterol. 25: 317-318 (2006). *
Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 45: 187-191 (2006). *
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin. Arthritis Rheum. 36: 182-188 (2006). *
Alamo JM, Gomez MA, Pareja F, Martinez A, Lopez F, Romero E, Barrera L, Serrano J, Garcia I, Bernardos A. Morbidity and mortality in liver retransplantation. Transplant. Proc. 38: 2475-2477 (2006). *
Alamoudi OS. Sleep-disordered breathing in patients with acquired retrognathia secondary to rheumatoid arthritis. Med. Sci. Monit. 12: CR530-CR534 (2006). *
Alarcon GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman J, Fernandez M, Fessler BJ, Vila L, Ahn C, Tan FK, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann. Rheum. Dis. 65: 1168-1174 (2006). *
Alarcon-Riquelme ME. Nucleic acid by-products and chronic inflammation. Nat. Genet. 38: 866-867 (2006). *
Alarcon-Riquelme ME. The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility. Springer Semin. Immunopathol. 28: 109-117 (2006). *
Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55: 2098-2105 (2006). *
Alavi A, Axford JS. The pivotal nature of sugars in normal physiology and disease. Wien. Med. Wochenschr. 156: 19-33 (2006).
Alazmi W, Bustamante M, O'loughlin C, Gonzalez J, Raskin JB. The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. Dig. Dis. Sci. 51: 732-736 (2006). *
Alazmi WM, Fogel EL, Schmidt S, Watkins JL, McHenry L, Sherman S, Lehman GA. ERCP findings in idiopathic pancreatitis: patients who are cystic fibrosis gene positive and negative. Gastrointest. Endosc. 63: 234-239 (2006).
Alazmi WM, Fogel EL, Watkins JL, McHenry L, Tector JA, Fridell J, Mosler P, Sherman S, Lehman GA. Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation. Endoscopy 38: 571-574 (2006).
Alazmi WM, McHenry L, Watkins JL, Fogel EL, Schmidt S, Sherman S, Lehman GL. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J. Clin. Gastroenterol. 40: 353-357 (2006).
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev. Med. Chil. 134: 372-379 (2006).
Alber G, Al-Robaiy S, Kleinschek M, Knauer J, Krumbholz P, Richter J, Schoeneberger S, Schuetze N, Schulz S, Toepfer K, Voigtlaender R, Lehmann J, Mueller U. Induction of immunity and inflammation by interleukin-12 family members. Ernst Schering Res. Found. Workshop 56: 107-127 (2006).
Albers M, Blume B, Schlueter T, Wright MB, Kober I, Kremoser C, Deuschle U, Koegl M. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J. Biol. Chem. 281: 4920-4930 (2006). *
Albert KM. Open access: implications for scholarly publishing and medical libraries. J. Med. Libr. Assoc. 94: 253-262 (2006). *
Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, Loundon N, Sergent-Allaoui A, Houang M, Joannard A, Schmerber S, Delobel B, Leman J, Journel H, Catros H, Dollfus H, Eliot MM, David A, Calais C, Drouin-Garraud V, Obstoy MF, Tran Ba Huy P, et al. SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur. J. Hum. Genet. 14: 773-779 (2006). *
Albillos A, Munoz L, Nieto M, Ubeda M, de-la-Hera A, Alvarez-Mon M. Systemic effects of TNF-alpha secreted by circulating monocytes and fatigue in cirrhosis. Hepatology 43: 1399 (2006). *
Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Skin involvement and outcome measures in systemic autoimmune diseases. Clin. Exp. Rheumatol. 24: S52-S59 (2006).
Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44: 788-794 (2006). *
Alcaro MC, Papini AM. Contribution of peptides to multiple sclerosis research. Biopolymers 84: 349-367 (2006). *
Aldamiz-Echevarria L, Sanjurjo P, Elorz J, Prieto JA, Perez C, Andrade F, Rodriguez-Soriano J. Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia. J. Inherit. Metab. Dis. 29: 58-63 (2006). *
Alden KJ, Marosy B, Nzegwu N, Justice CM, Wilson AF, Miller NH. Idiopathic scoliosis: identification of candidate regions on chromosome 19p13. Spine 31: 1815-1819 (2006).
Alderson MR, McGowan P, Baldridge JR, Probst P. TLR4 agonists as immunomodulatory agents. J. Endotoxin Res. 12: 313-319 (2006). *
Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Acta Haematol. 115: 68-73 (2006).
Alegre ML, Fallarino F. Mechanisms of CTLA-4-Ig in tolerance induction. Curr. Pharm. Des. 12: 149-160 (2006).
Aleksunes LM, Goedken M, Manautou JE. Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World J. Gastroenterol. 12: 1937-1940 (2006). *
Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis. Cell Stress Chaperones 11: 356-363 (2006).
Alenghat T, Yu J, Lazar MA. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor. EMBO J. 25: 3966-3974 (2006). *
Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv. Clin. Chem. 42: 297-326 (2006).
Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti ED, Valesini G. Anti-phospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res. Ther. 8: R180 (2006). *
Alestas T, Ganceviciene R, Fimmel S, Muller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B(4) and prostaglandin E(2) are active in sebaceous glands. J. Mol. Med. 84: 75-87 (2006). *
Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum. Dis. Clin. North Am. 32: 9-44 (2006).
Aletaha D, Smolen JS. Remission of rheumatoid arthritis: should we care about definitions? Clin. Exp. Rheumatol. 24: S045-S051 (2006). *
Alexander D, Friedrich B, Abruzzese T, Gondolph-Zink B, Wulker N, Aicher WK. The active form of leflunomide, HMR1726, facilitates TNF-alpha and IL-17 induced MMP-1 and MMP-3 expression. Cell. Physiol. Biochem. 17: 69-78 (2006). *
Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G. Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur. J. Immunol. 36: 2768-2780 (2006). *
Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Perez-Gracia J, Bendandi M, Prieto J, Lasarte J, Melero I. The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases. An. Sist. Sanit. Navar. 29: 77-96 (2006).
Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7: 813-818 (2006).
Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet. Genomics 16: 287-296 (2006).
Alhan E, Turkyilmaz S, Ercin C, Kaklikkaya N, Kural BV. Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats. Eur. Surg. Res. 38: 314-321 (2006).
Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study. J. Pak. Med. Assoc. 56: 452-456 (2006).
Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. FASEB J. 20: 326-328 (2006). *
Ali S, Roberts PR. Nutrients with immune-modulating effects: what role should they play in the intensive care unit? Curr. Opin. Anaesthesiol. 19: 132-139 (2006).
Ali-Khan SE, Hales BF. Retinoid receptor antagonists alter the pattern of apoptosis in organogenesis stage mouse limbs. Toxicol. Sci. 90: 208-220 (2006). *
Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran. J. Allergy Asthma Immunol. 5: 3-8 (2006).
Aliev SA, Aliev ES. Complications of the terminal colostomy and their treatment. Vestn. Khir. Im. I I Grek. 165: 71-75 (2006).
Alifirova VM, Orlova IuIu, Babenko SA, Rudko AA, Puzyrev VP. The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2006 Spec. No 3: 130-135 (2006).
Alique M, Lucio FJ, Herrero JF. Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration. Br. J. Pharmacol. 149: 65-72 (2006). *
Alique M, Lucio-Cazana FJ, Moreno V, Xu Q, Konta T, Nakayama K, Furusu A, Sepulveda JC, Kitamura M. Upregulation of cyclooxygenases by retinoic acid in rat mesangial cells. Pharmacology 79: 57-64 (2006).
Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ, Fliers E. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. Eur. J. Endocrinol. 154: 491-500 (2006). *
Alkofer B, Samstein B, Guarrera JV, Kin C, Jan D, Bellemare S, Kinkhabwala M, Brown R Jr, Emond JC, Renz JF. Extended-donor criteria liver allografts. Semin. Liver Dis. 26: 221-233 (2006).
Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL. Autoimmune hepatitis triggered by statins. J. Clin. Gastroenterol. 40: 757-776 (2006)..
Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 177: 5186-5194 (2006). *
Allcock R, Dolecki KJ, Boodhoo A, Abdul Khalil A, Wong AM, Price P. Genomic sequence and expression profile of murine Bat1a and Nfkbil1. DNA Seq. 17: 292-299 (2006).
Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit. Care Med. 34: 2658-2665 (2006).
Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity. Diabetes 55: 2523-2533 (2006). *
Allenspach K, Bergman PJ, Sauter S, Grone A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. J. Comp. Pathol. 134: 1-7 (2006). *
Allenspach K, Rufenacht S, Sauter S, Grone A, Steffan J, Strehlau G, Gaschen F. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. J. Vet. Intern. Med. 20: 239-244 (2006).
Allenspach K, Steiner JM, Shah BN, Berghoff N, Ruaux C, Williams DA, Blum JW, Gaschen F. Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic enteropathy. Am. J. Vet. Res. 67: 479-483 (2006).
Allgayer H, Kruis W. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin. Gastroenterol. Hepatol. 4: 521 (2006).
Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J. Autoimmun. 27: 232-241 (2006).
Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, Zuin M, Podda M, Battezzati PM. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 55: 1795-1800 (2006). *
Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes Immun. 7: 401-406 (2006). *
Almeida AR, Zaragoza B, Freitas AA. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J. Immunol. 177: 192-200 (2006). *
Almeida J, Galhenage S, Yu J, Kurtovic J, Riordan SM. Gut flora and bacterial translocation in chronic liver disease. World J. Gastroenterol. 12: 1493-1502 (2006). *
Almroth G, Axelsson T, Mussener E, Grodzinsky E, Midhagen G, Olcen P. Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders. Ups. J. Med. Sci. 111: 339-352 (2006). *
Alnajjar A, Chabane Sari D, Abuharfeil N, Hudaib M, Aburjai T. Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people. Prostaglandins Leukot. Essent. Fatty Acids 74: 347-356 (2006). *
Alnounou M, Munoz SJ. Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100 (2006). *
Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6: 205-217 (2006). *
Alonso A, Bignone ML, Brunzini M, Brunzini R. Ocular autoimmune pemphigoid and cyclosporin A. Allergol. Immunopathol. (Madr.) 34: 113-115 (2006).
Alonso A, Egues Olazabal N, Ayo Martin O. Infection by Epstein-Barr virus and multiple sclerosis. Neurologia 21: 249-255 (2006).
Alonso A, Jick SS, Hernan MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 66: 572-575 (2006).
Alonso A, Jick SS, Jick H, Hernan MA. Antibiotic use and risk of multiple sclerosis. Am. J. Epidemiol. 163: 997-1002 (2006). *
Alonso L AG. Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy. Ann. Hepatol. 5: 184-186 (2006). *
Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Agundez JA. The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases. Med. Clin. (Barc.) 126: 697-706 (2006).
Alonso-Navarro H, Martin R, Arenas JA, Jimenez-Jimenez FJ. Limbic encephalitis associated with primary biliary cirrhosis. Eur. Neurol. 55: 174-176 (2006).
Aloysius MM, Kaye PV, Lobo DN. Non-steroidal anti-inflammatory drug (NSAID)-induced colonic strictures and perforation: a case report. Dig. Liver Dis. 38: 276-278 (2006).
Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J. Autoimmun. 27: 89-95 (2006). *
Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum. Immunol. 67: 73-84 (2006).
Alper SL. Molecular physiology of SLC4 anion exchangers. Exp. Physiol. 91: 153-161 (2006). *
Alper SL, Stewart AK, Chernova MN, Zolotarev AS, Clark JS, Vandorpe DH. Anion exchangers in flux: functional differences between human and mouse SLC26A6 polypeptides. Novartis Found. Symp. 273: 107-119 (2006).
Alpers DH. Glutamine: do the data support the cause for glutamine supplementation in humans? Gastroenterology 130: S106-S116 (2006). *
Alsaeid K, Alawadhi A, Al-Saeed O, Haider MZ. Human leukocyte antigen DRB1*04 is associated with rheumatoid arthritis in Kuwaiti patients. Joint Bone Spine 73: 62-65 (2006). *
Alsaeid K, Haider MZ, Sharma PN, Ayoub EM. The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis. Rheumatol. Int. 26: 224-228 (2006). *
Alsarra IA, Brockmann WG, Cunningham ML, Badr MZ. Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for Kupffer cells? J. Carcinog. 5: 26 (2006). *
Alsasua Del Valle A. Implication of cannabinoids in neurological diseases. Cell. Mol. Neurobiol. 26: 577-589 (2006). *
Alter H. Hepatology highlights. Hepatology 43: 643-645 (2006). *
Alter H. Viral hepatitis. Hepatology 43: S230-S234 (2006). *
Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations. Neurology 66: 1061-1066 (2006).
Althoff CE, Hermann KG, Braun J, Sieper J. Ankylosing spondylitis - current state of imaging including scoring methods. Z. Rheumatol. 65: 688-699 (2006).
Altiparmak F, Akalin A, Ferhatosmanoglu H. Predicting the binding affinity of MHC class II peptides. Comput. Syst. Bioinformatics Conf. 2006: 331-334 (2006). *
Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol. Rev. 212: 330-343 (2006). *
Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, Gonzalez-Amaro R. Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 27: 110-118 (2006).
Alvarez F. Autoimmune hepatitis and primary sclerosing cholangitis. Clin. Liver Dis. 10: 89-107 (2006).
Alvarez-Lafuente R, De Las Heras V, Bartolome M, Garcia-Montojo M, Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol. 16: 20-27 (2006).
Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Bartolome M, Arroyo R. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J. Clin. Virol. 37 Suppl. 1: S24-S26 (2006).
Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am. J. Pathol. 169: 877-888 (2006). *
Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E. Estrogens and the pathophysiology of the biliary tree. World J. Gastroenterol. 12: 3537-3545 (2006). *
Alves A, Penna C. Surgical treatment of ulcerative colitis in a young woman. Ann. Chir. 131: 39-41 (2006).
Alves C, Meyer I, Toralles MB, Marback RL. Association of human histocompatibility antigens with ophthalmological disorders. Arq. Bras. Oftalmol. 69: 273-278 (2006).
Alves C, Vieira N, Toralles MB, Lyra A. Human histocompatibility system association with gastrointestinal diseases. Acta Gastroenterol. Latinoam. 36: 86-93 (2006).
Alves-Filho JC, Cunha FQ. Modulation of Toll-like receptor expression: a further effect of statins? Arterioscler. Thromb. Vasc. Biol. 26: e128 (2006).
Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470 (2006).
Alves-Filho JC, Tavares-Murta BM, Barja-Fidalgo C, Benjamim CF, Basile-Filho A, Arraes SM, Cunha FQ. Neutrophil function in severe sepsis. Endocr. Metab. Immune Disord. Drug Targets 6: 151-158 (2006).
Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian B, Gura KM, Nose V, Zauscher B, Moses MA, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1011-G1019 (2006). *
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55: 1265-1269 (2006). *
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS. Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079 (2006). *
Amagai M. Desmoglein, the target molecule in autoimmunity and infection. Nihon Rinsho Meneki Gakkai Kaishi 29: 325-333 (2006).
Amagai M, Ahmed AR, Kitajima Y, Bystryn JC, Milner Y, Gniadecki R, Hertl M, Pincelli C, Fridkis-Hareli M, Aoyama Y, Frusic-Zlotkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? Exp. Dermatol. 15: 815 (2006). *
Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, Ben-Asher E, Karni O, Mujaheed M, Segman RH, Maier W, Macciardi F, Beckmann JS, Lancet D, Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur. J. Hum. Genet. 14: 1111-1119 (2006). *
Amano K. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy. Intern. Med. 45: 991-992 (2006). *
Amantea G, Cammarano M, Zefferino L, Martin A, Romito G, Piccirillo M, Gentile V. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: celiac disease. Front. Biosci. 11: 249-255 (2006).
Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann. Hepatol. 5: 30-33 (2006). *
Amarapurkar DN, Punamiya S, Patel ND. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India. Ann. Hepatol. 5: 103-108 (2006). *
Amat M, Benjamim CF, Williams LM, Prats N, Terricabras E, Beleta J, Kunkel SL, Godessart N. Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo. Br. J. Pharmacol. 149: 666-575 (2006). *
Amati L, Passeri ME, Resta F, Triggiani V, Jirillo E, Sabba C. Ablation of T-helper 1 cell derived cytokines and of monocyte-derived tumor necrosis factor-alpha in hereditary hemorrhagic telangiectasia: immunological consequences and clinical considerations. Curr. Pharm. Des. 12: 1201-1208 (2006).
Amati L, Passeri ME, Selicato F, Mastronardi ML, Penna A, Jirillo E, Covelli V. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol. Immunotoxicol. 28: 665-681 (2006).
Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr. Pharm. Des. 12: 4247-4254 (2006).
Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, Siracusa G, Masini M, Sorbi S, Trojano M. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J. Neurol. 253: 1054-1059 (2006). *
Amcheslavsky A, Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J. Cell. Physiol. 207: 244-250 (2006). *
Amemori S, Iwakiri R, Endo H, Ootani A, Ogata S, Noda T, Tsunada S, Sakata H, Matsunaga H, Mizuguchi M, Ikeda Y, Fujimoto K. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J. Gastroenterol. 41: 444-449 (2006). *
Amend B, Doster H, Lange C, Dubois E, Kalbacher H, Melms A, Bischof F. Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo. J. Immunol. 177: 4384-4390 (2006). *
American Academy of Family Physicians. Information from your family doctor. Psoriasis: what you should know. Am. Fam. Physician 73: 646 (2006).
American Academy of Family Physicians. Information from your family doctor. Celiac disease: what you should know. Am. Fam. Physician 74: 1921-1922 (2006).
American Gastroenterological Association Institute. American Gastroenterological Association Institute medical position statement on the management of gastric subepithelial masses. Gastroenterology 130: 2215-2216 (2006). *
Amerine E. Celiac disease goes against the grain. Nursing 36: 46-48 (2006).
Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Clin. Exp. Dermatol. 31: 746-749 (2006). *
Amezcua-Guerra LM, Hernandez-Martinez B, Pineda C, Bojalil R. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis. Gut 55: 1059-1060 (2006). *
Amezcua-Guerra LM, Prieto P, Bojalil R, Pineda C, Amigo MC. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association? J. Rheumatol. 33: 2351-2353 (2006).
Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gomez-Garcia L, Vargas A, Bojalil R. Presence of antibodies against cyclic citrullinated peptides (anti-CCP) in patients with rhupus: a cross-sectional study. Arthritis Res. Ther. 8: R144 (2006). *
Amicosante M, Fontenot AP. T cell recognition in chronic beryllium disease. Clin. Immunol. 121: 134-143 (2006). *
Amigo L, Castro J, Miquel JF, Zanlungo S, Young SG, Nervi F. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones. Gastroenterology 131: 1870-1878 (2006). *
Amin EA, Welsh WJ. A preliminary in silico lead series of 2-phthalimidinoglutaric acid analogues designed as MMP-3 inhibitors. J. Chem. Inf. Model. 46: 2104-2109 (2006). *
Amin MR, Malakooti J, Sandoval R, Dudeja PK, Ramaswamy K. IFN-gamma and TNF-alpha regulate the human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line, C2BBe1. Am. J. Physiol. Cell Physiol. 291: C887-C896 (2006). *
Amit-Romach E, Reifen R, Uni Z. Mucosal function in rat jejunum and ileum is altered by induction of colitis. Int. J. Mol. Med. 18: 721-727 (2006). *
Amital H, Gershwin EM, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin. Arthritis Rheum. 35: 341-343 (2006). *
Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin. Vaccine Immunol. 13: 289-296 (2006). *
Ammann R. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med. Wkly. 136: 166-174 (2006). *
Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 72: 1100-1116 (2006).
Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F, Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF, Gregersen PK. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 7: 277-286 (2006). *
Amos JA, Bridge-Cook P, Ponek V, Jarvis MR. A universal array-based multiplexed test for cystic fibrosis carrier screening. Expert Rev. Mol. Diagn. 6: 15-22 (2006).
Amoudruz P, Minang JT, Sundstrom Y, Nilsson C, Lilja G, Troye-Blomberg M, Sverremark-Ekstrom E. Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responses. Immunology 119: 18-26 (2006). *
Amoura Z, Piette JC. New therapeutic approaches to autoimmune diseases. Presse. Med. 35: 709-713 (2006).
Amoura Z, Piette JC. New therapies for autoimmune diseases. Rev. Neurol. (Paris) 162 Spec. No. 1: 7-11 (2006).
Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am. J. Gastroenterol. 101: 1005-1011 (2006). *
Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 101: 645-652 (2006). *
Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Wijmenga C, Sollid LM. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum. Immunol. 67: 341-345 (2006).
Amundsen SS, Vatn M; the IBSEN study group; Wijmenga C, Sollid LM, Lie BA. Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens 68: 249-252 (2006). *
An H, Zhao W, Hou J, Zhang Y, Xie Y, Zheng Y, Xu H, Qian C, Zhou J, Yu Y, Liu S, Feng G, Cao X. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25: 919-928 (2006). *
An MM, Fan KX, Cao YB, Shen H, Zhang JD, Lu L, Gao PH, Jiang YY. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling. Biol. Pharm. Bull. 29: 2025-2030 (2006). *
Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Grigoriadis K, Arvanitidis D. Postinfantile giant-cell hepatitis associated with ulcerative colitis and autoimmune hepatitis. J. Gastroenterol. Hepatol. 21: 1863-1864 (2006). *
Anagnostopoulos GK, Shonde T, Kaye P, Ragunath K. A case of a "fragile" oesophagus. Gut 55: 1495 (2006). *
Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 43: 335-344 (2006). *
Anandarajah AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J. Cell. Biochem. 97: 226-232 (2006). *
Anapolsky A, Teng S, Dixit S, Piquette-Miller M. The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and metabolizing enzymes in mice. Drug Metab. Dispos. 34: 405-409 (2006). *
Anaya JM. Autoimmunity and autoimmune disease: a Colombian construction beyond deconstructions. Autoimmun. Rev. 5: 165-166 (2006).
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J. Autoimmun. 26: 208-214 (2006).
Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjogren's syndrome. How strong is the evidence? Clin. Dev. Immunol. 13: 209-222 (2006). *
Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin. Dev. Immunol. 13: 185-195 (2006). *
Anaya JM, Tobon GJ, Vega P, Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J. Rheumatol. 33: 2227-2234 (2006).
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 49: 75-82 (2006). *
Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 29: 2660-2663 (2006). *
Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: role of Toll-like receptor 3 and Toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol. Reprod. 74: 824-831 (2006). *
Andersen K, Vogt C, Blondin D, Beck A, Heinen W, Aurich V, Haussinger D, Modder U, Cohnen M. Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy. Eur. J. Radiol. 58: 140-146 (2006).
Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells. J. Invest. Dermatol. 126: 32-41 (2006). *
Andersen S, Okkels H, Krarup H, Laurberg P. Geographical clustering and maintained health in individuals harbouring the mutation for Greenland familial cholestasis: a population-based study. Scand. J. Gastroenterol. 41: 445-450 (2006). *
Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr. Opin. Immunol. 18: 665-669 (2006).
Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S. Perspective - FcRn transports albumin: relevance to immunology and medicine. Trends Immunol. 27: 343-348 (2006). *
Anderson EJ, McGrath MA, Thalhamer T, McInnes IB. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin. Immunopathol. 27: 425-442 (2006). *
Anderson JE, Hansen LL, Mooren FC, Post M, Hug H, Zuse A, Los M. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine. Drug Resist. Updat. 9: 198-210 (2006).
Anderson K, Fitzgerald M, Dupont M, Wang T, Paz N, Dorsch M, Healy A, Xu Y, Ocain T, Schopf L, Jaffee B, Picarella D. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity 39: 469-478 (2006).
Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav. Brain Res. 166: 32-38 (2006). *
Anderson KM, Czinn SJ, Redline RW, Blanchard TG. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J. Immunol. 176: 5306-5313 (2006). *
Anderson MK. At the crossroads: diverse roles of early thymocyte transcriptional regulators. Immunol. Rev. 209: 191-211 (2006).
Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett. 580: 5533-5540 (2006). *
Anderson RP, van Heel DA, Tye-Din JA, Jewell DP, Hill AV. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut 55: 485-491 (2006). *
Andersson M, Svenungsson E, Khademi M, Lampa J, Brundin L, Wallstrom E. No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab. Ann. Rheum. Dis. 65: 1237-1240 (2006). *
Andersson ML, Petersson IF, Karlsson K, Jonsson NE, Mansson B, Heinegard D, Saxne T. Diurnal variation in serum levels of cartilage oligomeric matrix protein (COMP) in individuals with knee osteoarthritis or rheumatoid arthritis. Ann. Rheum. Dis. 65: 1490-1494 (2006). *
Andersson P, Varenhorst E, Soderkvist P. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Eur. J. Cancer 42: 2833-2837 (2006). *
Anderton SM. Avoiding autoimmune disease - T cells know their limits. Trends Immunol. 27: 208-214 (2006). *
Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55: 158-164 (2006). *
Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol. Rep. 16: 103-107 (2006). *
Andoh A, Endo Y, Kushima R, Hata K, Tsujikawa T, Sasaki M, Mekata E, Tani T, Fujiyama Y. A case of Crohn's disease involving the gallbladder. World J. Gastroenterol. 12: 977-978 (2006). *
Andoh A, Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J. Gastroenterol. 12: 4452-4460 (2006). *
Andoh A, Yoshida T, Yagi Y, Bamba S, Hata K, Tsujikawa T, Kitoh K, Sasaki M, Fujiyama Y. Increased aggregation response of platelets in patients with inflammatory bowel disease. J. Gastroenterol. 41: 47-54 (2006). *
Andrade MC, Menezes JS, Cassali GD, Martins-Filho OA, Cara DC, Faria AM. Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin. Exp. Immunol. 146: 312-322 (2006). *
Andrade RJ, Lucena MI, Kaplowitz N, Garcia-Munoz B, Borraz Y, Pachkoria K, Garcia-Cortes M, Fernandez MC, Pelaez G, Rodrigo L, Duran JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Munoz-Yague T, Salmeron J, Hidalgo R. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 44: 1581-1588 (2006). *
Andrassy M, Igwe J, Autschbach F, Volz C, Remppis A, Neurath MF, Schleicher E, Humpert PM, Wendt T, Liliensiek B, Morcos M, Schiekofer S, Thiele K, Chen J, Kientsch-Engel R, Schmidt AM, Stremmel W, Stern DM, Katus HA, Nawroth PP, Bierhaus A. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am. J. Pathol. 169: 1223-1237 (2006). *
Andreani SM, Dang HH, Edwards DP, Baig MK, Khan M, Payne JG. Ovarian Crohn's disease: contiguous or metastatic? Inflamm. Bowel Dis. 12: 1091-1092 (2006). *
Andresen H, Zarse K, Grotzinger C, Hollidt JM, Ehrentreich-Forster E, Bier FF, Kreuzer OJ. Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor. J. Immunol. Methods 315: 11-18 (2006). *
Andresen M. Accutane registry compulsory in US, but not Canada. CMAJ 174: 1701 (2006). *
Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 69: 33-43 (2006). *
Andrews AL, Holloway JW, Holgate ST, Davies DE. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J. Immunol. 176: 7456-7461 (2006). *
Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 55: 2148-2152 (2006). *
Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA. Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett. 580: 5089-5095 (2006). *
Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342 (2006). *
Ang YS, Farrell RJ. Risk of lymphoma: inflammatory bowel disease and immunomodulators. Gut 55: 580-581 (2006). *
Angel Mercado M, Chan C, Orozco H, Barajas Olivas A, Villalta JM, Dominguez I, Erana J, Poucel F. Bile duct injuries related to misplacement of "T tubes". Ann. Hepatol. 5: 44-48 (2006). *
Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut 55: 1364-1365 (2006). *
Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 44: 1535-1542 (2006). *
Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60: 205-209 (2006). *
Anger T, Ekici AB, Daniel WG, Garlichs CD. Gene polymorphisms leading to calcified and stenotic aortic valves. Herz. 31: 635-643 (2006).
Angers I, Sancho-Shimizu V, Descoteaux A, Gewirtz AT, Malo D. Tlr5 is not primarily associated with susceptibility to Salmonella typhimurium infection in MOLF/Ei mice. Mamm. Genome 17: 385-397 (2006). *
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler. Thromb. Vasc. Biol. 26: 1895-1900 (2006).
Angulo S, Llopis M, Antolin M, Gironella M, Sans M, Malagelada JR, Pique JM, Guarner F, Panes J. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1155-G1162 (2006). *
Angus PW. Role of endothelin in systemic and portal resistance in cirrhosis. Gut 55: 1230-1232 (2006). *
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C. Ataxia associated with gluten sensitivity, myth or reality? Rev. Neurol. (Paris) 162: 214-221 (2006).
Anijeet DR, Graham C, Khooshabeh R. Giant cell arteritis-part of a spectrum of autoimmune disease? Eye 20: 1434-1435 (2006).
Annese V, Latiano A, Palmieri O, Lombardi G, Andriulli A; Italian Group of Inflammatory Bowel Disease. NOD2/CARD15 in healthy relatives of IBD patients. Eur. Rev. Med. Pharmacol. Sci. 10: 33-36 (2006).
Annese V, Latiano A, Rossi L, Bossa F, Damonte G, Dallapiccola B, Serafini S, Pierige F, Andriulli A, Magnani M. The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 27-31 (2006).
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J. Gastroenterol. 12: 3636-3644 (2006). *
Annibali V, Ristori G, Cannoni S, Romano S, Visconti A, Ghazaryan A, Figa Talamanca L, Salvetti M, Mechelli R. Multiple sclerosis: pharmacogenomics and personalised drug treatment. Neurol. Sci. 27 Suppl. 5: s347-s349 (2006). *
Annilo T, Chen ZQ, Shulenin S, Costantino J, Thomas L, Lou H, Stefanov S, Dean M. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics 88: 1-11 (2006). *
Anokhina SV. Effect of diet enriched with essential nutrients and S-adenosylmethionine on the structural and functional state of erythrocytes in patients with metabolic syndrome. Lik. Sprava. 2006: 16-23 (2006).
Ansari MJ, Sayegh MH. Costimulation couture: a designer approach to regulating autoimmunity. J. Clin. Invest. 116: 2080-2083 (2006). *
Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, Abdel Satir A. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J. Clin. Pathol. 59: 1066-1072 (2006). *
Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24: 607-656 (2006). *
Anselmi M, Acuna JC, Del Valle A, Gemmato AM. Endoscopic biliary stents for the temporary management of choledocholithiasis. Rev. Med. Chil. 134: 721-725 (2006).
Anson DS, Smith GJ, Parsons DW. Gene therapy for cystic fibrosis airway disease- is clinical success imminent? Curr. Gene Ther. 6: 161-179 (2006).
Antel J, Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 180: 3-8 (2006).
Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Muller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1131-G1137 (2006). *
Anthoni C, Mennigen RB, Rijcken EJ, Laukotter MG, Spiegel HU, Senninger N, Schurmann G, Krieglstein CF. Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease. Int. J. Colorectal Dis. 21: 409-418 (2006). *
Antinozzi PA, Garcia-Diaz A, Hu C, Rothman JE. Functional mapping of disease susceptibility loci using cell biology. Proc. Natl. Acad. Sci. U.S.A. 103: 3698-3703 (2006). *
Antoine JC. Coeliac disease and peripheral neuropathy of unknown cause. Rev. Neurol. (Paris) 162: 1290-1291 (2006).
Antolic B, Gersak K, Verdenik I, Novak-Antolic Z. Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia. J. Matern. Fetal Neonatal Med. 19: 651-654 (2006).
Anton DT, Moraru D, Cirdei E, Bozomitu L. Malnutrition and complex nutritional therapy in cystic fibrosis. Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 801-806 (2006).
Antonelli A, Sedie AD, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, Bombardieri S, Riente L. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J. Rheumatol. 33: 2026-2028 (2006).
Antonenkov VD, Hiltunen JK. Peroxisomal membrane permeability and solute transfer. Biochim. Biophys. Acta 1763: 1697-1706 (2006). *
Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34-43 (2006). *
Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M. A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Inflamm. Bowel Dis. 12: 117-122 (2006). *
Antoniu SA. Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting? Expert Opin. Investig. Drugs 15: 181-184 (2006).
Antoniv TT, Ivashkiv LB. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 54: 2711-2721 (2006). *
Antony JM, Izad M, Bar-Or A, Warren KG, Vodjgani M, Mallet F, Power C. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res. Hum. Retroviruses 22: 1253-1259 (2006).
Antonyak MA, Jansen JM, Miller AM, Ly TK, Endo M, Cerione RA. Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc. Natl. Acad. Sci. U.S.A. 103: 18609-18614 (2006). *
Antoun J, Amet Y, Simon B, Dreano Y, Corlu A, Corcos L, Salaun JP, Plee-Gautier E. CYP4A11 is repressed by retinoic acid in human liver cells. FEBS Lett. 580: 3361-3367 (2006). *
Antoun S, Merad M, Raynard B, Ruffie P. Malnutrition in cancer patients. Rev. Prat. 56: 2025-2029 (2006).
Antunes H, Abreu I, Nogueiras A, Sa C, Goncalves C, Cleto P, Garcia F, Alves A, Lemos D. First prevalence of celiac disease in a Portuguese population. Acta Med. Port. 19: 115-120 (2006).
Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Tima S, Chanarat P, Limtrakul P. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells. Arch. Pharm. Res. 29: 866-873 (2006).
Anwer MS, Ananthanarayanan M, Suchy FJ. Role of Ntcp phosphorylation in cAMP-mediated stimulation of hepatic bile acid uptake. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 29 (2006). *
Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J. Pharmacol. Sci. 100: 411-426 (2006). *
Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J. Rheumatol. 33: 647-651 (2006).
Aoki CA, Dawson K, Kenny TP, Gershwin ME, Bowlus CL. Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes. Clin. Dev. Immunol. 13: 265-271 (2006). *
Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27: 50-53 (2006).
Aoki K, Taniyama M, Nagayama C, Oikawa Y, Shimada A. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase. Ann. N. Y. Acad. Sci. 1079: 181-185 (2006). *
Aoki T, Hirota T, Tamari M, Ichikawa K, Takeda K, Arinami T, Shibasaki M, Noguchi E. An association between asthma and TNF-308G/A polymorphism: meta-analysis. J. Hum. Genet. 51: 677-685 (2006). *
Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, Koyasu S, Nishikawa T, Amagai M. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. J. Invest. Dermatol. 126: 105-113 (2006). *
Aosai F, Rodriguez Pena MS, Mun HS, Fang H, Mitsunaga T, Norose K, Kang HK, Bae YS, Yano A. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones 11: 13-22 (2006). *
Aouabdi S, Gibson GG, Plant N. Transcriptional regulation of the PXR gene: identification and characterization of a functional PPARalpha-binding site within the proximal promoter of the PXR gene. Drug Metab. Dispos. 34: 138-144 (2006). *
Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin. Exp. Res. 30: 1644-1649 (2006). *
Apan TZ, Kaygusuz S. Echinococcosis: a possible etiology in psoriatic disease. Dermatology 213: 334-336 (2006).
APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J. Gastroenterol. Hepatol. 21: 1009-1015 (2006). *
Apenteng T, Kaplan B, Meyers K. Renal outcomes in children with lupus and a family history of autoimmune disease. Lupus 15: 65-70 (2006).
Apiratpracha W, Ho JK, Powell JJ, Yoshida EM. Acute lower gastrointestinal bleeding from a dieulafoy lesion proximal to the anorectal junction post-orthotopic liver transplant. World J. Gastroenterol. 12: 7547-7548 (2006). *
Apostolopoulos J, Ooi JD, Odobasic D, Holdsworth SR, Kitching AR. The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease. J. Immunol. Methods 308: 167-178 (2006). *
Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int. 69: 1939-1944 (2006). *
Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J. Immunol. 177: 3028-3034 (2006). *
Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44: 992-1002 (2006). *
Ara C, Esrefoglu M, Polat A, Isik B, Aladag M, Gul M, Ay S, Tekerleklioglu MS, Yilmaz S. The effect of caffeic acid phenethyl ester on bacterial translocation and intestinal damage in cholestatic rats. Dig. Dis. Sci. 51: 1754-1760 (2006). *
Arabi A, Khoury N, Birbari A, Zahed L, El-Hajj Fuleihan G. Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D. J. Clin. Endocrinol. Metab. 91: 2480-2483 (2006). *
Aracena C R, Nogales-Gaete J. Coexistence of myasthenia gravis and systemic lupus erythematosus: is it more frequent than we thought? Rev. Med. Chil. 134: 1203-1205 (2006).
Arachchige PG, Takahashi Y, Ide T. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats. Metabolism 55: 381-390 (2006). *
Arafat HA, Lada E, Katakam AK, Amin N. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes. Exp. Clin. Endocrinol. Diabetes 114: 555-562 (2006).
Arakawa S, Hatano Y, Katagiri K, Terashi H, Fujiwara S. Effects of ultraviolet B irradiation on the production of regulated upon activation normal T-cell expressed and secreted protein in cultured human epidermal keratinocytes. Arch. Dermatol. Res. 297: 377-380 (2006). *
Araki T, Parc Y, Lefevre J, Dehni N, Tiret E, Parc R. The effect on morbidity of mesentery lengthening techniques and the use of a covering stoma after ileoanal pouch surgery. Dis. Colon Rectum 49: 621-628 (2006). *
Araki Y, Sugihara H, Hattori T. The free radical scavengers edaravone and tempol suppress experimental dextran sulfate sodium-induced colitis in mice. Int. J. Mol. Med. 17: 331-334 (2006). *
Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol. Rep. 16: 1357-1362 (2006). *
Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC. The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis. Mediators Inflamm. 2006: 73098 (2006). *
Aranami T, Miyake S, Yamamura T. Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J. Immunol. 177: 5659-5667 (2006). *
Aratari A, Caprilli R. Seasonality in onset of symptoms in Crohn's disease. Dig. Liver Dis. 38: 356 (2006).
Aratari A, Papi C, Galletti B, Angelucci E, Viscido A, D'Ovidio V, Ciaco A, Abdullahi M, Caprilli R. Seasonal variations in onset of symptoms in Crohn's disease. Dig. Liver Dis. 38: 319-323 (2006).
Araujo J, da Silva GA, de Melo FM. Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus. J. Pediatr. (Rio J.) 82: 210-214 (2006). *
Araujo J, Silva GA, Melo FM. Prevalence of celiac disease in children and adolescents with type 1 diabetes - authors' reply. J. Pediatr. (Rio J.) 82: 401 (2006).
Aravindhan K, Webb CL, Jaye M, Ghosh A, Willette RN, Dinardo NJ, Jucker BM. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study. J. Lipid Res. 47: 1250-1260 (2006). *
Araya QM. Improving the management of celiac disease: an urgent challenge. Rev. Med. Chil. 134: 361-364 (2006).
Arbour N, Lapointe R, Saikali P, McCrea E, Regen T, Antel JP. A new clinically relevant approach to expand myelin specific T cells. J. Immunol. Methods 310: 53-61 (2006). *
Arcavi M, Orfus G. Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies. Medicina (B. Aires) 66: 327-331 (2006).
Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131: 1844-1855 (2006). *
Archer KA, Roy CR. MyD88-dependent responses involving Toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect. Immun. 74: 3325-3333 (2006). *
Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 13: 347-356 (2006).
Arcus VL, Lott JS, Johnston JM, Baker EN. The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov. Today 11: 28-34 (2006).
Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised, controlled trial, of azathioprine and 5-aminosalicylic acid for treatment of steroid-dependent ulcerative colitis. Gut 55: 47-53 (2006). *
Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin. Nutr. 25: 245-259 (2006).
Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH. T cell epitope mimicry in antiglomerular basement membrane disease. J. Immunol. 176: 1252-1258 (2006). *
Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N. Engl. J. Med. 355: 809-817 (2006). *
Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S. Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4. Oral. Microbiol. Immunol. 21: 245-251 (2006). *
Arias IM. Reflections on the first five years of Hepatology, 1981-1986. Hepatology 43: S3-S4 (2006). *
Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 7: 1209-1216 (2006). *
Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J. Pediatr. Gastroenterol. Nutr. 42: 77-82 (2006). *
Arimura Y, Goto A, Yamashita K, Endo T, Ikeda H, Tanaka K, Tsutsumi H, Shinomura Y, Imai K. Intractable colitis associated with chronic granulomatous disease. J. Med. Microbiol. 55: 1587-1590 (2006). *
Arish N, Eldor R, Fellig Y, Bogot N, Laxer U, Izhar U, Rokach A. Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins. Thorax 61: 1096-1097 (2006). *
Aristodemou P, Stanford M. Therapy insight: the recognition and treatment of retinal manifestations of systemic vasculitis. Nat. Clin. Pract. Rheumatol. 2: 443-451 (2006). *
Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M, Sato M. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc. Natl. Acad. Sci. U.S.A. 103: 5291-5396 (2006). *
Arita M, Oh S, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, Serhan CN. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 281: 22847-22854 (2006). *
Arkkila PE. Thromboangiitis obliterans (Buerger's disease). Orphanet J. Rare Dis. 1: 14 (2006). *
Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 643-648 (2006).
Armentano F, Knight T, Makker S, Tramontano A. Induction of covalent binding antibodies. Immunol. Lett. 103: 51-57 (2006).
Armstrong D, Wright S, McVeigh C, Finch M. Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis? Clin. Rheumatol. 25: 583-584 (2006). *
Arndt T, Meier U, Nauck M, Gressner AM. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods. Clin. Chim. Acta 372: 184-187 (2006). *
Arnold HL, Harrison SA. H. pylori and platelet counts. Hepatology 44: 1685-1687 (2006). *
Arnold JN, Dwek RA, Rudd PM, Sim RB. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol. Lett. 106: 103-110 (2006).
Arnold JN, Wallis R, Willis AC, Harvey DJ, Royle L, Dwek RA, Rudd PM, Sim RB. Interaction of mannan binding lectin with alpha-2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol-ester protein family? J. Biol. Chem. 281: 6955-6963 (2006). *
Aroeira LS. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis. Clin. Immunol. 119: 252-260 (2006). *
Aronson PS. Role of SLC26-mediated Cl-/base exchange in proximal tubule NaCl transport. Novartis Found. Symp. 273: 148-158 (2006).
Aronson PS. Ion exchangers mediating Na+, HCO3 - and Cl- transport in the renal proximal tubule. J. Nephrol. 19 Suppl. 9: S3-S10 (2006).
Aronson PS. Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis. Kidney Int. 70: 1207-1213 (2006). *
Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martinez C. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis. Ann. N. Y. Acad. Sci. 1070: 129-134 (2006). *
Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium. J. Cell. Physiol. 208: 238-245 (2006). *
Arrese M. Cholestasis during pregnancy: rare hepatic diseases unmasked by pregnancy. Ann. Hepatol. 5: 216-218 (2006). *
Arrese M, Miquel JF, Ananthanarayanan M. BetaKlotho: a new kid on the bile acid biosynthesis block. Hepatology 43: 191-193 (2006). *
Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann. Hepatol. 5: 202-205 (2006). *
Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatr. Allergy Immunol. 17: 323-328 (2006). *
Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 55: 1512-1520 (2006). *
Arrieta-Aguirre I, Garcia-Etxebarria K, Jugo BM. Optimization of the MhcOvar-DRB1 gene typing. Tissue Antigens 67: 222-228 (2006). *
Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441: 595-600 (2006). *
Arroyo M, Crawford JM. Hepatitic inherited metabolic disorders. Semin. Diagn. Pathol. 23: 182-189 (2006).
Arroyo V, Terra C, Gines P. New treatments of hepatorenal syndrome. Semin. Liver Dis. 26: 254-264 (2006).
Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Connors AF Jr, Cominelli F. Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? Clin. Gastroenterol. Hepatol. 4: 1135-1142 (2006).
Arslan N, Mavi A, Kalkan S, Aydin A, Ortac R, Buyukgebiz B, Durak H. Findings of hepatobiliary scintigraphy and liver biopsy in Maroteaux-Lamy syndrome presenting as neonatal cholestasis. Pediatr. Int. 48: 498-500 (2006). *
Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83: 1467S-1476S (2006). *
Arthur JS, Darragh J. Signaling downstream of p38 in psoriasis. J. Invest. Dermatol. 126: 1689-1691 (2006). *
Artigas P, Al'aref SJ, Hobart EA, Diaz LF, Sakaguchi M, Straw S, Andersen OS. 2,3 Butanedione monoxime affects CFTR channel function through phosphorylation-dependent and phosphorylation-independent mechanisms. The role of bilayer material properties. Mol. Pharmacol. 70: 2015-2026 (2006). *
Arulampalam V, Greicius G, Pettersson S. The long and winding road to gut homeostasis. Curr. Opin. Gastroenterol. 22: 349-353 (2006).
Arulmozhi DK, Dwyer DS, Bodhankar SL. Antipsychotic induced metabolic abnormalities: an interaction study with various PPAR modulators in mice. Life Sci. 79: 1865-1872 (2006). *
Arulventhan R, Larcos G, Gruenewald S, Farrell G. Primary sclerosing cholangitis: correlation of hepatobiliary scintigraphy with clinical and laboratory status. Australas. Radiol. 50: 330-334 (2006).
Aruna BV, Ben-David H, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis. Immunology 118: 413-424 (2006). *
Arvanitakis M, Deviere J. Primary sclerosing cholangitis and recognition of bile duct cancer: problem solved? Endoscopy 38: 743-744 (2006).
Arya S, Rana SS, Sinha SK, Nagi B, Bhasin DK. Celiac disease and chronic calcific pancreatitis with pancreas divisum. Gastrointest. Endosc. 63: 1080-1081 (2006).
Asada Y, Isomoto H, Shikuwa S, Wen CY, Fukuda E, Miyazato M, Okamoto K, Nakamura T, Nishiyama H, Mizuta Y, Migita K, Ito M, Kohno S. Development of ulcerative colitis during the course of rheumatoid arthritis: association with selective IgA deficiency. World J. Gastroenterol. 12: 5240-5243 (2006). *
Asahina A, Tamaki K. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary? J. Dermatol. Sci. 44: 1-9 (2006).
Asahina K, Teramoto K, Teraoka H. Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease. Curr. Stem Cell Res. Ther. 1: 139-156 (2006).
Asai M, Yoshida M, Miura Y. Immunologic tolerance to intravenously injected insulin. N. Engl. J. Med. 354: 307-309 (2006).
Asai T, Okumura K, Takahashi R, Matsui H, Numaguchi Y, Murakami H, Murakami R, Murohara T. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc. Res. 70: 566-577 (2006). *
Asaka JI, Terada T, Okuda M, Katsura T, Inui KI. Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3. Pharm. Res. 23: 697-704 (2006). *
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese. Ann. N. Y. Acad. Sci. 1079: 47-50 (2006). *
Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J. Invest. Dermatol. 126: 1761-1769 (2006). *
Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation. Expert Rev. Neurother. 6: 1313-1325 (2006).
Asashima N, Fujimoto M, Watanabe R, Nakashima H, Yazawa N, Okochi H, Tamaki K. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris. Br. J. Dermatol. 155: 330-336 (2006). *
Asatiani G, Tokhadze L, Gopodze L. Oxidative homeostasis of organism during mechanical jaundice. Georgian Med. News 134: 115-118 (2006).
Aschoff AJ. MDCT of the abdomen. Eur. Radiol. 16 Suppl. 7: M54-M57 (2006).
Ashcroft DM, Seston E, Griffiths CE. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. Br. J. Dermatol. 155: 1236-1241 (2006). *
Asheim P, Uggen PE, Aasarod K, Aadahl P. Intraperitoneal fluid therapy: an alternative to intravenous treatment in a patient with limited vascular access. Anaesthesia 61: 502-504 (2006). *
Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun. Rev. 6: 64-67 (2006).
Asherson RA, Bosman C, Tikly M, Spiro F, Pope FM. Ehlers-Danlos syndrome type IV in a young man. J. Rheumatol. 33: 2091-2096 (2006).
Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A. The antiphospholipid antibody syndrome: diagnosis, skin. Clin. Exp. Rheumatol. 24: S46-S51 (2006).
Ashfield R, Jakobsen BK. Making high-affinity T-cell receptors: a new class of targeted therapeutics. IDrugs 9: 554-559 (2006).
Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation. Transplant. Proc. 38: 3629-3632 (2006). *
Ashizuka S, Nishiura R, Ishikawa N, Yamaga J, Inatsu H, Fujimoto S, Eto T. Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications. Ther. Apher. Dial. 10: 54-58 (2006).
Ashour HM, Niederkorn JY. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J. Immunol. 176: 5950-5957 (2006). *
Ashraf VV, Taly AB, Veerendrakumar M, Rao S. Myasthenia gravis in children: a longitudinal study. Acta Neurol. Scand. 114: 119-123 (2006). *
Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6: 532-540 (2006). *
Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3(+) lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173: 126-134 (2006).
Asif AR, Ljubojevic M, Sabolic I, Shnitsar V, Metten M, Anzai N, Mueller GA, Burckhardt G, Hagos Y. Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEAS treatment in adrenocortical cells. Am. J. Physiol. Endocrinol. Metab. 291: E1351-E1359 (2006). *
Asimuakopoulos G. Pregnancy and liver disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 326-333 (2006).
Aslam R, Speck ER, Kim M, Crow AR, Bang KA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107: 637-641 (2006). *
Aslamkhan AG, Thompson DM, Perry JL, Bleasby K, Wolff NA, Barros S, Miller DS, Pritchard JB. The flounder organic anion transporter fOat has sequence, function and substrate specificity similarity to both mammalian Oat1 and Oat3. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R1773-R1780 (2006). *
Aslanian FM, Marques MT, Matos HJ, Pontes LF, Porto LC, Azevedo LM, Filgueira AL. HLA markers in familial lichen sclerosus. J. Dtsch. Dermatol. Ges. 4: 842-847 (2006). *
Aslanidis S, Pyrpasopoulou A, Leontsini M, Zamboulis C. Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event. Int. J. Dermatol. 45: 982-983 (2006). *
Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, Levy AP. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo. Circ. Res. 99: 1419-1425 (2006). *
Asma SD, Soumaya Y, Kahena J, Raouf DM, Nejib D. Perianal Crohn disease. Dermatol. Online J. 12: 18 (2006).
Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease. Endocr. J. 53: 377-385 (2006). *
Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J. Immunol. 177: 383-394 (2006). *
Aspberg S, Dahlquist G, Kahan T, Kallen B. Fetal and perinatal risk factors for inflammatory bowel disease. Acta Paediatr. 95: 1001-1004 (2006). *
Aspinall AI, Adams DH. Sickness behaviors in chronic cholestasis: an immune-mediated process? Hepatology 43: 20-23 (2006). *
Aspinall R. T cell development, ageing and interleukin-7. Mech. Ageing Dev. 127: 572-578 (2006).
Asriri A, Mahmal A. Bronchectasia revealing ulcerative colitis. Rev. Pneumol. Clin. 62: 403-406 (2006).
Assaraf YG. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist. Updat. 9: 227-246 (2006).
Assi K, Pillai R, Gomez-Munoz A, Owen D, Salh B. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 118: 112-121 (2006). *
Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Georgiou CD, Scopa CD, Nikolopoulou VN, Vagianos CE. Evidence for intestinal oxidative stress in patients with obstructive jaundice. Eur. J. Clin. Invest. 36: 181-187 (2006).
Assisi A, Banzi R, Buonocore C, Capasso F, Muzio VD, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int. Clin. Psychopharmacol. 21: 319-336 (2006).
Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand. J. Gastroenterol. 41: 1064-1072 (2006). *
Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK. Polymorphisms in the IL-10 but not in the IL-1beta and IL-4 genes are associated with inhibitor development in patients with hemophilia A. Blood 107: 3167-3172 (2006). *
Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116: 3252-3257 (2006). *
Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33: 699-703 (2006). *
Atalay C, Deliloglu Gurhan I, Irkkan C, Gunduz U. Multidrug resistance in locally advanced breast cancer. Tumour Biol. 27: 309-318 (2006).
Atchia II, Kidd CE, Bell RW. Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab. J. Clin. Rheumatol. 12: 291-293 (2006).
Atherton HJ, Bailey NJ, Zhang W, Taylor J, Major H, Shockcor J, Clarke K, Griffin JL. A combined 1H NMR spectroscopy and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol. Genomics 27: 178-186 (2006). *
Atkins EJ, Biousse V, Newman NJ. The natural history of optic neuritis. Rev. Neurol. Dis. 3: 45-56 (2006).
Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 130: 34-43 (2006). *
Atochina O, Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp. Dermatol. 15: 461-468 (2006). *
Atreya R, Atreya I, Neurath MF. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease. Ann. N. Y. Acad. Sci. 1072: 98-113 (2006). *
Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 4: 9-14 (2006). *
Attvall E, Frigyesi A, Sternby B. What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease? Int. J. Colorectal Dis. 21: 705-710 (2006). *
Auada MP, Puzzi MB, Cintra ML, Steiner CE, Alexandrino F, Sartorato EL, Aguiar TS, Azulay RD, Carney G, Rizzo WB. Sjogren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene. Br. J. Dermatol. 154: 770-773 (2006). *
Aubareda A, Mulero MC, Perez-Riba M. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. Cell. Signal. 18: 1430-1438 (2006). *
Aubart FC, Ouayoun M, Brauner M, Attali P, Kambouchner M, Valeyre D, Nunes H. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) 85: 365-371 (2006).
Aubin CN, Linsdell P. Positive charges at the intracellular mouth of the pore regulate anion conduction in the CFTR chloride channel. J. Gen. Physiol. 128: 535-545 (2006). *
Aucejo F, Rofaiel G, Miller C. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? J. Hepatol. 44: 19-23 (2006). *
Aud D, Peng SL. Mechanisms of disease: transcription factors in inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 2: 434-442 (2006). *
Augereau P, Badia E, Carascossa S, Castet A, Fritsch S, Harmand PO, Jalaguier S, Cavailles V. The nuclear receptor transcriptional coregulator RIP140. Nucl. Recept. Signal. 4: e024 (2006). *
August A, Mueller C, Weaver V, Polanco TA, Walsh ER, Cantorna MT. Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma. J. Nutr. 136: 695-699 (2006). *
Aulock SV, Deininger S, Draing C, Gueinzius K, Dehus O, Hermann C. Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J. Interferon Cytokine Res. 26: 887-892 (2006).
Aung CS, Faddy HM, Lister EJ, Monteith GR, Roberts-Thomson SJ. Isoform specific changes in PPARalpha and beta in colon and breast cancer with differentiation. Biochem. Biophys. Res. Commun. 340: 656-660 (2006). *
Ausch C, Madoff RD, Gnant M, Rosen HR, Garcia-Aguilar J, Holbling N, Herbst F, Buxhofer V, Holzer B, Rothenberger DA, Schiessel R. Aetiology and surgical management of toxic megacolon. Colorectal Dis. 8: 195-201 (2006). *
Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect. 8: 714-720 (2006). *
Ausman JI. Why omega-3 fatty acids are important to neurosurgeons. Surg. Neurol. 65: 325 (2006).
Aust S, Brucker B, Graf J, Klimpfinger M, Thalhammer T. Melatonin modulates acid/base transport in human pancreatic carcinoma cells. Cell. Physiol. Biochem. 18: 91-102 (2006). *
Austin GL, Shaheen NJ, Sandler RS. Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am. J. Gastroenterol. 101: 413-416 (2006). *
Autret-Leca E, Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F. Pharmacovigilance of vaccines. Arch. Pediatr. 13: 175-180 (2006).
Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPARgamma-dependent pathway. Mol. Endocrinol. 20: 3165-3178 (2006). *
Avital S, Hermon H, Greenberg R, Karin E, Skornick Y. Learning curve in laparoscopic colorectal surgery: our first 100 patients. Isr. Med. Assoc. J. 8: 683-686 (2006). *
Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-CCP (cyclic citrullinated protein) antibodies in rheumatoid arthritis: a systematic literature review. Ann. Rheum. Dis. 65: 845-851 (2006). *
Avril T, Attrill H, Zhang J, Raper A, Crocker PR. Negative regulation of leucocyte functions by CD33-related siglecs. Biochem. Soc. Trans. 34: 1024-1027 (2006). *
Awad J, Farah R, Reshef R, Cohen H, Horn I. Pyloric stenosis as a presenting symptom of Crohn's disease. J. Gastrointestin. Liver Dis. 15: 175-177 (2006). *
Awadallah NS, Chen YK, Piraka C, Antillon MR, Shah RJ. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am. J. Gastroenterol. 101: 284-291 (2006). *
Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, Manabe T, Kamoto T, Habuchi T, Ogawa O. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 241: 59-63 (2006). *
Awomoyi A, Sirugo G, Newport MJ, Tishkoff S. Global distribution of a novel trinucleotide microsatellite polymorphism (ATA) in intron 8 of the SLC11A1 gene and susceptibility to pulmonary tuberculosis. Int. J. Immunogenet. 33: 11-15 (2006). *
Axtell RC, Xu L, Barnum SR, Raman C. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J. Immunol. 177: 8542-8549 (2006). *
Ayadi-Kaddour A, Saiji E, Ben Slama S, Chelly-Ennaiffer I, Lahmar-Boufaroua A, Goutallier-Ben Fadhel C, Ben Sassi L, Khalfallah MT, Mzabi-Regaya S. Hepatic mesenchymal hamartoma in adulthood: a case report with literature review. Tunis. Med. 84: 263-265 (2006).
Ayala YM, Pagani F, Baralle FE. TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580: 1339-1344 (2006). *
Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsuzu F. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages. Arterioscler. Thromb. Vasc. Biol. 26: 163-168 (2006). *
Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. Int. J. Urol. 13: 1380-1384 (2006). *
Aydinli B, Ozturk G, Balik AA, Aslan S, Erdogan F. Spontaneous rupture of the spleen in secondary amyloidosis: a patient with rheumatoid arthritis. Amyloid 13: 160-163 (2006).
Aydog E, Yesilli O, Sever A, Usan H. Dermatitis herpetiformis and rheumatoid arthritis. Saudi Med. J. 27: 881-884 (2006).
Aydogan K, Karadogan SK, Adim SB, Tunali S. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus. Int. J. Dermatol. 45: 1057-1061 (2006). *
Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin. Exp. Dermatol. 31: 424-429 (2006). *
Ayed K, Ayed-Jendoubi S, Ben Abdallah T, Bardi R, Gorgi Y, Sfar I, Dhrif B, Abderrahim E, Kheder A. Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction. Transpl. Immunol. 15: 303-309 (2006).
Ayensu WK, Tchounwou PB. Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Int. J. Environ. Res. Public Health 3: 141-173 (2006).
Aylett P. Digestive Disease Week 2006. Therapies for Crohn's disease and ulcerative colitis. IDrugs 9: 452-454 (2006).
Ayse Selimoglu M, Ertekin V, Gursan N, Orbak Z, Esrefoglu M. Brunner's gland hyperplasia in a child with diabetes mellitus and coeliac disease. Acta Paediatr. 95: 508-510 (2006). *
Aytac S, Kargili A, Turkay C. A prolonged gestational intrahepatic cholestasis: a case report. Turk. J. Gastroenterol. 17: 206-208 (2006). *
Ayyildiz O, Altintas A, Isikdogan A, Tuzcu A.. Aggressive natural killer cell leukemia in a patient with common variable immunodeficiency syndrome. Gynecol. Endocrinol. 22: 286-287 (2006).
Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation. Exp. Clin. Transplant. 4: 416-419 (2006).
Azevedo TD, Feijo GC, Bezerra AC. Presence of developmental defects of enamel in cystic fibrosis patients. J. Dent. Child. (Chic.) 73: 159-163 (2006).
Azkargorta M, Arizmendi JM, Elortza F, Alkorta N, Zubiaga AM, Fullaondo A. Differential proteome profiles in E2F2-deficient T lymphocytes. Proteomics 6 Suppl. 1: S42-S50 (2006). *
Azoulay L, Oraichi D, Berard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Eur. J. Clin. Pharmacol. 62: 667-674 (2006). *
Azulay JP. The extent of the clinical manifestations of chronic polyradiculoneuropathy. Rev. Neurol. (Paris) 162: 518-521 (2006).
Azulay JP. The diagnosis of chronic axonal polyneuropathy: the poorly understood chronic polyradiculoneuritides. Rev. Neurol. (Paris) 162: 1292-1295 (2006).
Azzam N, Al Ashgar H, Dababo M, Al Kahtani N, Shahid M. Mesentric vein thrombosis as a presentation of subclinical celiac disease. Ann. Saudi Med. 26: 471-473 (2006).
B'chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M'rad S, Ben Dridi M; le groupe tunisien d'etude sur la maladie de Behcet. Behcet's disease in Tunisia. Clinical study of 519 cases. Rev. Med. Interne. 27: 742-750 (2006).
Baba MI, Kaul D, Grover A. Importance of blood cellular genomic profile in coronary heart disease. J. Biomed. Sci. 13: 17-26 (2006). *
Baba N, Kobashi H, Yamamoto K, Terada R, Suzuki T, Hakoda T, Okano N, Shimada N, Fujioka S, Iwasaki Y, Shiratori Y. Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Transl. Res. 148: 103-113 (2006). *
Baba T, Ishizu A, Iwasaki S, Suzuki A, Tomaru U, Ikeda H, Yoshiki T, Kasahara M. CD4/CD8 double-positive macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype. Blood 107: 2004-2012 (2006). *
Babatin MA, Sanai FM, Swain MG. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Aliment. Pharmacol. Ther. 24: 813-820 (2006). *
Babbin BA, Crawford K, Sitaraman SV. Malabsorption work-up: utility of small bowel biopsy. Clin. Gastroenterol. Hepatol. 4: 1193-1198 (2006).
Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26: 12826-12837 (2006).
Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J. Immunol. 176: 3248-3256 (2006). *
Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am. J. Gastroenterol. 101: 1354-1361 (2006). *
Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun. 7: 693-695 (2006). *
Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease. Clin. Exp. Dermatol. 31: 699-701 (2006). *
Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116: 1713-1722 (2006). *
Baccini F, Aloe Spiriti MA, Vannella L, Monarca B, Delle Fave G, Annibale B. Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron-deficiency anaemia presentation. Aliment. Pharmacol. Ther. 23: 915-921 (2006). *
Bach JF. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. C. R. Biol. 329: 260-262 (2006). *
Bach JF. Therapeutic monoclonal antibodics. Ann. Pharm. Fr. 64: 308-311 (2006).
Bach SP, Mortensen NJ. Revolution and evolution: 30 years of ileoanal pouch surgery. Inflamm. Bowel Dis. 12: 131-145 (2006). *
Bachar O, Adner M, Cardell LO. Toll-like receptor activation in airway smooth muscle - dual actions, via separate MAPK pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L322-L323 (2006). *
Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 130: 8-16 (2006). *
Bachmann MF, Kopf M, Marsland BJ. Chemokines: more than just road signs. Nat. Rev. Immunol. 6: 159-164 (2006). *
Bachmann MP, Bartsch H, Gross JK, Maier SM, Gross TF, Workman JL, James JA, Farris AD, Jung B, Franke C, Conrad K, Schmitz M, Buttner C, Buyon JP, Semsei I, Harley JB, Rieber EP. Autoimmunity as a result of escape from RNA surveillance. J. Immunol. 177: 1698-1707 (2006). *
Bachmeyer C. Cutaneous infections in a patient with idiopathic thrombocytopenic purpura. J. Am. Acad. Dermatol. 55: 364-365 (2006).
Bachmeyer C, Barrier A, Frazier A, Fulgencio JP, Lecomte I, Grateau G, Callard P. Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome. Eur. J. Gastroenterol. Hepatol. 18: 1011-1014 (2006).
Bachmeyer C, Rohaut B. Sarcoidosis mimicking rheumatoid arthritis. Presse. Med. 35: 623-624 (2006).
Bacon BR. Hepatology: where do we go from here? Gastroenterology 131: 1373-1374 (2006). *
Badagnani I, Castro RA, Taylor TR, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE, Carlson EJ, Burchard EG, Giacomini KM. Interaction of methotrexate with OATP1A2 and its genetic variants. J. Pharmacol. Exp. Ther. 318: 521-529 (2006). *
Badn W, Kalliomaki S, Widegren B, Sjogren HO. Low-dose combretastatin a4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma. Clin. Cancer Res. 12: 4714-4719 (2006). *
Badriashvili N, Topuridze M, Chakhunachvili G, Tabutsadze D, Khvtisiashvili N. Interferon system in children with cystic fibrosis. Georgian Med. News 136: 74-77 (2006).
Bae SC, Lee YH. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene 366: 58-66 (2006). *
Bae SH, Kim JS, Kim DH. Deflazacort for type-1 autoimmune hepatitis in a Korean girl. J. Korean Med. Sci. 21: 758-760 (2006). *
Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci. 97: 774-779 (2006). *
Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212: 203-216 (2006). *
Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631 (2006). *
Baechler EC, Batliwalla FM, Reed AM, Peterson EJ, Gaffney PM, Moser KL, Gregersen PK, Behrens TW. Gene expression profiling in human autoimmunity. Immunol. Rev. 210: 120-137 (2006). *
Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, Feltelius N, Enblad G, Sundstrom C, Klareskog L, Askling J, Rosenquist R. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum. 54: 3774-3781 (2006). *
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 54: 692-701 (2006). *
Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131: 1553-1560 (2006). *
Bafna V, Bansal V. Inference about recombination from haplotype data: lower bounds and recombination hotspots. J. Comput. Biol. 13: 501-521 (2006).
Bagaeva LV, Rao P, Powers JM, Segal BM. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176: 7676-7685 (2006). *
Bagci S, Ercin CN, Yesilova Z, Ozcan A, Degertekin B, Dagalp K. Levels of serologic markers of celiac disease in patients with reflux esophagitis. World J. Gastroenterol. 12: 6707-6710 (2006). *
Bager P, Nielsen NM, Bihrmann K, Frisch M, Wohlfart J, Koch-Henriksen N, Melbye M, Westergaard T. Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark. Am. J. Epidemiol. 163: 1112-1117 (2006). *
Bagi Z, Hamar P, Kardos M, Koller A. Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice. Lupus 15: 326-334 (2006).
Bagnato F, Ohayon JM, Ehrmantraut M, Chiu AW, Riva M, Ikonomidou VN. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis. Expert Rev. Neurother. 6: 599-612 (2006).
Bagnato G, De Filippis LG, Caliri A, Bruno A, Gambardella N, Muscatello MR, Cambria R, Zoccali R. Comparation of levels of anxiety and depression in patients with autommune and chronic-degenerative rheumatic: preliminary data. Reumatismo 58: 206-211 (2006).
Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult. Scler. 12: 397-411 (2006).
Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am. J. Physiol. Endocrinol. Metab. 291: E199-E206 (2006). *
Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases. Postgrad. Med. J. 82: 376-382 (2006). *
Bai AP, Ouyang Q, Xiao XR, Li SF. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int. J. Clin. Pract. 60: 284-288 (2006). *
Bai L, Kao JY, Law DJ, Merchant JL. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection. Gastroenterology 131: 841-852 (2006). *
Bai M, Katsanos KH, Economou M, Kamina S, Balli C, Briasoulis E, Kappas AM, Agnantis N, Tsianos EV. Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature. Scand. J. Gastroenterol. 41: 866-869 (2006). *
Baichi MM, Arifuddin RM, Mantry PS. What we have learned from 5 cases of permanent capsule retention. Gastrointest. Endosc. 64: 283-287 (2006).
Baici A, Muntener K, Willimann A, Zwicky R. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death. Biol. Chem. 387: 1017-1021 (2006).
Baier G, Asadullah K, Zugel U. The immunological synapse: kinases in T cell signalling as potential drug targets. Immunol. Lett. 105: 3-5 (2006).
Baier PK, Arampatzis G, Imdahl A, Hopt UT. The iliopsoas abscess: aetiology, therapy, and outcome. Langenbecks Arch. Surg. 391: 411-417 (2006). *
Baier PK, Hempel S, Waldvogel B, Baumgartner U. Zonation of hepatic bile salt transporters. Dig. Dis. Sci. 51: 587-593 (2006). *
Baig MK, Weiss EG, Nogueras JJ, Wexner SD. Lengthening of small bowel mesentery: stepladder incision technique. Am. J. Surg. 191: 715-717 (2006). *
Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J. Exp. Med. 203: 1357-1369 (2006). *
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 55: 2896-2902 (2006). *
Baillat D, Leprivier G, Regnier D, Vintonenko N, Begue A, Stehelin D, Aumercier M. Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter. Oncogene 25: 5764-5776 (2006). *
Bailly-Maitre B, Fondevila C, Kaldas F, Droin N, Luciano F, Ricci JE, Croxton R, Krajewska M, Zapata JM, Kupiec-Weglinski JW, Farmer D, Reed JC. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 103: 2809-2814 (2006). *
Baishanbo A, Gargala G, Duclos C, Francois A, Rossignol JF, Ballet JJ, Favennec L. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model. J. Antimicrob. Chemother. 57: 353-355 (2006). *
Bajaj JS, Bajaj S, Dua KS, Jaradeh S, Rittmann T, Hofmann C, Shaker R. Influence of sleep stages on esophago-upper esophageal sphincter contractile reflex and secondary esophageal peristalsis. Gastroenterology 130: 17-25 (2006). *
Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25: 989-1001 (2006). *
Bajor A, Kilander A, Galman C, Rudling M, Ung KA. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Aliment. Pharmacol. Ther. 24: 1643-1649 (2006). *
Bajtay Z, Csomor E, Sandor N, Erdei A. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol. Lett. 104: 46-52 (2006).
Bak H, Lee JW, Ahn HJ, Hwang SM, Choi EH, Lee SH, Ahn SK. An unusual case with membranous lipodystrophy in a hypertensive patient with transepidermal elimination. Yonsei. Med. J. 47: 428-431 (2006). *
Bak-Romaniszyn L, Cedzynski M, Szemraj J, St Swierzko A, Zeman K, Kaluzynski A, Planeta-Malecka I. Mannan-binding lectin in children with chronic gastritis. Scand. J. Immunol. 63: 131-135 (2006). *
Bakema JE, de Haij S, den Hartog-Jager CF, Bakker J, Vidarsson G, van Egmond M, van de Winkel JG, Leusen JH. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction. J. Immunol. 176: 3603-3610 (2006). *
Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JL, Matthee B, Peijnenburg AA, van Loveren H. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int. J. Food Microbiol. 112: 8-18 (2006). *
Baker BS, Powles A, Fry L. Peptidoglycan: a major aetiological factor for psoriasis? Trends Immunol. 27: 545-551 (2006). *
Baker DE. MMX Mesalamine. Rev. Gastroenterol. Disord. 6: 146-152 (2006).
Bakker-Jonges LE, ter Borg PC, van Buuren HR, Hooijkaas H. A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis. Ned. Tijdschr. Geneeskd. 150: 490-494 (2006).
Bako W, Marek A, Sikorska-Wisniewska G, Liberek A, Raczkowska-Kozak J, Gora-Gebka M, Szlagatys-Sidorkiewicz A, Zagierski M, Jankowska A. Short bowel syndrome in children - own experience. Med. Wieku. Rozwoj. X: 563-572 (2006).
Bakrac M, Bonaci B, Krstic M, Simic S, Colovic M. A rare case of enteropathy-associated T-cell lymphoma presenting as acute renal failure. World J. Gastroenterol. 12: 2301-2304 (2006). *
Baksh MF, Balding DJ, Vyse TJ, Whittaker JC. A likelihood ratio approach to family-based association studies with covariates. Ann. Hum. Genet. 70: 131-139 (2006). *
Bala G, Swincow G, Rytarowska A, Czerwionka-Szaflarska M. Non-specific inflammatory bowel disease or allergic colitis in small children - what is the final diagnosis? Med. Wieku. Rozwoj. X: 475-482 (2006).
Balaban YH, Sumer H, Simsek H, Us D, Tatar G. Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). Ann. Hepatol. 5: 109-114 (2006). *
Balabanov R, Strand K, Kemper A, Lee JY, Popko B. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. J. Neurosci. 26: 5143-5152 (2006).
Balachandran P, Pugh ND, Ma G, Pasco DS. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int. Immunopharmacol. 6: 1808-1814 (2006).
Balada E, Simeon-Aznar CP, Serrano-Acedo S, Martinez-Lostao L, Selva-O' Callaghan A, Fonollosa-Pla V, Vilardell-Tarres M. Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis. Clin. Exp. Rheumatol. 24: 321-324 (2006).
Balada E, Villarreal-Tolchinsky J, Ordi-Ros J, Labrador M, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens 68: 432-438 (2006). *
Balakrishnan A, Polli JE. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. Mol. Pharm. 3: 223-230 (2006). *
Balakrishnan A, Wring SA, Coop A, Polli JE. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. Mol. Pharm. 3: 282-292 (2006). *
Balakrishnan A, Wring SA, Polli JE. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. Pharm. Res. 23: 1451-1459 (2006). *
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-C allele, HLA-Cw*0742, with a novel HLA polymorphism at exon 3. Tissue Antigens 68: 530-531 (2006). *
Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, Utz PJ. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 24: 391-418 (2006). *
Baldan A, Tarr P, Lee R, Edwards PA. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol. 17: 227-232 (2006).
Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit. Rev. Immunol. 26: 407-442 (2006).
Baldwin HE. Coping with the isotretinoin registry. Dermatol. Ther. 19: 241-250 (2006).
Baldys-Waligorska A, Kusnierz-Cabala B, Huszno B. A special case of thyroid associated ophthalmopathy in the course of Graves-Basedow disease. Endokrynol. Pol. 57: 536-540 (2006).
Balic A, Harcus YM, Taylor MD, Brombacher F, Maizels RM. IL-4R signaling is required to induce IL-10 for the establishment of T(h)2 dominance. Int. Immunol. 18: 1421-1431 (2006). *
Balint BL, Nagy L. Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases. Endocr. Metab. Immune Disord. Drug Targets 6: 33-43 (2006).
Balistreri CR, Grimaldi MP, Vasto S, Listi F, Chiappelli M, Licastro F, Lio D, Caruso C, Candore G. Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from northern Italy. Ann. N. Y. Acad. Sci. 1089: 454-461 (2006). *
Balistreri WF, Bezerra JA. Whatever happened to �neonatal hepatitis�? Clin. Liver Dis. 10: 27-53 (2006).
Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189: 19-30 (2006).
Ballanger F, Allix ML, Rimbert M, Audrain M, Muller JY, Dreno B. Auto-immunity induced by low doses of interferon in melanoma stage I. Ann. Dermatol. Venereol. 133: 543-548 (2006).
Ballatori N, Henson JH, Seward DJ, Cai SY, Runnegar M, Fricker G, Miller DS, Boyer JL. Retention of structural and functional polarity in cultured skate hepatocytes undergoing in vitro morphogenesis. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 144: 167-179 (2006). *
Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, Marin JJ. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps. Biochem. Pharmacol. 72: 729-738 (2006). *
Ballestero Y, Hernandez MI, Rojo P, Manzanares J, Nebreda V, Carbajosa H, Infante E, Baro M. Hyponatremic dehydration as a presentation of cystic fibrosis. Pediatr. Emerg. Care 22: 725-727 (2006).
Ballotti S, Chiarelli F, de Martino M. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II. Horm. Res. 66: 142-152 (2006).
Ballow M. Biologic immune modifiers: trials and tribulations - are we there yet? J. Allergy Clin. Immunol. 118: 1209-1215 (2006). *
Bamba S, Lee CY, Brittan M, Preston S, Direkze N, Poulsom R, Alison M, Wright N, Otto W. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J. Pathol. 209: 265-273 (2006). *
Bamias G, Cominelli F. Novel strategies to attenuate immune activation in Crohn's disease. Curr. Opin. Pharmacol. 6: 401-407 (2006).
Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. U.S.A. 103: 8441-8446 (2006). *
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 17: 2333-2340 (2006). *
Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, Dipaola RS, Abate-Shen C. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice. Clin. Cancer Res. 12: 5895-5901 (2006). *
Banales JM, Arenas F, Rodriguez-Ortigosa CM, Saez E, Uriarte I, Doctor RB, Prieto J, Medina JF. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 43: 266-275 (2006). *
Banales JM, Prieto J, Medina JF. Cholangiocyte anion exchange and biliary bicarbonate excretion. World J. Gastroenterol. 12: 3496-3511 (2006). *
Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392 (2006). *
Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J. Immunol. 177: 1904-1912 (2006). *
Bandyopadhyay SK, Bandyopadhyay R, Dutta A. Primary amyloidosis presenting as intrahepatic cholestasis. Indian J. Pathol. Microbiol. 49: 557-559 (2006).
Bandyopadhyay SK, Moulick A, Dutta A. Retinal vasculitis - an initial presentation of systemic lupus erythematosus. J. Indian Med. Assoc. 104: 526-527 (2006).
Banerjee A, Gugasyan R, McMahon M, Gerondakis S. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 103: 3274-3279 (2006). *
Banerjee S, Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center: role of thiopurine methyltransferase and 6-mercaptopurine metabolite measurements. J. Pediatr. Gastroenterol. Nutr. 43: 324-330 (2006). *
Banerjee S, Rahhal R, Bishop WP. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. J. Pediatr. Gastroenterol. Nutr. 43: 353-356 (2006). *
Bang B, Gniadecki R. Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report. Acta Derm. Venereol. 86: 456-457 (2006).
Bangs SC, McMichael AJ, Xu XN. Bystander T cell activation - implications for HIV infection and other diseases. Trends Immunol. 27: 518-524 (2006). *
Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol. 27: 541-544 (2006). *
Banham AH, Powrie FM, Suri-Payer E. FOXP3+ regulatory T cells: current controversies and future perspectives. Eur. J. Immunol. 36: 2832-2836 (2006). *
Bania J, Dabrowska A, Rozalska B, Sadowska B, Wieckowska-Szakiel M, Korzekwa K, Zarczynska A, Bystron J, Chrzanowska J, Molenda J. Superantigen types in Staphylococcus aureus isolated from patients with cystic fibrosis. Folia. Microbiol. (Praha.) 51: 614-618 (2006).
Baniasadi V, Narain N, Goswami R, Das SN. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67: 383-389 (2006). *
Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Tager M, Ansorge S. Triggering endogenous immunosuppressive mechanisms by combined targeting of dipeptidyl peptidase IV (DPIV/CD26) and aminopeptidase N (APN/ CD13) - a novel approach for the treatment of inflammatory bowel disease. Int. Immunopharmacol. 6: 1925-1934 (2006).
Banka NH, Dhavan P, Chevale BP. Coeliac sprue - new frontiers in diagnosis and role of capsule endoscopy. J. Assoc. Physicians India 54: 959-961 (2006).
Bankar RN, Dafe CO, Kohnke A, Babu PS. Ulcerative colitis probably associated with isotretinoin. Indian J. Gastroenterol. 25: 171-172 (2006). *
Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am. J. Gastroenterol. 101: 2379-2400 (2006). *
Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M. Lupus erythematosus and the skin. Clin. Exp. Rheumatol. 24: S26-S35 (2006).
Bansback N, Young A, Brennan A, Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis. J. Rheumatol. 33: 1503-1510 (2006).
Bantis C, Heering PJ, Aker S, Siekierka M, Kuhr N, Grabensee B, Ivens K. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am. J. Nephrol. 26: 12-15 (2006).
Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, Mooi FR, Hoebee B, van Kranen HJ, Kimman TG. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect. Immun. 74: 2596-2605 (2006). *
Banville N, Broderick A, Fitzgerald R, Drumm B, McDermott M. Giant inflammatory polyposis coli as a manifestation of Crohn's disease in patients with coexistent cystic fibrosis. Pediatr. Dev. Pathol. 9: 25-30 (2006).
Banwell B, Reder AT, Krupp L, Tenembaum S, Eraksoy M, Alexey B, Pohl D, Freedman M, Schelensky L, Antonijevic I. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 66: 472-476 (2006).
Banwell CM, Maccartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O'neill LP, Turner BM, Colston KW, Campbell MJ. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res. 12: 2004-2013 (2006). *
Bar-Meir S. Review article: capsule endoscopy - are all small intestinal lesions Crohn's disease? Aliment. Pharmacol. Ther. 24 Suppl. 3: 19-21 (2006). *
Bar-Meir S, Wallace MB. Diagnostic colonoscopy: the end is coming. Gastroenterology 131: 992-994 (2006). *
Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78 (2006). *
Baran W, Szepietowski JC, Mazur G, Baran E. A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol. Alp. Panonica Adriat. 15: 113-118 (2006). *
Barancik M, Bohacova V, Sedlak J, Sulova Z, Breier A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 29: 426-434 (2006). *
Baranzini SE. Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis. Autoimmunity 39: 651-662 (2006).
Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 103: 5460-5465 (2006). *
Barath S, Sipka S, Aleksza M, Szegedi A, Szodoray P, Vegh J, Szegedi G, Bodolay E. Regulatory T cells in peripheral blood of patients with mixed connective tissue disease. Scand. J. Rheumatol. 35: 300-304 (2006). *
Baratti C, De Simone A, Grassi C, Righi I, Massara PP, Pizzi M, Ferla F, Sposato J, Ardizzone S, Trabucchi E. Inflammatory colitis: classification and surgical treatment. Ann. Ital. Chir. 77: 313-317 (2006).
Barbato M, Curione M, Viola F, Versacci P, Parisi F, Amato S, Cucchiara S. Cardiac involvement in children with IBD during infliximab therapy. Inflamm. Bowel Dis. 12: 828-829 (2006). *
Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes 55: 2437-2445 (2006). *
Barber CE, Geldenhuys L, Hanly JG. Sustained remission of lupus nephritis. Lupus 15: 94-101 (2006).
Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687 (2006). *
Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, Aragaki CC. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 4: 250-255 (2006). *
Barbosa FA, de Labio RW, de Oliveira S Rigolin V, Minett T, Bertolucci PH, de Arruda Cardoso Smith M, Payao SL. Apolipoprotein A-V gene polymorphism -1131T>C and Alzheimer's disease. J. Alzheimers Dis. 10: 365-369 (2006).
Barcellos LF, Kamdar BB, Ramsay PP, Deloa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-Vance MA, Oksenberg JR, Hauser SL. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol. 5: 924-931 (2006).
Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Ucelli A, Savettieri G, Lincoln RL, Deloa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 15: 2813-2824 (2006). *
Barcena R, Moreno A, Foruny JR, Moreno A, Sanchez J, Gil-Grande L, Blazquez J, Nuno J, Fortun J, Rodriguez-Gandia MA, Oton E. Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome? Clin. Transplant. 20: 517-523 (2006). *
Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat. Rev. Immunol. 6: 457-464 (2006). *
Bardet V, Junior AP, Coste J, Lecoq-Lafon C, Chouzenoux S, Bernard D, Soubrane O, Lacombe C, Calmus Y, Conti F. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors. Liver Transpl. 12: 1649-1654 (2006). *
Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm. Bowel Dis. 12: 16-21 (2006). *
Baricevic I, Jones DR, Nikolic JA, Nedic O. Gastrointestinal inflammation and the circulating IGF system in humans. Horm. Metab. Res. 38: 22-27 (2006).
Barile S, Medda E, Nistico L, Bordignon V, Cordiali-Fei P, Carducci M, Rainaldi A, Marinelli R, Bonifati C. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp. Dermatol. 15: 368-376 (2006).
Baris N, Akdeniz B, Ozerkan F, Onder RM, Akarca U, Guneri S. The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism. Cardiovasc. Hematol. Disord. Drug Targets 6: 57-61 (2006).
Barisani D, Ceroni S, Meneveri R, Cesana BM, Bardella MT. IL-10 polymorphisms are associated with early-onset celiac disease and severe mucosal damage in patients of Caucasian origin. Genet. Med. 8: 169-174 (2006).
Barish GD. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity. J. Nutr. 136: 690-694 (2006). *
Barish GD, Narkar VA, Evans RM. PPARdelta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116: 590-597 (2006). *
Barisic GI, Krivokapic ZV, Adzic TN, Pavlovic AR, Popovic MA, Gojnic M. Fecopneumothorax and colopleural fistula - uncommon complications of Crohn's disease. BMC Gastroenterol. 6: 17 (2006). *
Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, Christopher States J, Hein DW. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1. Pharmacogenet. Genomics 16: 515-525 (2006). *
Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91: 1210-1217 (2006). *
Barker RH Jr, Dagher R, Davidson DM, Marquis JK. Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties. Aliment. Pharmacol. Ther. 24: 1525-1534 (2006). *
Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, Rowan AD. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum. 54: 3244-3253 (2006). *
Barlan I, Bahceciler NN, Akdis M, Akdis CA. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases. Immunol. Allergy Clin. North Am. 26: 365-377 (2006).
Barlic J, Zhang Y, Foley JF, Murphy PM. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation 114: 807-819 (2006).
Barlow C. Ulcerative colitis, pregnancy, prenatal expression and breastfeeding. Breastfeed. Rev. 14: 17-19 (2006).
Barnacle AM, Aylwin AC, Jackson JE. Angiographic diagnosis of inflammatory bowel disease in patients presenting with gastrointestinal bleeding. AJR Am. J. Roentgenol. 187: 976-985 (2006). *
Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J. Allergy Clin. Immunol. 118: 70-77 (2006). *
Barnes KC, Grant AV, Baltadzhieva D, Zhang S, Berg T, Shao L, Zambelli-Weiner A, Anderson W, Nelsen A, Pillai S, Yarnall DP, Dienger K, Ingersoll RG, Scott AF, Fallin MD, Mathias RA, Beaty TH, Garcia JG, Wills-Karp M. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun. 7: 27-35 (2006). *
Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin. Pharmacother. 7: 607-615 (2006).
Barnes PJ. Receptor heterodimerization: a new level of cross-talk. J. Clin. Invest. 116: 1210-1212 (2006). *
Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens 68: 390-398 (2006). *
Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N. Engl. J. Med. 354: 2751-2763 (2006). *
Barnett MH, Sutton I. The pathology of multiple sclerosis: a paradigm shift. Curr. Opin. Neurol. 19: 242-247 (2006).
Barnstein BO, Li G, Wang Z, Kennedy S, Chalfant C, Nakajima H, Bunting KD, Ryan JJ. Stat5 expression is required for IgE-mediated mast cell function. J. Immunol. 177: 3421-3426 (2006). *
Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S, Morton DG. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131: 1674-1682 (2006). *
Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, Hoffinan B, Jacobson BC, Petrini JL, Safdi MA, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for endoscopic retrograde cholangiopancreatography. Am. J. Gastroenterol. 101: 892-897 (2006). *
Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, Buommino E. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch. Dermatol. Res. 297: 280-288 (2006). *
Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354: 2667-2676 (2006). *
Barquero-Romero J, Rodriguez Vazquez C. Carotenodermia in a patient with ulcerative colitis. Gastroenterol. Hepatol. 29: 431 (2006).
Barr M, Mackenzie SM, Wilkinson DM, Holloway CD, Friel EC, Miller S, Macdonald T, Fraser R, Connell JM, Davies E. Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene. Clin. Endocrinol. (Oxf.) 65: 816-825 (2006). *
Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, Langnas AN, Delmonico FL. A report of the Vancouver forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 81: 1373-1385 (2006).
Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J. Autoimmun. 27: 166-173 (2006).
Barreales M, Perez-Carreras M, Meizoso T, Garrido M, Masedo A, Colina F, Solis JA. Epstein-Barr virus infection and cholestatic hepatitis. An. Med. Interna. 23: 483-486 (2006).
Barrie A, Plevy S. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. Gastroenterol. Clin. North Am. 35: 883-893 (2006).
Barrier M, Lacroix-Lamande S, Mancassola R, Auray G, Bernardet N, Chausse AM, Uematsu S, Akira S, Laurent F. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J. Infect. Dis. 193: 1400-1407 (2006). *
Barro Soria R, Spitzner M, Schreiber R, Kunzelmann K. Bestrophin 1 enables Ca2+ activated Cl- conductance in epithelia. J. Biol. Chem. Sep 26 [Epub ahead of print] (2006). *
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49: 501-505 (2006). *
Barroso S, Rieubland C, Josealvarez A, Lopez-Trascasa M, Bart PA, Nunez-Roldan A, Sanchez B. Molecular defects of the C7 gene in two patients with complement C7 deficiency. Immunology 118: 257-260 (2006). *
Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91: 1446-1452 (2006). *
Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation. Transpl. Infect. Dis. 8: 108-112 (2006). *
Barta SK, Yahalom J, Shia J, Hamlin PA. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. Clin. Lymphoma Myeloma 7: 77-82 (2006).
Barta Z, Toth L, Zeher M. Pulse cyclophosphamide therapy for inflammatory bowel disease. World J. Gastroenterol. 12: 1278-1280 (2006). *
Bartee E, McCormack A, Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2: e107 (2006). *
Bartek J, Lukas J. The stress of finding NEMO. Science 311: 1110-1111 (2006). *
Barter P. Managing diabetic dyslipidaemia-beyond LDL-C:HDL-C and triglycerides. Atheroscler. Suppl. 7: 17-21 (2006).
Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation 113: 1553-1555 (2006). *
Barth A, Braun J, Muller D. Influence of verapamil and cyclosporin A on bile acid metabolism and transport in rat liver slices. Exp. Toxicol. Pathol. 58: 31-37 (2006). *
Barth A, Braun J, Muller D. Bile acid transport and metabolism in rat liver slices. Exp. Toxicol. Pathol. 57: 313-319 (2006).
Barthet M, Lesavre N, Desplats S, Panuel M, Gasmi M, Bernard JP, Dagorn JC, Grimaud JC. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology 6: 464-471 (2006).
Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D. TGIF inhibits retinoid signaling. Mol. Cell. Biol. 26: 990-1001 (2006). *
Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. In Vivo 20: 729-733 (2006).
Barton BE. STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance. Expert Opin. Ther. Targets 10: 459-470 (2006).
Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7: 49-56 (2006). *
Bartosik-Psujek H, Stelmasiak Z. Multiple sclerosis - difficult answers to easy questions. Neurol. Neurochir. Pol. 40: 441-445 (2006).
Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J. Gastroenterol. 12: 5680-5686 (2006). *
Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch. Surg. 391: 499-510 (2006). *
Bartsch O, Rasi S, Delicado A, Dyack S, Neumann LM, Seemanova E, Volleth M, Haaf T, Kalscheuer VM. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome. Hum. Genet. 120: 179-186 (2006). *
Bartsocas CS, Gerasimidi-Vazeou A. Genetics of type 1 diabetes mellitus. Pediatr. Endocrinol. Rev. 3 Suppl. 3: 508-513 (2006).
Bartt RE. Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy. Curr. Opin. Neurol. 19: 341-349 (2006).
Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am. J. Neuroradiol. 27: 2179-2190 (2006). *
Bartz H, Avalos NM, Baetz A, Heeg K, Dalpke AH. Involvement of suppressors of cytokine signaling in Toll-like receptor-mediated block of dendritic cell differentiation. Blood 108: 4102-4108 (2006). *
Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, Rovere-Querini P. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J. Leukoc. Biol. 80: 87-95 (2006). *
Barve S, Joshi-Barve S, Song Z, Hill D, Hote P, Deaciuc I, McClain C. Interactions of cytokines, S-adenosylmethionine, and S-adenosylhomocysteine in alcohol-induced liver disease and immune suppression. J. Gastroenterol. Hepatol. 21 Suppl. 3: S38-S42 (2006). *
Basaranoglu M. Symptom date is better than the endoscopic diagnosis date in seasonal variation studies in IBD. Am. J. Gastroenterol. 101: 2668-2669 (2006). *
Basavaraju KP, Hale RJ, Ahluwalia NK. An unusual cause of rectal bleeding. Gut 55: 1402 (2006). *
Bascones-Ilundain C, Gonzalez-Moles MA, Esparza-Gomez G, Gil-Montoya JA, Bascones-Martinez A. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions. Anticancer Res. 26: 357-362 (2006).
Baselga J. Targeting tyrosine kinases in cancer: the second wave. Science 312: 1175-1178 (2006). *
Basic S, Hajnsek S, Poljakovic Z, Basic M. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 47: 449 (2006). *
Basile G, Chiarenza S, Di Mari P, Leanza S, Boscarelli G, Buffone A. Crohn's disease in the elderly. Ann. Ital. Chir. 77: 247-251 (2006).
Basili G, Lorenzetti L, Celona G, Biondi G, Preziuso E, Angrisano C, Goletti O, Belcari C, Venturini G. Gallstone ileus in patient with Crohn's disease: report of a clinical observation. Surg. Endosc. 20: 703-704 (2006).
Basiratnia M, Vasei M, Bahador A, Ebrahimi E, Derakhshan A. Acute acalculous cholecystitis in a child with systemic lupus erythematosus. Pediatr. Nephrol. 21: 873-876 (2006). *
Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, Gores GJ. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology 44: 252-262 (2006). *
Baskin-Bey ES, Moreno Luna LE, Gores GJ. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology. J. Hepatol. 45: 476-479 (2006). *
Basler T, Jeckstadt S, Valentin-Weigand P, Goethe R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages. J. Leukoc. Biol. 79: 628-638 (2006). *
Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin. Nutr. 25: 454-465 (2006).
Basso D, Guariso G, Fasolo M, Pittoni M, Schiavon S, Fogar P, Greco E, Navaglia F, Zambon CF, Plebani M. A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies. J. Pediatr. Gastroenterol. Nutr. 43: 613-618 (2006). *
Basso D, Guariso G, Fogar P, Navaglia F, Zambon CF, Plebani M. Insights in the laboratory diagnosis of celiac disease. Lupus 15: 462-465 (2006).
Bassotti G, Villanacci V, Mazzocchi A, Castellani D, Giuliano V, Corsi S, Morelli A. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission. Eur. J. Gastroenterol. Hepatol. 18: 507-510 (2006).
Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler. Thromb. Vasc. Biol. 26: 995-1001 (2006). *
Basu A, Yang K, Wang M, Liu S, Chintala R, Palm T, Zhao H, Peng P, Wu D, Zhang Z, Hua J, Hsieh MC, Zhou J, Petti G, Li X, Janjua A, Mendez M, Liu J, Longley C, Zhang Z, Mehlig M, Borowski V, Viswanathan M, Filpula D. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Bioconjug. Chem. 17: 618-630 (2006). *
Bataller R. Time to ban smoking in patients with chronic liver diseases. Hepatology 44: 1394-1396 (2006). *
Bates IR, Hebert B, Luo Y, Liao J, Bachir AI, Kolin DL, Wiseman PW, Hanrahan JW. Membrane lateral diffusion and capture of CFTR within transient confinement zones. Biophys. J. 91: 1046-1058 (2006). *
Bates JM, Mittge E, Kuhlman J, Baden KN, Cheesman SE, Guillemin K. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev. Biol. 297: 374-386 (2006). *
Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. J. Rheumatol. 33: 234-243 (2006).
Bathum L, Hansen H, Teisner B, Koch C, Garred P, Rasmussen K, Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 43: 473-479 (2006). *
Batrakova EV, Kelly DL, Li S, Li Y, Yang Z, Xiao L, Alakhova DY, Sherman S, Alakhov VY, Kabanov AV. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol. Pharm. 3: 113-123 (2006). *
Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177: 8338-8347 (2006). *
Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936 (2006). *
Battista N, Fezza F, Finazzi-Agro A, Maccarrone M. The endocannabinoid system in neurodegeneration. Ital. J. Biochem. 55: 283-289 (2006).
Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World J. Gastroenterol. 12: 6128-6132 (2006). *
Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc. Natl. Acad. Sci. U.S.A. 103: 8419-8424 (2006). *
Bauch A, Superti-Furga G. Charting protein complexes, signaling pathways, and networks in the immune system. Immunol. Rev. 210: 187-207 (2006). *
Baudino L, Azeredo da Silveira S, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin. Immunopathol. 28: 175-184 (2006). *
Bauer AW. Possibilities and limits of retrospective diagnoses. Pathobiografical notes on Wolfgang Amadeus Mozart's diseases (1756-1791). Wurzbg. Medizinhist. Mitt. 25: 153-173 (2006).
Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, Miller DS. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein upregulation. Mol. Pharmacol. 70: 1212-1219 (2006). *
Bauer E, Williams BA, Smidt H, Verstegen MW, Mosenthin R. Influence of the gastrointestinal microbiota on development of the immune system in young animals. Curr. Issues Intest. Microbiol. 7: 35-51 (2006).
Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3: e491 (2006). *
Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Goedde S, Dinges H, Mueller-Ladner U, Renner C. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res. Ther. 8: R171 (2006). *
Bauerfeind P, Beglinger C, Beltinger J, Braegger C, Eigenmann F, Fried M, Guyot J, Hurlimann R, Michetti P, Seibold F, Straumann A. Infliximab - practical guidelines for the treatment of Crohn's disease. Rev. Med. Suisse. 2: 1807-1815 (2006).
Bauerova K, Ponist S, Ondrejickova O, Komendova D, Mihalova D. Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuro. Endocrinol. Lett. 27: S172-S175 (2006).
Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am. J. Respir. Crit. Care Med. 174: 795-802 (2006). *
Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - a long-term follow-up. Am. J. Gastroenterol. 101: 1048-1056 (2006). *
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342 (2006). *
Baussano I, Tardivo I, Bellezza-Fontana R, Forneris MP, Lezo A, Anfossi L, Castello M, Aleksandar V, Bignamini E. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics 118: 888-895 (2006). *
Bayary J, Dasgupta S, Misra N, Ephrem A, Duong Van Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri S. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int. Immunopharmacol. 6: 528-534 (2006).
Bayazit YA. Genetics of headache and catechol-O-methyltransferase gene polymorphism. J. Headache Pain 7: 60 (2006). *
Bayazit YA, Yilmaz M. An overview of hereditary hearing loss. ORL J. Otorhinolaryngol. Relat. Spec. 68: 57-63 (2006).
Bayoumi RA, Simsek M, Yahya TM, Bendict S, Al-Hinai A, Al-Barwani H, Hassan MO. Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum. Biol. 78: 103-108 (2006).
Bays H. Clinical overview of omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am. J. Cardiol. 98: S71-S76 (2006). *
Bazan NG. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29: 263-271 (2006). *
Bazarah SM, Ritenour R, Patel ST, Hirsch G, Peltekian KM, Cruess AF. Choroidal neovascularization with interferon associated retinopathy: case report and review of literature. Ann. Hepatol. 5: 172-176 (2006). *
Bazin R, Lemieux R, Tremblay T. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody. Br. J. Haematol. 135: 97-100 (2006). *
Bazzigaluppi E, Roggero P, Parma B, Brambillasca MF, Meroni F, Mora S, Bosi E, Barera G. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet. Dig. Liver Dis. 38: 98-102 (2006).
Bdioui F, Sakly N, Hassine M, Saffar H. Prevalence of celiac disease in Tunisian blood donors. Gastroenterol. Clin. Biol. 30: 33-36 (2006). *
Beadling C, Slifka MK. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch. Immunol. Ther. Exp. (Warsz.) 54: 15-24 (2006).
Beasley RP. Diabetes and hepatocellular carcinoma. Hepatology 44: 1408-1410 (2006). *
Beattie RM. The changing face of coeliac disease. Arch. Dis. Child. 91: 955-956 (2006). *
Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease. Arch. Dis. Child. 91: 426-432 (2006). *
Beaudette-Zlatanova BC, Ling T, Shlomchik MJ, Marshak-Rothstein A, Rifkin IR. B cells and dendritic cells from Vkappa8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells. J. Immunol. 177: 45-52 (2006). *
Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of disabling Crohn�s disease. Gastroenterology 130: 650-656 (2006). *
Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu. Rev. Med. 57: 313-329 (2006). *
Bebb JR, Lawson A, Knight T, Long RG. Long-term follow-up of coeliac disease - what do coeliac patients want? Aliment. Pharmacol. Ther. 23: 827-831 (2006). *
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J. Immunol. 176: 6055-6064 (2006). *
Bechade D, Desrame J, Sallansonnet-Froment M, Taillia H, Algayres JP. Cerebral venous thrombosis and ulcerative colitis. Rev. Med. Interne. 27: 958-961 (2006).
Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84: 532-543 (2006). *
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 24: 2283-2289 (2006). *
Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, Nikolaev A, Lehr HA, Murphy AJ, Valenzuela DM, Yancopoulos GD, Galle PR, Karow M, Neurath MF. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177: 2760-2764 (2006). *
Becker H, Gaubitz M, Domschke W, Kucharzik T. Joint involvement in chronic inflammatory bowel disease - current diagnostics and treatment options. Z. Gastroenterol. 44: 497-502 (2006).
Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M. Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides. Clin. Rheumatol. 25: 368-372 (2006). *
Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundam. Clin. Pharmacol. 20: 429-447 (2006). *
Becker JM, Prushik SG, Stucchi AF. Infliximab for ulcerative colitis. N. Engl. J. Med. 354: 1424-1426 (2006). *
Becker M, Cotena A, Gordon S, Platt N. Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur. J. Immunol. 36: 950-960 (2006). *
Becker Y. Molecular immunological approaches to biotherapy of human cancers - a review, hypothesis and implications. Anticancer Res. 26: 1113-1134 (2006).
Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Arthritis Res. Ther. 8: R162 (2006). *
Becker-Merok A, Nikolaisen C, Nossent HC. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15: 570-576 (2006).
Becker-Merok A, Nossent HC. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J. Rheumatol. 33: 1570-1577 (2006).
Becq F. On the discovery and development of CFTR chloride channel activators. Curr. Pharm. Des. 12: 471-484 (2006).
Becquemont L, Glaeser H, Drescher S, Hitzl M, Simon N, Murdter TE, Heinkele G, Hofmann U, Schaefer C, Burk O, Verstuyft C, Eichelbaum M, Fromm MF. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. Clin. Pharmacol. Ther. 79: 449-460 (2006). *
Becvar R, Stork J, Jansa P. New trends in diagnosis and treatment of systemic sclerosis. Vnitr. Lek. 52: 712-717 (2006).
Beddy D, Mulsow J, Watson RW, Fitzpatrick JM, O'Connell PR. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease. Br. J. Surg. 93: 1290-1296 (2006). *
Bedeir A, Jukic DM, Wang L, Mullady DK, Regueiro M, Krasinskas AM. Systemic mastocytosis mimicking inflammatory bowel disease: a case report and discussion of gastrointestinal pathology in systemic mastocytosis. Am. J. Surg. Pathol. 30: 1478-1482 (2006).
Bedford PA, Todorovic V, Westcott ED, Windsor AC, English NR, Al-Hassi HO, Raju KS, Mills S, Knight SC. Adipose tissue of human omentum is a major source of dendritic cells, which lose MHC class II and stimulatory function in Crohn's disease. J. Leukoc. Biol. 80: 546-554 (2006). *
Bedir A, Aliyazicioglu Y, Kahraman H, Yurdakul Z, Uysal M, Suvaci DE, Okuyucu A, Hokelek M, Alvur M. Genotoxicity in rats treated with the antidiabetic agent, rosiglitazone. Environ. Mol. Mutagen. 47: 718-724 (2006). *
Beech JT, Andreakos E, Ciesielski CJ, Green P, Foxwell BM, Brennan FM. T cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NF-kappaB: implications for rheumatoid arthritis. Arthritis Res. Ther. 8: R168 (2006). *
Beer TM, Myrthue A. Calcitriol in the treatment of prostate cancer. Anticancer Res. 26: 2647-2651 (2006).
Beer TM, Venner PM, Ryan CW, Petrylak DP, Chatta G, Dean Ruether J, Chi KN, Curd JG, Deloughery TG. High dose calcitriol may reduce thrombosis in cancer patients. Br. J. Haematol. 135: 392-394 (2006). *
Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, Leehealey CJ, S Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U.S.A. 103: 17414-17419 (2006). *
Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE. Mutation of a critical GTP-binding arginine in transglutaminase 2 disinhibits intracellular crosslinking activity. J. Biol. Chem. 281: 12603-12609 (2006). *
Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol. Biomarkers Prev. 15: 2422-2426 (2006). *
Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM. Microbial induction of CARD15 expression in intestinal epithelial cells via Toll-like receptor 5 triggers an antibacterial response loop. J. Cell. Physiol. 209: 241-252 (2006). *
Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130: 1962-1974 (2006). *
Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional disorders of gallbladder and sphincter of oddi. Gastroenterology 130: 1498-1509 (2006). *
Behera AK, Hildebrand E, Szafranski J, Hung HH, Grodzinsky AJ, Lafyatis R, Koch AE, Kalish R, Perides G, Steere AC, Hu LT. Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum. 54: 3319-3329 (2006). *
Behr MA, Schurr E. Mycobacteria in Crohn's disease: a persistent hypothesis. Inflamm. Bowel Dis. 12: 1000-1004 (2006). *
Beissert S, Cavazzana I, Mascia F, Meroni P, Pastore S, Tessari G, Girolomoni G. Mechanisms of immune-mediated skin diseases: an overview. Clin. Exp. Rheumatol. 24: S1-S6 (2006).
Beissert S, Schwarz A, Schwarz T. Regulatory T cells. J. Invest. Dermatol. 126: 15-24 (2006). *
Beitz E, Wu B, Holm LM, Schultz JE, Zeuthen T. Point mutations in the aromatic/arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and protons. Proc. Natl. Acad. Sci. U.S.A. 103: 269-274 (2006). *
Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett. 233: 21-27 (2006). *
Belaiche J, Louis E. Diagnosis of small bowel malabsorption syndromes in adults. Acta Gastroenterol. Belg. 69: 31-37 (2006).
Belakavadi M, Fondell JD. Role of the mediator complex in nuclear hormone receptor signaling. Rev. Physiol. Biochem. Pharmacol. 156: 23-43 (2006).
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307 (2006). *
Belhocine K, Chaoui F. Menetrier disease and ulcerative colitis: an unusual association. Gastroenterol. Clin. Biol. 30: 1105-1107 (2006).
Belizon A, Sardinha CT, Sher ME. Converted laparoscopic colectomy: what are the consequences? Surg. Endosc. 20: 947-951 (2006). *
Belkaid Y, Blank RB, Suffia I. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 212: 287-300 (2006). *
Bell AJ, Price AB, Forbes A, Ciclitira PJ, Groves C, Nicholls RJ. Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy. Colorectal Dis. 8: 402-410 (2006). *
Bell AW, Michalopoulos GK. Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR. Hepatology 44: 186-194 (2006). *
Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291: C1318-C1325 (2006). *
Bell DA. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? J. Rheumatol. 33: 2369-2371 (2006).
Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. U.S.A. 103: 8792-8797 (2006). *
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Davies DR, Segal DM. The molecular structure of the TLR3 extracellular domain. J. Endotoxin Res. 12: 375-378 (2006). *
Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin. Exp. Allergy 36: 1546-1555 (2006). *
Bellomo-Brandao MA, Costa-Pinto EA, Tommaso AM, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq. Gastroenterol. 43: 45-49 (2006). *
Belmont HM. Treatment of ANCA-associated systemic vasculitis. Bull. Hosp. Jt. Dis. 64: 60-66 (2006). *
Belo A, Marchbank T, Fitzgerald A, Ghosh S, Playford RJ. Gastroprotective effects of oral nucleotide administration. Gut 55: 165-171 (2006). *
Belousova E. Epidemiology of inflammatory bowel disease in Russia. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 31 (2006). *
Belov K, Deakin JE, Papenfuss AT, Baker ML, Melman SD, Siddle HV, Gouin N, Goode DL, Sargeant TJ, Robinson MD, Wakefield MJ, Mahony S, Cross JG, Benos PV, Samollow PB, Speed TP, Graves JA, Miller RD. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. PLoS Biol. 4: e46 (2006). *
Belpoggi F, Soffritti M, Tibaldi E, Falcioni L, Bua L, Trabucco F. Results of long-term carcinogenicity bioassays on Coca-Cola administered to Sprague-Dawley rats. Ann. N. Y. Acad. Sci. 1076: 736-752 (2006). *
Beltran B, Nos P, Bastida G, Iborra M, Hoyos M, Ponce J. Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease. Gut 55: 1670-1671 (2006). *
Beltran S, Lescure FX, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm. Res. 66: 21-26 (2006).
Belvederesi L, Bianchi F, Loretelli C, Gagliardini D, Galizia E, Bracci R, Rosati S, Bearzi I, Viel A, Cellerino R, Porfiri E. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur. J. Hum. Genet. 14: 853-859 (2006). *
Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Eur. J. Pharmacol. 533: 101-109 (2006). *
Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J. Ethnopharmacol. 105: 1-25 (2006). *
Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 16: 38-52 (2006). *
Ben-David H, Aruna BV, Seger R, Sela M, Mozes E. A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses. Proc. Natl. Acad. Sci. U.S.A. 103: 18232-18237 (2006). *
Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I. Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage among memory function, gut homing, and Th1 polarization. J. Leukoc. Biol. 79: 676-685 (2006). *
Ben-Hur T, van Heeswijk RB, Einstein O, Aharonowiz M, Xue R, Frost EE, Mori S, Reubinoff BE, Bulte JW. Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn. Reson. Med. 57: 164-171 (2006).
Ben-Nun A, de Rosbo NK, Kaushansky N, Eisenstein M, Cohen L, Kaye JF, Mendel I. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2(b) mice. Eur. J. Immunol. 36: 478-493 (2006). *
Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, Buchegger F, Pichard C. omega-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 22: 931-939 (2006). *
Bendayan D, Shitrit D, Kramer MR. Pulmonary arterial hypertension associated with autoimmune disease: a single medical center experience. Isr. Med. Assoc. J. 8: 252-254 (2006). *
Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. Arthritis Rheum. 54: 3782-3789 (2006). *
Bene J, Komlosi K, Havasi V, Talian G, Gasztonyi B, Horvath K, Mozsik G, Hunyad y B, Melegh B, Figler M. Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. World J. Gastroenterol. 12: 110-113 (2006). *
Bene J, Magyari L, Talian G, Komlosi K, Gasztonyi B, Tari B, Varkonyi A, Mozsik G, Melegh B. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J. Gastroenterol. 12: 5550-5553 (2006). *
Benedek TG. The history of bacteriologic concepts of rheumatic fever and rheumatoid arthritis. Semin. Arthritis Rheum. 36: 109-123 (2006). *
Benelli R, Lorusso G, Albini A, Noonan DM. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr. Pharm. Des. 12: 3101-3115 (2006).
Benes Z, Koten J, Kabelkova M, Benes J. Imported cryptococcal infection mimicking primary sclerosing cholangitis. Klin. Mikrobiol. Infekc. Lek. 12: 240-243 (2006).
Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J. Parenter. Enteral Nutr. 30: 45-51 (2006). *
Bengmark S, Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr. Hosp. 21 Suppl. 2: 72-84, 73-86 (2006).
Bengtson MB, Ronning T, Vatn M, Harris J. Irritable bowel syndrome in twins: genes and environment. Gut 55: 1754-1759 (2006). *
Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, Remuzzi G. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. J. Am. Soc. Nephrol. 17: 1624-1632 (2006). *
Benito Conejero S, Diaz Espejo C, Lopez Dominguez JM, Pujol de la Llave E. Cerebral calcifications: a clue for a diagnostic process in a inespecific clinical case. An. Med. Interna. 23: 127-129 (2006).
Benito P, Caballero J, Moreno J, Gutierrez-Alcantara C, Munoz C, Rojo G, Garcia S, Soriguer FC. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin. Nutr. 25: 581-587 (2006).
Bennett DJ, Cooke AJ, Edwards AS. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis. Recent Patents Cardiovasc. Drug Discov. 1: 21-46 (2006).
Bennett JL. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis. Neurol. Res. 28: 291-298 (2006).
Bennouna S, Sukhumavasi W, Denkers EY. Toxoplasma gondii inhibits Toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils. Infect. Immun. 74: 4274-4281 (2006). *
Benoist C, Germain RN, Mathis D. A plaidoyer for 'systems immunology'. Immunol. Rev. 210: 229-234 (2006). *
Benson JD, Chen YN, Cornell-Kennon SA, Dorsch M, Kim S, Leszczyniecka M, Sellers WR, Lengauer C. Validating cancer drug targets. Nature 441: 451-456 (2006). *
Benson M, Carlsson L, Guillot G, Jernas M, Langston MA, Rudemo M, Andersson B. A network-based analysis of allergen-challenged CD4+ T cells from patients with allergic rhinitis. Genes Immun. 7: 514-521 (2006). *
Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, Bouche O, Thiefin G, Cadiot G. Complementary and alternative medicine use by patients with inflammatory bowel disease. Gastroenterol. Clin. Biol. 30: 14-23 (2006). *
Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M. Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers. Recenti Prog. Med. 97: 134-139 (2006).
Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16: 225-236 (2006).
Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177: 7833-7840 (2006). *
Bercion R, Demartin M, Recio C, Massamba PM, Frank T, Escriba JM, Grimont F, Grimont PA, Weill FX. Molecular epidemiology of multidrug-resistant Shigella dysenteriae type 1 causing dysentery outbreaks in Central African Republic, 2003-2004. Trans. R. Soc. Trop. Med. Hyg. 100: 1151-1158 (2006).
Berdeli A, Gurkan A, Emingil G, Atilla G, Kose T. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases. J. Periodontol. 77: 1348-1354 (2006).
Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, Salar K, Gurpinar AR. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol. Int. 26: 726-731 (2006). *
Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. Lack of association between TNFalpha gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients. Scand. J. Rheumatol. 35: 44-47 (2006). *
Berdiev BK, Benos DJ. Epithelial sodium channel in planar lipid bilayers. Methods Mol. Biol. 337: 89-99 (2006).
Bereket A. Vitamin D receptor polymorphism in nutritional rickets. Pediatr. Endocrinol. Rev. 3 Suppl. 3: 476-479 (2006).
Berends MA, Snoek J, DE Jong EM, VAN DE Kerkhof PC, VAN Oijen MG, VAN Krieken JH, Drenth JP. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Aliment. Pharmacol. Ther. 24: 805-811 (2006). *
Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sorbo JH, Tjonnfjord GE. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91: 460-466 (2006). *
Beresford MW, Davidson JE. Adolescent development and SLE. Best Pract. Res. Clin. Rheumatol. 20: 353-368 (2006).
Berg CP, Stein GM, Klein R, Pascu M, Berg T, Kammer W, Priemer M, Nordheim A, Schulze-Osthoff K, Gregor M, Wesselborg S, Berg PA. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients. Liver Int. 26: 846-855 (2006). *
Berg DT, Gerlitz B, Sharma GR, Richardson MA, Stephens EJ, Grubbs RL, Holmes KC, Fynboe K, Montani D, Cramer MS, Engle SD, Jakubowski JA, Heuer JG, Grinnell BW. FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis. Clin. Vaccine Immunol. 13: 426-432 (2006). *
Bergamaschi R, Montomoli C, Candeloro E, Monti MC, Cioccale R, Bernardinelli L, Fratino P, Cosi V; the PREMS (Pavia REgister of Multiple Sclerosis) Group. Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy. J. Neurol. Sci. 244: 127-131 (2006). *
Bergamo P, Luongo D, Maurano F, Mazzarella G, Stefanile R, Rossi M. Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/lpr mice. J. Lipid Res. 47: 2382-2391 (2006). *
Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology 44: 1317-1323 (2006). *
Berger A, Roberts MA, Hoff B. How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome. Lipids Health Dis. 5: 10 (2006). *
Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin. Colorectal Cancer 5: 338-343 (2006).
Berger CL, Vasquez JG, Shofner J, Mariwalla K, Edelson RL. Langerhans cells: mediators of immunity and tolerance. Int. J. Biochem. Cell Biol. 38: 1632-1636 (2006). *
Berger JR. Natalizumab. Drugs Today (Barc.) 42: 639-655 (2006).
Berger T, Reindl M. Biomarkers in multiple sclerosis: role of antibodies. Dis. Markers 22: 207-212 (2006).
Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in ZDF rats: a comparison to PPARgamma agonism. Endocrinology 147: 4252-4262 (2006). *
Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J. Pharmacol. Exp. Ther. 316: 592-600 (2006). *
Bergheim I, Harsch S, Mueller O, Schimmel S, Fritz P, Stange EF. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J. Lipid Res. 47: 42-50 (2006). *
Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J. Immunol. 177: 2088-2096 (2006). *
Berglund LJ, Jones GJ, Murali R, Fulcher DA. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency. J. Allergy Clin. Immunol. 117: 870-877 (2006). *
Bergman E, Forsell P, Tevell A, Persson EM, Hedeland M, Bondesson U, Knutson L, Lennernas H. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. Eur. J. Pharm. Sci. 29: 205-214 (2006). *
Bergman R, Parkes M. Systematic review: the use of mesalazine in inflammatory bowel disease. Aliment. Pharmacol. Ther. 23: 841-855 (2006). *
Bergquist A, Glaumann H, Lindberg B, Broome U. Primary sclerosing cholangitis can present with acute liver failure: report of two cases. J. Hepatol. 44: 1005-1008 (2006). *
Bergquist A, Montgomery SM, Lund U, Ekbom A, Olsson R, Lindgren S, Prytz H, Hultcrantz R, Broome U. Perinatal events and the risk of developing primary sclerosing cholangitis. World J. Gastroenterol. 12: 6037-6040 (2006). *
Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients. Dis. Colon Rectum 49: 1620-1628 (2006). *
Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunol. 177: 7287-7295 (2006). *
Berin MC, Li H, Sperber K. Antibody-mediated antigen sampling across intestinal epithelial barriers. Ann. N. Y. Acad. Sci. 1072: 253-261 (2006). *
Berin MC, Zheng Y, Domaradzki M, Li XM, Sampson HA. Role of TLR4 in allergic sensitization to food proteins in mice. Allergy 61: 64-71 (2006).
Berkhout M, Friederich P, van Krieken JH, Peters WH, Nagengast FM. Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis. Inflamm. Bowel Dis. 12: 112-116 (2006). *
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology 84: 346-352 (2006).
Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 55: 850-855 (2006). *
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 54: 2423-2433 (2006). *
Bermejo Velasco PE, Burgos Garcia A. Neurological complications of celiac disease. Med. Clin. (Barc.) 127: 500-507 (2006).
Bernal I, Domenech E, Garcia-Planella E, Marin L, Manosa M, Navarro M, Cabre E, Gassull MA. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig. Dis. Sci. 51: 2165-2169 (2006). *
Bernal I, Manosa M, Domenech E, Garcia-Planella E, Navarro M, Lorenzo-Zuniga V, Cabre E, Gassull MA. Predictors of clinical response to systemic steroids in active ulcerative colitis. Dig. Dis. Sci. 51: 1434-1438 (2006). *
Bernal NP, Stehr W, Coyle R, Erwin CR, Warner BW. Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice. Gastroenterology 130: 412-423 (2006). *
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 54: 2550-2557 (2006). *
Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senecal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 15: 835-839 (2006).
Bernatsky S, Clarke A, Pope J, Hanly JG, Smith CD, Peschken C, Rich E, Boire G, Fortin PR. Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: a pilot study. Lupus 15: 695-696 (2006).
Bernatsky S, Pineau CA, Lee JL, Clarke AE. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus. Lupus 15: 671-674 (2006).
Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr. Opin. Rheumatol. 18: 129-134 (2006).
Bernatsky S, Ramsey-Goldman R, Lachance S, Pineau CA, Clarke AE. Lymphoma in a patient with systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 570-574 (2006). *
Bernbom N, Norrung B, Saadbye P, Molbak L, Vogensen FK, Licht TR. Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender. J. Microbiol. Methods 66: 87-95 (2006). *
Berndt SI, Dodson JL, Huang WY, Nicodemus KK. A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J. Urol. 175: 1613-1623 (2006).
Berner IC, Dudler J. Viral arthritis. Rev. Med. Suisse. 2: 732-734, 737 (2006).
Bernhardt WM, Schefold JC, Weichert W, Rudolph B, Frei U, Groneberg DA, Schindler R. Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin. Nephrol. 65: 216-221 (2006).
Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig. Liver Dis. 38: 381-387 (2006).
Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev. Mol. Diagn. 6: 319-331 (2006).
Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 12: 402-412 (2006). *
Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res. Ther. 8: 217 (2006). *
Bernstein CN. Biomarkers, surveillance strategies, chromoendoscopy medication-induced malignancies and chemoprevention (past). Inflamm. Bowel Dis. 12 Suppl. 3: S10-S11 (2006).
Bernstein CN. Inflammatory bowel diseases as secondary causes of osteoporosis. Curr. Osteoporos. Rep. 4: 116-123 (2006).
Bernstein CN. Natural history and management of flat and polypoid dysplasia in inflammatory bowel disease. Gastroenterol. Clin. North Am. 35: 573-579 (2006).
Bernstein CN. Osteoporosis in patients with inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 4: 152-156 (2006).
Bernstein CN. Neoplasia in inflammatory bowel disease: surveillance and management strategies. Curr. Gastroenterol. Rep. 8: 513-518 (2006).
Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am. J. Gastroenterol. 101: 110-118 (2006). *
Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am. J. Gastroenterol. 101: 993-1002 (2006). *
Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 101: 1559-1568 (2006). *
Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD. Am. J. Gastroenterol. 101: 782-785 (2006). *
Bernstein H, Holubec H, Bernstein C, Ignatenko N, Gerner E, Dvorak K, Besselsen D, Ramsey L, Dall'Agnol M, Blohm-Mangone KA, Padilla-Torres J, Cui H, Garewal H, Payne CM. Unique dietary-related mouse model of colitis. Inflamm. Bowel Dis. 12: 278-293 (2006). *
Bernstein LR. Does nucleolin bind the NF kappa B DNA binding motif? Hepatology 43: 376 (2006). *
Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7: 122-129 (2006). *
Bernt C, Vennegeerts T, Beuers U, Rust C. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis. Biochem. Biophys. Res. Commun. 340: 800-806 (2006). *
Berruyer C, Pouyet L, Millet V, Martin FM, Legoffic A, Canonici A, Garcia S, Bagnis C, Naquet P, Galland F. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J. Exp. Med. 203: 2817-2827 (2006). *
Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N. Engl. J. Med. 354: 697-708 (2006). *
Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM. Hypertriglyceridemia: management of atherogenic dyslipidemia. J. Fam. Pract. 55: S1-S8 (2006).
Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin. Gastroenterol. Hepatol. 4: 514-520 (2006).
Berthelot C, Cather J, Jones D, Duvic M. Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy. Clin. Lymphoma Myeloma 6: 329-332 (2006).
Berthelot P, Carricajo A, Aubert G, Akhavan H, Gazielly D, Lucht F. Outbreak of postoperative shoulder arthritis due to Propionibacterium acnes infection in nondebilitated patients. Infect. Control Hosp. Epidemiol. 27: 987-990 (2006). *
Berti I, Della Vedova R, Paduano R, Devetta M, Caradonna M, Villanacci V, Not T, Martelossi S, Tamburlini G, Ventura A. Coeliac disease in primary care: evaluation of a case-finding strategy. Dig. Liver Dis. 38: 461-467 (2006).
Bertinetto FE, Dall'omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int. J. Immunogenet. 33: 375-384 (2006). *
Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15: 172-178 (2006).
Bertoli AM, Alarcon GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: clinical features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 54: 1580-1587 (2006). *
Bertoli AM, Fernandez M, McGwin G Jr, Alarcon GS, Tan FK, Reveille JD, Vila LM. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum. 54: 1703-1704 (2006). *
Bertolotti M, Gabbi C, Anzivino C, Mitro N, Godio C, De Fabiani E, Crestani M, Del Puppo M, Ricchi M, Carulli L, Rossi A, Loria P, Carulli N. Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. Eur. J. Clin. Invest. 36: 170-175 (2006).
Bertrand PP. Real-time measurement of serotonin release and motility in guinea pig ileum. J. Physiol. 577: 689-704 (2006). *
Bertuzzo CS, Pinto W. Molecular screening of CFTR gene in Brazilian men with bilateral agenesis of the vas deferens. Hum. Fertil. (Camb.) 9: 53-56 (2006).
Berven FS, Flikka K, Berle M, Vedeler C, Ulvik RJ. Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis. Curr. Pharm. Biotechnol. 7: 147-158 (2006).
Berzigotti A, Magalotti D, Zappoli P, Rossi C, Callea F, Zoli M. Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. World J. Gastroenterol. 12: 3612-3615 (2006). *
Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum. 55: 892-899 (2006). *
Bessard A, Coutant A, Rescan C, Ezan F, Fremin C, Courselaud B, Ilyin G, Baffet G. An MLCK-dependent window in late G1 controls S phase entry of proliferating rodent hepatocytes via ERK-p70S6K pathway. Hepatology 44: 152-163 (2006). *
Bessis N, Boissier MC. Gene therapy for patients with rheumatoid arthritis. Joint Bone Spine 73: 169-176 (2006). *
Best WR. Predicting the Crohn's disease activity index from the Harvey-Bradshaw index. Inflamm. Bowel Dis. 12: 304-310 (2006). *
Beswick EJ, Suarez G, Reyes VE. H. pylori and host interactions that influence pathogenesis. World J. Gastroenterol. 12: 5599-5605 (2006). *
Bethoux F. Fatigue and multiple sclerosis. Ann. Readapt. Med. Phys. 49: 355-360 (2006).
Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H, Gazit R, Mandelboim O. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides. J. Immunol. 176: 6762-6769 (2006). *
Bettelli E, Baeten D, Jager A, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116: 2393-2402 (2006). *
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238 (2006). *
Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehls O, Partsch CJ, Schwarz HP, Stahnke N, Ranke MB. Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J. Pediatr. Endocrinol. Metab. 19: 149-154 (2006).
Betterle C. Parathyroid and autoimmunity. Ann. Endocrinol. (Paris) 67: 147-154 (2006).
Betterle C, Lazzarotto F, Spadaccino AC, Basso D, Plebani M, Pedini B, Chiarelli S, Albergoni M. Celiac disease in North Italian patients with autoimmune Addison's disease. Eur. J. Endocrinol. 154: 275-279 (2006). *
Beuers U. Mechanisms of action of ursodeoxycholic acid for treatment of primary sclerosing cholangitis. Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 12 (2006). *
Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 318-328 (2006). *
Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. Hepatology 44: 280-281 (2006). *
Beuers U, Hohenester S, Pusl T, Rust C, Wimmer R. Tauroursodeoxycholic acid antagonizes taurolithocholic acid induced cholestasis via a cooperative protein kinase C- and protein kinase A-dependent signaling pathway in the perfused rat liver. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 81 (2006). *
Beuers U, Pusl T. Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders? Hepatology 43: 647-649 (2006). *
Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24: 353-389 (2006). *
Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Int. J. Mol. Med. 18: 415-423 (2006). *
Bevins CL. Host factors that shape the enteric flora: what changes in IBD? Inflamm. Bowel Dis. 12 Suppl. 3: S3 (2006).
Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochem. Soc. Trans. 34: 263-266 (2006). *
Bewley MS, Pena JT, Plesch FN, Decker SE, Weber GJ, Forrest Jr JN. Shark rectal gland vasoactive intestinal peptide receptor: cloning, functional expression, and regulation of CFTR chloride channels. Am. J Physiol. Regul. Integr. Comp. Physiol. 291: R1157-R1164 (2006). *
Beyan H, Ola T, David R, Leslie G. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult. Ann. N. Y. Acad. Sci. 1079: 81-89 (2006). *
Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 108: 804-811 (2006). *
Beyersdorf N, Balbach K, Hunig T, Kerkau T. Large-scale expansion of rat CD4 CD25 T cells in the absence of T-cell receptor stimulation. Immunology 119: 441-450 (2006). *
Beyersdorf N, Hanke T, Kerkau T, Hunig T. CD28 superagonists put a break on autoimmunity by preferentially activating CD4(+)CD25(+) regulatory T cells. Autoimmun. Rev. 5: 40-45 (2006).
Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J. Pediatr. Gastroenterol. Nutr. 43: S23-S29 (2006). *
Bezerra JA, Balistreri WF. Pediatric hepatology: progress in deciphering mechanisms and advancing therapy. Clin. Liver Dis. 10: ix-xii (2006). *
Bhaduri N, Mukhopadhyay K. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci. Lett. 402: 12-16 (2006). *
Bhandoola A, Sambandam A. From stem cell to T cell: one route or many? Nat. Rev. Immunol. 6: 117-126 (2006). *
Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J. Immunol. 177: 5631-5638 (2006). *
Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G820-829 (2006). *
Bharucha AE. Pro: Anorectal testing is useful in fecal incontinence. Am. J. Gastroenterol. 101: 2679-2681 (2006). *
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol. 6: 42 (2006). *
Bhat R, Eissmann P, Endt J, Hoffmann S, Watzl C. Fine-tuning of immune responses by SLAM-related receptors. J. Leukoc. Biol. 79: 417-424 (2006). *
Bhatia AS, Mihas AA. Cholestatic liver disease. Recognizing the clinical signs. Postgrad. Med. 119: 67-75, 82 (2006).
Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, Panagopoulos G, Ofer A, Tamas E, Kotsali P, Vele O. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J. Gastroenterol. 12: 6167-6171 (2006). *
Bhatia V, Viswanathan P. Insulin resistance and PPAR insulin sensitizers. Curr. Opin. Investig. Drugs 7: 891-897 (2006).
Bhatnagar S, Phillips AD, Bhan MK. Celiac disease in India. J. Pediatr. Gastroenterol. Nutr. 43: 263-264 (2006). *
Bhatnagar S, Tandon N. Diagnosis of celiac disease. Indian J. Pediatr. 73: 703-709 (2006). *
Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J. Hum. Genet. 51: 575-580 (2006). *
Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, Ramakrishnan L, Shankar S. Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand. J. Rheumatol. 35: 128-132 (2006). *
Bhattacharjee RN, Akira S. Modifying Toll-like receptor 9 signaling for therapeutic use. Mini. Rev. Med. Chem. 6: 287-291 (2006).
Bhattacharjee RN, Park KS, Kumagai Y, Okada K, Yamamoto M, Uematsu S, Matsui K, Kumar H, Kawai T, Iida T, Honda T, Takeuchi O, Akira S. VP1686, a Vibrio type III secretion protein, induces Toll-like receptor independent apoptosis in macrophage through NF-kappa B inhibition. J. Biol. Chem. 281: 36897-36904 (2006). *
Bhattacharya A, Ghosal S, Bhattacharya SK. Effect of fish oil on offensive and defensive factors in gastric ulceration in rats. Prostaglandins Leukot. Essent. Fatty Acids 74: 109-116 (2006). *
Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A. Imaging of proteolytic activity using a conditional cell surface receptor. Mol. Imaging 5: 129-137 (2006).
Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC, Balkrishnan R. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J. Dermatolog. Treat. 17: 294-301 (2006).
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual. Life Outcomes 4: 35 (2006).
Bi EG, Shi W, Zou J, Hao ZH, Li ZH, Cai D, Zhang HQ, Sun B. IL-12p40 is not required for islet allograft rejection. Acta Pharmacol. Sin. 27: 1065-1070 (2006). *
Bi YA, Kazolias DC, Duignan DB. Use of cryopreserved human hepatocytes in sandwich-culture to measure hepatobiliary transport. Drug Metab. Dispos. 34: 1658-1665 (2006). *
Biagi F, Campanella J, Laforenza U, Gastaldi G, Tritto S, Grazioli M, Villanacci V, Corazza GR. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent. Dig. Liver Dis. 38: 652-658 (2006).
Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR. Prevalence of coeliac disease in Italian patients affected by Addison's disease. Scand. J. Gastroenterol. 41: 302-305 (2006). *
Biagi F, Rondonotti E, Campanella J, Villa F, Bianchi PI, Klersy C, De Franchis R, Corazza GR. Video capsule endoscopy and histology for small-bowel mucosa evaluation: a comparison performed by blinded observers. Clin. Gastroenterol. Hepatol. 4: 998-1003 (2006).
Biagini MR, Tozzi A, Grippo A, Galli A, Milani S, Amantini A. Muscle fatigue in women with primary biliary cirrhosis: spectral analysis of surface electromyography. World J. Gastroenterol. 12: 5186-5190 (2006). *
Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J. Gastroenterol. 12: 1607-1612 (2006). *
Biagioni C, Favilli F, Catarzi S, Marcucci T, Fazi M, Tonelli F, Vincenzini MT, Iantomasi T. Redox state and O2*- production in neutrophils of Crohn's disease patients. Exp. Biol. Med. (Maywood) 231: 186-195 (2006). *
Bianchi A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction. Gastroenterology 130: S138-S146 (2006). *
Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F. Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest. Endosc. 63: 486-492 (2006).
Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benezzato L, Papi C, Meucci G, Riegler G, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched-pair study. Gut 55: 228-233 (2006). *
Biank VF, Kugathasan S. What are the risk factors for surgery and their implications for management of children with Crohn's disease? Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 660-661 (2006). *
Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J. Med. Microbiol. 55: 1141-1149 (2006). *
Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am. J. Hematol. 81: 391-396 (2006). *
Biecker E, Sauerbruch T. Control of infection in gastrointestinal endoscopy. Dtsch. Med. Wochenschr. 131: 2726-2732 (2006).
Biedermann T. Dissecting the role of infections in atopic dermatitis. Acta Derm. Venereol. 86: 99-109 (2006). *
Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103: 5941-5946 (2006). *
Bielicki D, Wasilewicz MP. Acute lower gastrointestinal tract bleeding caused by Dieulafoy lesion in rectum - case report. Pol. Merkuriusz. Lek. 20: 708-709 (2006).
Bienvenu F. Will serologic tests allow to diagnose coeliac disease in children? Arch. Pediatr. 13: 574-575 (2006).
Bierbaum S, Nickel R, Zitnik S, Ahlert I, Lau S, Deichmann KA, Wahn U, Heinzmann A. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls. Allergy 61: 576-580 (2006). *
Bierbaum S, Sengler C, Gerhold K, Berner R, Heinzmann A. Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 24: 219 (2006).
Bierhaus A, Humpert PM, Nawroth PP. Linking stress to inflammation. Anesthesiol. Clin. 24: 325-340 (2006).
Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin. Liver Dis. 26: 211-220 (2006).
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130: 1652-1660 (2006). *
Bihl F, Emmenegger U, Reichen J, Neftel KA, Zimmermann A, Cerny A. Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis. J. Hepatol. 44: 1208-1212 (2006). *
Bijl M, Kallenberg CG. Ultraviolet light and cutaneous lupus. Lupus 15: 724-727 (2006).
Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus (SLE): correlates with decreased serum levels of complement. Ann. Rheum. Dis. 65: 57-63 (2006). *
Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. U.S.A. 103: 732-737 (2006). *
Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP. Development and progression of alopecia in the vitamin D receptor null mouse. J. Cell. Physiol. 207: 340-353 (2006). *
Bilavsky E, Yarden-Bilavsky H, Zevit N, Amir J. Primary meningococcal arthritis in a child: case report and literature review. Scand. J. Infect. Dis. 38: 396-399 (2006). *
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7: 550-554 (2006). *
Bilinska M, Frydecka I, Kosmaczewska A, Ciszak L, Koszewicz M, Pokryszko-Dragan A. CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis. Pol. Merkuriusz. Lek. 20: 41-45 (2006).
Billack B. Macrophage activation: role of Toll-like receptors, nitric oxide, and nuclear factor kappa B. Am. J. Pharm. Educ. 70: 102 (2006).
Billaut-Laden I, Allorge D, Crunelle-Thibaut A, Rat E, Cauffiez C, Chevalier D, Houdret N, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H(2)S detoxification enzyme. Toxicology 225: 1-11 (2006). *
Billaut-Laden I, Rat E, Allorge D, Crunelle-Thibaut A, Cauffiez C, Chevalier D, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme. Toxicol. Lett. 165: 101-111 (2006).
Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Muller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur. Respir. J. 28: 1085-1091 (2006).
Billiau A. Anti-inflammatory properties of type I interferons. Antiviral Res. 71: 108-116 (2006). *
Bilodeau M. Central fatigue in continuous and intermittent contractions of triceps brachii. Muscle Nerve 34: 205-213 (2006).
Bilu Martin D, Deng A, Gaspari A, Pearson F. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole. Skinmed. 5: 302-305 (2006). *
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. Am. J. Physiol. Endocrinol. Metab. 290: E716-E722 (2006). *
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 26: 1175-1186 (2006). *
Binder A. Identification of genes for a complex trait: examples from hypertension. Curr. Pharm. Biotechnol. 7: 1-13 (2006).
Binder B, Ahlgrimm-Siess V, Hofmann-Wellenhof R. Eruptive melanocytic nevi of the palms and soles in a patient with Crohn disease. J. Dtsch. Dermatol. Ges. 4: 486-488 (2006).
Binder HJ. Causes of chronic diarrhea. N. Engl. J. Med. 355: 236-239 (2006). *
Binder SR. Autoantibody detection using multiplex technologies. Lupus 15: 412-421 (2006).
Binder SR, Hixson C, Glossenger J. Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease. Autoimmun. Rev. 5: 234-241 (2006).
Binder T, Salaj P, Zima T, Vitek L. Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP). Ceska. Gynekol. 71: 92-98 (2006).
Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J. Perinat. Med. 34: 383-391 (2006).
Bingham S. The fibre-folate debate in colo-rectal cancer. Proc. Nutr. Soc. 65: 19-23 (2006). *
Binion DG, Kugathasan S, Dwinell MB. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. Am. J. Gastroenterol. 101: 107-109 (2006). *
Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7: 284-292 (2006). *
Biondo M, Field J, Toh BH, Alderuccio F. Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J. Pathol. 209: 384-391 (2006). *
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Tanaka AM, Kraemer MH. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. Eur. J. Dermatol. 16: 523-529 (2006).
Birand B, Cabre P, Bonnan M, Olindo S, Smadja D. A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative. Rev. Med. Interne. 27: 616-619 (2006).
Bird NC, Ooi RC, Luo XY, Chin SB, Johnson AG. Investigation of the functional three-dimensional anatomy of the human cystic duct: a single helix? Clin. Anat. 19: 528-534 (2006).
Birinci A, Bilgici A, Kuru O, Durupinar B. HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol. Int. 26: 285-287 (2006). *
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community. Acta Derm. Venereol. 86: 209-214 (2006). *
Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA. Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum. 54: 3291-3299 (2006). *
Biro A. Clarifying omega-3 fatty acid recommendations. Can. Fam. Physician. 52: 1060-1061 (2006). *
Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, Szucs G, Zeher M, Bodolay E, Szegedi G, Bako G. Association of systemic and thyroid autoimmune diseases. Clin. Rheumatol. 25: 240-245 (2006). *
Biros DJ, Taylor AW, Kitaichi N. Melanocortin 5 receptor and ocular immunity. Cell. Mol. Biol. (Noisy-le-grand) 52: 53-59 (2006).
Birring SS, Pavord ID, Mund E, Larsson K. Idiopathic chronic cough and organ-specific autoimmune disease. Chest 129: 213-214 (2006). *
Bischoff SC, Gebhardt T. Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease. Adv. Exp. Med. Biol. 579: 177-208 (2006).
Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, Dieckgraefe BK. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 130: 137-149 (2006). *
Bisi A, Gobbi S, Rampa A, Belluti F, Piazzi L, Valenti P, Gyemant N, Molnar J. New potent P-glycoprotein inhibitors carrying a polycyclic scaffold. J. Med. Chem. 49: 3049-3051 (2006). *
Bisschops R, Rutgeerts P. Magnification imaging in inflammatory bowel disease: a useful aid for the prediction of disease relapse? Endoscopy 38: 1268-1270 (2006).
Bissett DL. Glucosamine: an ingredient with skin and other benefits. J. Cosmet. Dermatol. 5: 309-315 (2006).
Bissonnette R. Etanercept for the treatment of psoriasis. Skin Therapy Lett. 11: 1-4 (2006).
Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; on behalf of the ISA247 Psoriasis Study Group. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis. J. Am. Acad. Dermatol. 54: 472-478 (2006).
Biswas-Fiss EE. Interaction of the nucleotide binding domains and regulation of the ATPase activity of the human retina specific ABC transporter, ABCR. Biochemistry 45: 3813-3823 (2006). *
Bittencourt VC, da Figueiredo RT, Silva RB, Mourao-Sa DS, Fernandez PL, Sassaki GL, Mulloy B, Bozza MT, Barreto-Bergter E. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and TLR activation. J. Biol. Chem. 281: 22614-22623 (2006). *
Bizzaro N, Tampoia M, Villalta D, Platzgummer S, Liguori M, Tozzoli R, Tonutti E. Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis. J. Clin. Lab. Anal. 20: 184-189 (2006).
Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. ELR(+) CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol. Ther. 112: 139-149 (2006). *
Bjorkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr. Opin. Lipidol. 17: 527-533 (2006).
Bjorkhem I, Meaney S, Heverin M, Andersson U, Axelsson M, Panzenboek U, Sattler W. Role of oxysterols and cholestenoic acids in a crosstalk between the brain and the liver. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 23 (2006). *
Bjorkkjaer T, Brun JG, Valen M, Arslan G, Lind R, Brunborg LA, Berstad A, Froyland L. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis. 5: 6 (2006). *
Bjorkman DJ, Popp JW Jr. Measuring the quality of endoscopy. Am. J. Gastroenterol. 101: 864-865 (2006). *
Bjorksten B. The gut microbiota: a complex ecosystem. Clin. Exp. Allergy 36: 1215-1217 (2006). *
Bjornsson E, Nordlinder H, Olsson R. Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J. Hepatol. 44: 791-797 (2006). *
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27: 140-144 (2006).
Bjoro K, Brandsaeter B, Foss A, Schrumpf E. Liver transplantation in primary sclerosing cholangitis. Semin. Liver Dis. 26: 69-79 (2006). *
Black A. Antiphospholipid syndrome: an overview. Clin. Lab. Sci. 19: 144-147 (2006).
Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med. Hypotheses 67: 879-891 (2006).
Blackman SM, Deering-Brose R, McWilliams R, Naughton K, Coleman B, Lai T, Algire M, Beck S, Hoover-Fong J, Hamosh A, Fallin MD, West K, Arking DE, Chakravarti A, Cutler DJ, Cutting GR, Cutting G. Relative contribution of genetic and non-genetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 131: 1030-1039 (2006). *
Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle 5: 2087-2102 (2006). *
Blair HC, Carrington JL. Bone cell precursors and the pathophysiology of bone loss. Ann. N. Y. Acad. Sci. 1068: 244-249 (2006). *
Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab. Invest. 86: 191-201 (2006). *
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547 (2006). *
Blanchard DS. Omega-3 fatty acid supplementation in perinatal settings. MCN Am. J. Matern. Child. Nurs. 31: 250-256 (2006).
Blanco Y, Gomez-Choco M, Arostegui JL, Casanova B, Martinez-Rodriguez JE, Bosca I, Munteis E, Yague J, Graus F, Saiz A. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci. Lett. 396: 217-219 (2006). *
Blanco-Barca O, Gomez-Lado C, Rodrigo-Saez E, Curros-Novos C, Briones-Godino P, Eiris-Punal J, Castro-Gago M. Pyruvate dehydrogenase deficit associated to the C515T mutation in exon 6 of the E1alpha gene. Rev. Neurol. 43: 341-345 (2006).
Blanco-Quiros A, Solis-Sanchez P, Garrote-Adrados JA, Arranz-Sanz E. Common variable immunodeficiency. Old questions are getting clearer. Allergol. Immunopathol. (Madr.) 34: 263-275 (2006).
Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat. Immunol. 7: 1029-1035 (2006). *
Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812 (2006). *
Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J. Gastroenterol. 12: 5932-5940 (2006). *
Blank C. The use of questionnaires in pediatric inflammatory bowel disease. Curr. Gastroenterol. Rep. 8: 242-245 (2006).
Blank M, Gisondi P, Mimouni D, Peserico A, Piaserico S, Shoenfeld Y. New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin. Exp. Rheumatol. 24: S20-S25 (2006).
Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) 45: 833-841 (2006). *
Blank RB, Lamb EW, Tocheva AS, Crow ET, Lim KC, McKerrow JH, Davies SJ. The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells. J. Infect. Dis. 194: 1609-1616 (2006). *
Blaschke F, Caglayan E, Hsueh WA. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol. Metab. Clin. North Am. 35: 561-574 (2006).
Blaschke F, Spanheimer R, Khan M, Law RE. Vascular effects of TZDs: new implications. Vascul. Pharmacol. 45: 3-18 (2006).
Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ. Res. 99: e88-e99 (2006). *
Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 26: 28-40 (2006). *
Blaszyk H, Hyman NH, Cooper K. Herpes simplex virus colitis in ulcerative colitis, simulating malignancy. Histopathology 49: 316-318 (2006). *
Blattman JN, Greenberg PD. PD-1 blockade: rescue from a near-death experience. Nat. Immunol. 7: 227-228 (2006). *
Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM. Familial aggregation of alopecia areata. J. Am. Acad. Dermatol. 54: 627-632 (2006).
Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin. Cell. Dev. Biol. 17: 592-604 (2006). *
Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 44: 1465-1477 (2006). *
Blei AT. Innovations in hepatology. Hepatology 44: 1373 (2006). *
Blei DA. 25 years of Hepatology. Hepatology 43: S1 (2006). *
Blendis L. Child, MELD, hyponatremia, and now portal pressure. Gastroenterology 130: 1920-1921 (2006). *
Blendis L. Budd-Chiari syndrome: a clinical model of the hepatorenal reflex? Gastroenterology 131: 671-672 (2006). *
Blendis L. Percutaneous ethanol ablation of small hepatocellular carcinomas: twenty years on. Gastroenterology 130: 280-282 (2006). *
Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Lab. Invest. 86: 1136-1148 (2006). *
Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsoe B, Torp-Pedersen S. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scand. J. Rheumatol. 35: 341-345 (2006). *
Bloch DB, Gulick T, Bloch KD, Yang WH. Processing body autoantibodies reconsidered. RNA 12: 707-709 (2006). *
Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes. Genes Immun. 7: 130-140 (2006). *
Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J. Neurobiol. 66: 606-630 (2006).
Blonski W, Lichtenstein GR. Safety of biologics in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 9: 221-233 (2006).
Blonski W, Lichtenstein GR. Complications of biological therapy for inflammatory bowel diseases. Curr. Opin. Gastroenterol. 22: 30-43 (2006).
Blonski W, Lichtenstein GR. Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject-that is the question. Gastrointest. Endosc. 63: 493-496 (2006).
Bloomfeld RS. Are COX-2 inhibitors safe for anyone. Inflamm. Bowel Dis. 12: 922-923 (2006). *
Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin. Exp. Allergy 36: 402-425 (2006). *
Blossom SJ, Doss JC, Gilbert KM. Ability of trichloroethylene metabolite to promote immune pathology is strain-specific. J. Immunotoxicol. 3: 179-187 (2006).
Blossom SJ, Gilbert KM. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding. Toxicol. Sci. 92: 103-114 (2006). *
Bloudickova S, Rajnoch J, Lodererova A, Honsova E, Viklicky O. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat. Kidney Blood Press. Res. 29: 60-66 (2006).
Blouquit S, Regnier A, Dannhoffer L, Fermanian C, Naline E, Boucher R, Chinet T. Ion and fluid transport properties of small airways in cystic fibrosis. Am. J. Respir. Crit. Care Med. 174: 299-305 (2006). *
Bluestone JA, Boehmer H. Regulatory T cells. Semin. Immunol. 18: 77 (2006). *
Bluestone JA, St Clair EW, Turka LA. CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24: 233-238 (2006). *
Blum HE. Gene therapy for liver diseases: experimental strategies. Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 44-45 (2006). *
Blum KS, Pabst R. Keystones in lymph node development. J. Anat. 209: 585-595 (2006). *
Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J. Biol. Chem. 281: 11205-11213 (2006). *
Blumenberg M. DNA microarrays in dermatology and skin biology. OMICS 10: 243-260 (2006).
Blumenthal S. Multiple sclerosis. Radiol. Technol. 77: 309-321 (2006).
Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res. 66: 2195-2201 (2006). *
Boadu E, Choi HY, Lee DW, Waddington EI, Chan T, Asztalos B, Vance JE, Chan A, Castro G, Francis GA. Correction of apolipoprotein A-I-mediated lipid efflux and HDL particle formation in human Niemann-Pick type C disease fibroblasts. J. Biol. Chem. 281: 37081-37090 (2006). *
Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: a novel promising therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975 (2006). *
Bober A. Passing it on: should health care professionals be permitted to disclose patients' genetic information to their reproductive partners? J. Law Med. 14: 262-281 (2006).
Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J. Hepatol. 45: 568-574 (2006). *
Bobota AC, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mentzikof CM. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases. J. BUON. 11: 485-489 (2006).
Boccia S, Cadoni G, La Torre G, Arzani D, Volante M, Cattel C, Gianfagna F, Paludetti G, Almadori G, Ricciardi G. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J. Cancer Res. Clin. Oncol. 132: 466-472 (2006). *
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55: 2626-2630 (2006). *
Bockelmann R, Gollnick H, Bonnekoh B. Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis. Arthritis Rheum. 54: 1701-1702 (2006). *
Bockenstedt LK, Liu N, Schwartz I, Fish D. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks. Infect. Immun. 74: 2154-2160 (2006). *
Bocker U. Infliximab in ulcerative colitis. Scand. J. Gastroenterol. 41: 997-1000 (2006). *
Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet. Med. 8: 518-524 (2006).
Bodano A, Gonzalez A, Ferreiros-Vidal I, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. Rheumatology (Oxford) 45: 819-823 (2006). *
Bode L, Freeze HH. Applied glycoproteomics-approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim. Biophys. Acta 1760: 547-559 (2006). *
Boden G, Zhang M. Recent findings concerning thiazolidinediones in the treatment of diabetes. Expert Opin. Investig. Drugs 15: 243-250 (2006).
Bodger K, Halfvarson J, Dodson A, Campbell F, Wilson S, Lee R, Lindberg E, Jarnerot G, Tysk C, Rhodes J. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 55: 973-977 (2006). *
Bodily KD, Fletcher JG, Solem CA, Johnson CD, Fidler JL, Barlow JM, Bruesewitz MR, McCollough CH, Sandborn WJ, Loftus EV Jr, Harmsen WS, Crownhart BS. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation. Radiology 238: 505-516 (2006). *
Boehm I. Apoptosis in physiological and pathological skin: implications for therapy. Curr. Mol. Med. 6: 375-394 (2006).
Boehm T. Co-evolution of a primordial peptide-presentation system and cellular immunity. Nat. Rev. Immunol. 6: 79-84 (2006). *
Boehm T, Zufall F. MHC peptides and the sensory evaluation of genotype. Trends Neurosci. 29: 100-107 (2006). *
Boehncke WH, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review. J. Rheumatol. 33: 1447-1451 (2006).
Boers M. Abatacept in rheumatoid arthritis: a new branch on the "biologics" tree. Ann. Intern. Med. 144: 933-935 (2006). *
Boeshans KM, Wolf R, Voscopoulos C, Gillette W, Esposito D, Mueser TC, Yuspa SH, Ahvazi B. Purification, crystallization and preliminary X-ray diffraction of human S100A15. Acta Crystallograph. Sect. F. Struct. Biol. Cryst. Commun. 62: 467-470 (2006).
Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, Blum HE, Thimme R. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80: 3532-3540 (2006). *
Bogardus ST Jr. What do we know about diverticular disease?: a brief overview. J. Clin. Gastroenterol. 40 Suppl. 3: S108-111 (2006).
Bogas M, Afonso Mdo C, Araujo D. Erosive enteropathy in a patient with a polyarthritis. Acta Reumatol. Port. 31: 349-354 (2006).
Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells - fact or fancy? Trends Immunol. 27: 282-290 (2006). *
Bogdanos DP, Koutsoumpas A, Baum H, Vergani D. Borrelia burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis. Dig. Liver Dis. 38: 781-782 (2006).
Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin. Chim. Acta 373: 183-184 (2006). *
Bogdanos DP, Vergani D. Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int. 26: 633-635 (2006). *
Boggild M. Rationale and experience with combination therapies in multiple sclerosis. J. Neurol. 253: vi45-vi51 (2006). *
Bogoevska V, Horst A, Klampe B, Lucka L, Wagener C, Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via LewisX residues. Glycobiology 16: 197-209 (2006). *
Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting. Bioessays 28: 923-934 (2006). *
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int. J. Immunogenet. 33: 135-140 (2006). *
Bogunia-Kubik K, Uklejewska A, Dickinson A, Jarvis M, Lange A. HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. Transplantation 82: 1116-1117 (2006).
Bohm I. Quantification of absolute peripheral white blood cells and their subsets in patients with lupus erythematosus: comparison with other inflammatory diseases with and without autoimmune background. Biomed. Pharmacother. 60: 92-95 (2006).
Bohm I. The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus. Z. Rheumatol. 65: 541-544 (2006).
Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases. Clin. Exp. Rheumatol. 24: S67-S71 (2006).
Bohm S, Kruis W. Probiotics in chronic inflammatory bowel disease. MMW Fortschr. Med. 148: 30-34 (2006).
Bohm SK, Kruis W. Probiotics: do they help to control intestinal inflammation? Ann. N. Y. Acad. Sci. 1072: 339-350 (2006). *
Bohn E, Bechtold O, Zahir N, Frick JS, Reimann J, Jilge B, Autenrieth IB. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm. Bowel Dis. 12: 853-862 (2006). *
Bohnhorst J, Rasmussen T, Moen SH, Flottum M, Knudsen L, Borset M, Espevik T, Sundan A. Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia 20: 1138-1144 (2006).
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J. Rheumatol. 33: 703-708 (2006).
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Grazia Catanoso M, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 54: 4011-4017 (2006). *
Boirivant M, Pallone F, Di Giacinto C, Fina D, Monteleone I, Marinaro M, Caruso R, Colantoni A, Palmieri G, Sanchez M, Strober W, Macdonald TT, Monteleone G. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 131: 1786-1798 (2006). *
Bolander FF. Vitamins: not just for enzymes. Curr. Opin. Investig. Drugs 7: 912-915 (2006).
Bolder U, Jeschke MG, Landmann L, Wolf F, de Sousa C, Schlitt HJ, Przkora R. Heat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanisms. Cell Stress Chaperones 11: 89-100 (2006). *
Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum. Immunol. 67: 722-734 (2006).
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 7: 393-400 (2006). *
Bolek T, Baker ME, Walsh RM. Imaging's roles in acute pancreatitis. Cleve. Clin. J. Med. 73: 857-862 (2006). *
Bolton C, Paul C. Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm. 2006: 93684 (2006). *
Bommareddy A, Arasada BL, Mathees DP, Dwivedi C. Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr. Cancer 54: 216-222 (2006). *
Bommireddy R, Pathak LJ, Martin J, Ormsby I, Engle SJ, Boivin GP, Babcock GF, Eriksson AU, Singh RR, Doetschman T. Self-antigen recognition by TGFbeta1-deficient T cells causes their activation and systemic inflammation. Lab. Invest. 86: 1008-1019 (2006). *
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354: 1578-1588 (2006). *
Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J. Clin. Immunol. 26: 438-446 (2006). *
Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RP, Picarelli A, Magliocca FM, Mora B, Bardella MT, Verrienti A, Fiore B, Uccini S, Megiorni F, Mazzilli MC, Tiberti C. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J. Pediatr. Gastroenterol. Nutr. 42: 150-154 (2006). *
Bonarius HP, Baas F, Remmerswaal EB, van Lier RA, Berge IJ, Tak PP, de Vries N. Monitoring the T-cell receptor repertoire at single-clone resolution. PLoS ONE 1: e55 (2006). *
Bonavita S, Dinacci D, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Bresciamorra V, Orefice G, Paciello M, Coniglio G, Di Costanzo A, Valentino P, Patti F, Salemi G, Simone I, Tedeschi G. Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. Neurol. Sci. 27 Suppl. 5: s365-s368 (2006).
Bond JH. The case for direct colonoscopy screening for colorectal cancer. Am. J. Gastroenterol. 101: 263-265 (2006). *
Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases and other destructive and inflammatory responses in osteoarthritis. Arthritis Res. Ther. 8: R187 (2006). *
Bonfield TL, Barna BP, John N, Malur A, Culver DA, Kavuru MS, Thomassen MJ. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF. J. Autoimmun. 26: 37-41 (2006).
Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. J. Leukoc. Biol. 79: 133-139 (2006). *
Bongiovanni M, Ranieri R, Ferrero S, Casanova F, Monforte AD. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin. AIDS 20: 1989-1990 (2006).
Bonif M, Meuwis MA, Close P, Benoit V, Heyninck K, Chapelle JP, Bours V, Merville MP, Piette J, Beyaert R, Chariot A. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation. Biochem. J. 394: 593-603 (2006). *
Bonifati V. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics. Eur. J. Hum. Genet. 14: 1061-1062 (2006). *
Bonilla FA, Geha RS. 2. Update on primary immunodeficiency diseases. J. Allergy Clin. Immunol. 117: S435-S441 (2006). *
Bonini S, Bresciani M, Gramiccioni C. Global environmental changes and immune diseases. Inflamm. Bowel Dis. 12 Suppl. 3: S1 (2006).
Boniotto M, Berti I, Santon D, Ventura A, Crovella S. Absence of maternal microchimerism in very early onset inflammatory bowel disease R1. J. Gastroenterol. Hepatol. 21: 1082-1084 (2006). *
Bonis PA, Kaplan M. Methotrexate for treatment of primary biliary cirrhosis. Hepatology 43: 632 (2006). *
Bonnard A, Fouquet V, Berrebi D, Hugot JP, Belarbi N, Bruneau B, Aigrain Y, de Lagausie P. Crohn's disease in children. Preliminary experience with a laparoscopic approach. Eur. J. Pediatr. Surg. 16: 90-93 (2006).
Bonnekoh B, Bockelmann R, Pommer AJ, Malykh Y, Philipsen L, Gollnick H. The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by multi-epitope ligand cartography robot technology. Introduction of a novel biological drug-binding biochip assay. Skin Pharmacol. Physiol. 20: 96-111 (2006).
Bonnel AS, Quinque K, Le Roux P, Le Luyer B. Semi-invasive necrotic aspergillosis in a child with cystic fibrosis. Rev. Mal. Respir. 23: 343-347 (2006).
Bontrop RE. Comparative genetics of MHC polymorphisms in different primate species: duplications and deletions. Hum. Immunol. 67: 388-397 (2006).
Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV; NHLBI Working Group. Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am. J. Med. Genet. A. 140: 1033-1040 (2006).
Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int. 26: 566-571 (2006). *
Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126: 789-799 (2006). *
Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. J. Virol. 80: 6024-6032 (2006). *
Boone RH, Cheung AM, Girlan LM, Heathcote EJ. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Dig. Dis. Sci. 51: 1103-1112 (2006). *
Boonen A, van der Linden SM. The burden of ankylosing spondylitis. J. Rheumatol. Suppl. 78: 4-11 (2006). *
Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur. Heart J. 27: 136-149 (2006). *
Booya F, Fletcher JG, Huprich JE, Barlow JM, Johnson CD, Fidler JL, Solem CA, Sandborn WJ, Loftus EV Jr, Harmsen WS. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 241: 787-795 (2006). *
Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur. Cytokine Netw. 17: 224-252 (2006).
Boraschi D, Tagliabue A. The interleukin-1 receptor family. Vitam. Horm. 74C: 229-254 (2006).
Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M, Hozo I, Puljiz Z, Terzic J. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin. Genet. 70: 156-160 (2006). *
Boraska V, Terzic J, Skrabic V, Cacev T, Bucevic-Popovic V, Peruzovic M, Markotic A, Zemunik T. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Croat. Med. J. 47: 571-578 (2006). *
Borba EF, Carvalho JF, Bonfa E. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin. Dev. Immunol. 13: 203-208 (2006). *
Borchers AT, Chang C, Keen CL, Gershwin ME. Airborne environmental injuries and human health. Clin. Rev. Allergy Immunol. 31: 1-101 (2006).
Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis. Autoimmun. Rev. 5: 279-298 (2006).
Bordet R, Ouk T, Petrault O, Gele P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart JC, Bastide M. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem. Soc. Trans. 34: 1341-1346 (2006). *
Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors. Genes Nutr. 1: 95-106 (2006).
Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors. Genes & Nutrition 1: 95-106 (2006). *
Borer JS. Cyclooxygenase inhibition: what should we do to resolve the confusion? An American perspective. J. Cardiovasc. Pharmacol. 47 Suppl. 1: S87-S91 (2006).
Borg M. Symptomatic myoclonus. Neurophysiol. Clin. 36: 309-318 (2006).
Borgaonkar MR, Duggan PR, Adams G. Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation. Dig. Dis. Sci. 51: 210-212 (2006). *
Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, Safari A. Neurological manifestations of Behcet s disease. Saudi Med. J. 27: 1542-1546 (2006).
Borjesson L, Lundstam U, Oresland T, Brevinge H, Hulten L. The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis? Tech. Coloproctol. 10: 237-241 (2006). *
Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, Wirth M, Zacharowski K. The role of Toll-like receptors in the immune-adrenal crosstalk. Ann. N. Y. Acad. Sci. 1088: 307-318 (2006). *
Borody TJ, Heifets LB. Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy. Gut 55: 1211 (2006). *
Boross P, Verbeek JS. The complex role of Fcgamma receptors in the pathology of arthritis. Springer Semin. Immunopathol. 28: 339-350 (2006). *
Borrelli F, Capasso F, Capasso R, Ascione V, Aviello G, Longo R, Izzo AA. Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation. Br. J. Pharmacol. 148: 553-560 (2006). *
Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin. Gastroenterol. Hepatol. 4: 744-753 (2006).
Borska L, Fiala Z, Krejsek J, Andrys C, Vokurkova D, Hamakova K, Kremlacek J, Ettler K. Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8. Physiol. Res. 55: 699-706 (2006). *
Borst P, Zelcer N, van de Wetering K, Poolman B. On the putative co-transport of drugs by multidrug resistance proteins. FEBS Lett. 580: 1085-1093 (2006). *
Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Klow NE. Bowel magnetic resonance imaging of pediatric patients with oral mannitol MRI compared to endoscopy and intestinal ultrasound. Eur. Radiol. 16: 207-214 (2006).
Borum ML, Liu E. Crohn's disease mimicking bulimia nervosa. Prim. Care Companion J. Clin. Psychiatry 8: 311-312 (2006). *
Borutinskaite VV, Navakauskiene R, Magnusson KE. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells. Ann. N. Y. Acad. Sci. 1091: 346-355 (2006). *
Bos CL, Diks SH, Hardwick JC, Walburg KV, Peppelenbosch MP, Richel DJ. Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity. Carcinogenesis 27: 2371-2382 (2006). *
Bos JD, de Korte J. Effects of etanercept on quality of life, fatigue, and depression in psoriasis. Lancet 367: 6-7 (2006). *
Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. The pathogenesis of inflammatory dermatoses, especially psoriasis. Ned. Tijdschr. Geneeskd. 150: 179-183 (2006).
Bosca MM, Perez-Baylach CM, Solis MA, Anton R, Mayordomo E, Pons S, Minguez M, Benages A. Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor. Gut 55: 294-295 (2006). *
Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin. Liver Dis. 26: 348-362 (2006).
Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Screening for polymorphisms in the PXR gene in a Dutch population. Eur. J. Clin. Pharmacol. 62: 395-399 (2006). *
Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin. Cancer Res. 12: 5786-5793 (2006). *
Bosch X, Guilabert A. Kikuchi-Fujimoto disease. Orphanet J. Rare Dis. 1: 18 (2006). *
Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 368: 404-418 (2006). *
Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily. Thromb. Haemost. 96: 154-159 (2006).
Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, Piemonti L, Pastore MR, Paroni R. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49: 2824-2827 (2006). *
Bosse T, Piaseckyj CM, Burghard E, Fialkovich JJ, Rajagopal S, Pu WT, Krasinski SD. Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine. Mol. Cell. Biol. 26: 9060-9070 (2006). *
Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P. Interactions of TNF and TNF receptor family members in the mouse and human. J. Biol. Chem. 281: 13964-13971 (2006). *
Bosso JA, Mauldin PD, Steed LL. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Ann. Pharmacother. 40: 1946-1949 (2006).
Bossuyt X. Serologic markers in inflammatory bowel disease. Clin. Chem. 52: 171-181 (2006). *
Bosworth BP, Sanders A, Maltz C. Common variable immunodeficiency masquerading as Crohn's ileocolitis. Inflamm. Bowel Dis. 12: 151-152 (2006). *
Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C. Neurotrophins in skin biology and pathology. J. Invest. Dermatol. 126: 1719-1727 (2006). *
Botella C, Marin L, Moya-Quiles R, Miras M, Sanchez-Bueno F, Minguela A, Bermejo J, Parrilla P, Alvarez-Lopez R, Muro M. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome. Transpl. Int. 19: 98-104 (2006). *
Botolin D, Wang Y, Christian B, Jump DB. Docosahexaneoic acid [22:6,n-3] regulates rat hepatocyte sterol regulatory element binding protein-1 (SREBP-1) nuclear abundance by Erk- and 26S proteasome-dependent pathways. J. Lipid Res. 47: 181-192 (2006). *
Bottazzi B, Garlanda C, Salvatori G, Jeannin P, Manfredi A, Mantovani A. Pentraxins as a key component of innate immunity. Curr. Opin. Immunol. 18: 10-15 (2006).
Bottcher A, Gaipl US, Furnrohr BG, Herrmann M, Girkontaite I, Kalden JR, Voll RE. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum. 54: 927-938 (2006). *
Botti J, Djavaheri-Mergny M, Pilatte Y, Codogno P. Autophagy signaling and the cogwheels of cancer. Autophagy 2: 67-73 (2006). *
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18: 207-213 (2006). *
Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, Bowie AG, Ong SJ, Cook SJ, Sorensen OE, Manzo BA, Inohara N, Klein NJ, Nunez G, Atherton JC, Bajaj-Elliott M. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J. Biol. Chem. 281: 11637-11648 (2006). *
Bougnoux ME, Diogo D, Francois N, Sendid B, Veirmeire S, Colombel JF, Bouchier C, Van Kruiningen H, d'Enfert C, Poulain D. Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J. Clin. Microbiol. 44: 1810-1820 (2006). *
Bougnoux P, Giraudeau B, Couet C. Diet, cancer, and the lipidome. Cancer Epidemiol. Biomarkers Prev. 15: 416-421 (2006). *
Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. J. Steroid Biochem. Mol. Biol. 102: 156-162 (2006).
Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G. Vitamin D resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20: 627-645 (2006).
Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol. Res. 53: 89-103 (2006). *
Boulanger H, Mansouri R, Gautier JF, Glotz D. Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies? Nephrol. Dial. Transplant. 21: 2696-2702 (2006).
Boumendjel A, Tawk L, Malefijt Rde W, Boulay V, Yssel H, Pene J. IL-27 induces the production of IgG1 by human B cells. Eur. Cytokine Netw. 17: 281-289 (2006).
Bour-Jordan H, Bluestone JA. Sensory neurons link the nervous system and autoimmune diabetes. Cell 127: 1097-1099 (2006). *
Bourbon JR, Benachi A. CFTR gene therapy, a method to rescue lung hypoplasia in congenital diaphragmatic hernia? Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1-L3 (2006). *
Bourikas LA, Sidiropoulos PI, Goulielmos GN, Boumpas DT, Kritikos HD. Concomitant onset of Graves disease and rheumatoid arthritis after a serious life event. J. Clin. Rheumatol. 12: 326-327 (2006).
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10: 377-385 (2006).
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health Aging 10: 386-399 (2006).
Bourre JM, Galea F. An important source of omega-3 fatty acids, vitamins D and E, carotenoids, iodine and selenium: a new natural multi-enriched egg. J. Nutr. Health Aging 10: 371-376 (2006).
Bourreille A, Jarry M, D'Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, Sacher-Huvelin S, Vahedy K, Lerebours E, Heresbach D, Bretagne JF, Colombel JF, Galmiche JP. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of post-operative recurrence of Crohn's disease: a prospective study. Gut 55: 978-983 (2006). *
Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC; and the Members of the Challenges in Pediatric IBD Study Groups. Challenges in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 12: 885-913 (2006). *
Boutlis CS, Yeo TW, Anstey NM. Malaria tolerance - for whom the cell tolls? Trends Parasitol. 22: 371-377 (2006). *
Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum. Immunol. 67: 247-256 (2006).
Bovenschen HJ, Tjioe M, Vermaat H, Hoop D, Witteman BM, Janssens RW, Stoof TJ, Kerkhof PC. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br. J. Dermatol. 154: 880-884 (2006). *
Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, van Erp PE. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis. Dermatology 213: 111-117 (2006).
Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol. 126: 1012-1021 (2006). *
Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 55: 1985-1994 (2006). *
Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, Yashiro K, Chawengsaksophak K, Wilson MJ, Rossant J, Hamada H, Koopman P. Retinoid signaling determines germ cell fate in mice. Science 312: 596-600 (2006). *
Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M; the IBSEN study group; Schrumpf E, Lie BA, Boberg KM. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J. Hepatol. 45: 704-710 (2006). *
Bowman EP, Chackerian AA, Cua DJ. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Curr. Opin. Infect. Dis. 19: 245-252 (2006).
Boyce BF, Schwarz EM, Xing L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18: 427-432 (2006).
Boyd AS. Localized chronic cutaneous lupus erythematosus masquerading as pigmented lesions: a new clinical subset? Lupus 15: 292-295 (2006).
Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S, Petrof BJ. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin. Infect. Immun. 74: 6829-6838 (2006). *
Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, Zollner G, Lee JY, Ballatori N. Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OSTalpha-OSTbeta, in cholestasis in humans and rodents. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1124-G1130 (2006). *
Boyle DL, Jones TL, Hammaker D, Svensson CI, Rosengren S, Albani S, Sorkin L, Firestein GS. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med. 3: e338 (2006). *
Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail. J. Immunol. 176: 6464-6472 (2006). *
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect. 114: 1547-1552 (2006). *
Boyman O, Cho JH, Tan JT, Surh CD, Sprent J. A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J. Exp. Med. 203: 1817-1825 (2006). *
Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927 (2006). *
Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin. Biol. Ther. 6: 1323-1331 (2006).
Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, Jewell DP, Kon OM, Smith J, Rose M, Newman-Taylor AJ, Cole P, Wilson R, Altmann DM. IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 68: 325-330 (2006). *
Bozzi A, Pereira PP, Reis BS, Goulart MI, Pereira MC, Pedroso EP, Leite MF, Goes AM. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis. Hum. Immunol. 67: 931-939 (2006).
Bozzolo E, Scotti R, Franchini S, Baldissera E, Angeli E, Sabbadini MG. Celiac disease in a young woman with Takayasu arteritis. J. Clin. Rheumatol. 12: 213-214 (2006).
Braat H, Peppelenbosch MP, Hommes DW. Immunology of Crohn's disease. Ann. N. Y. Acad. Sci. 1072: 135-154 (2006). *
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4: 754-759 (2006).
Braaten DC, McClellan JS, Messaoudi I, Tibbetts SA, McClellan KB, Nikolich-Zugich J, Virgin HW. Effective control of chronic gamma-herpesvirus infection by unconventional MHC class Ia-independent CD8 T cells. PLoS Pathog. 2: e37 (2006). *
Bracken SC, Kilmartin C, Wieser H, Jackson J, Feighery C. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa. Aliment. Pharmacol. Ther. 23: 1307-1314 (2006). *
Braddock M, Murray C. 10th Anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit 20 - 21 March 2006, New Brunswick, USA. Expert Opin. Investig. Drugs 15: 721-727 (2006).
Bradna P. Gout and diabetes. Vnitr. Lek. 52: 488-492 (2006).
Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre. Intern. Med. J. 36: 355-361 (2006). *
Braga-Neto UM, Marques ET. From functional genomics to functional immunomics: new challenges, old problems, big rewards. PLoS Comput. Biol. 2: e81 (2006). *
Bramstedt KA. Living liver donor mortality: where do we stand? Am. J. Gastroenterol. 101: 755-759 (2006). *
Branagan G, Thompson MR, Senapati A. Cleft closure for the treatment of unhealed perineal sinus. Colorectal Dis. 8: 314-317 (2006). *
Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkuhn T, Goke B, Auernhammer CJ, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827-G838 (2006). *
Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Goke B, Ochsenkuhn T, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype. Am. J. Gastroenterol. 101: 99-106 (2006). *
Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Goke B, Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J. Cell. Biochem. 97: 709-723 (2006). *
Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NH, Groten JP, van Bladeren PJ, Rietjens IM. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed. Pharmacother. 60: 508-519 (2006).
Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Gobel G, Margreiter R, Konigsrainer A, Fuchs D, Amberger A. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin. Cancer Res. 12: 1144-1151 (2006). *
Brandoni A, Anzai N, Kanai Y, Endou H, Torres AM. Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3. Biochim. Biophys. Acta 1762: 673-682 (2006). *
Brandoni A, Villar SR, Picena JC, Anzai N, Endou H, Torres AM. Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology 43: 1092-1100 (2006). *
Brandsch M. Transport of L-proline, L-proline-containing peptides and related drugs at mammalian epithelial cell membranes. Amino Acids 31: 119-136 (2006). *
Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann. Allergy Asthma Immunol. 96: 526-532 (2006).
Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun. Rev. 5: 465-470 (2006).
Brandt J, Braun J. Anti-TNF-alpha agents in the treatment of psoriatic arthritis. Expert Opin. Biol. Ther. 6: 99-107 (2006).
Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol. Lett. 105: 127-139 (2006).
Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease. Adv. Exp. Med. Biol. 579: 149-167 (2006).
Brannagan TH 3rd, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve 34: 246-250 (2006).
Brannstrom J, Hassler S, Peltonen L, Herrmann B, Winqvist O. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens. Clin. Immunol. 121: 265-273 (2006). *
Branski D, Fasano A, Troncone R. Latest developments in the pathogenesis and treatment of celiac disease. J. Pediatr. 149: 295-300 (2006). *
Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am. J. Med. 119: 786-790 (2006). *
Brar P, Lee AR, Lewis SK, Bhagat G, Green PH. Celiac disease in African-Americans. Dig. Dis. Sci. 51: 1012-1015 (2006). *
Brasaemle DL. Cell biology. A metabolic push to proliferate. Science 313: 1581-1582 (2006). *
Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Balloum M, Qu K, Herlaar E, Lau A, Young C, Wong BR, Lovell S, Sun T, Park G, Argade A, Jurcevic S, Pine P, Singh R, Grossbard EB, Payan DG, Masuda ES. R406, an orally svailable Syk kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 319: 998-1008 (2006). *
Brass SD, Chen NK, Mulkern RV, Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 17: 31-40 (2006).
Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun. 7: 310-315 (2006). *
Bratcher JM, Korelitz BI. Toxicity of infliximab in the course of treatment of Crohn's disease. Expert Opin. Drug Saf. 5: 9-16 (2006).
Brauer DJ. A method for pattern recognition. Res. Theory Nurs. Pract. 20: 277-289 (2006).
Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM. Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. J. Cyst. Fibros. 5: 33-41 (2006).
Braun F, Behrend M. Basic immunosuppressive drugs outside solid organ transplantation. Expert Opin. Investig. Drugs 15: 267-291 (2006).
Braun J. In search of desire: mimicry, MAP, and Crohn's disease. Gastroenterology 131: 312-314 (2006). *
Braun J, Sieper J. Early diagnosis of spondyloarthritis. Nat. Clin. Pract. Rheumatol. 2: 536-545 (2006). *
Braun J, Sieper J. Spondylarthritides. Z. Rheumatol. 65: 613-632 (2006).
Braun J, Targan SR. Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel disease. Adv. Exp. Med. Biol. 579: 209-218 (2006).
Braun J, Zochling J, Baraliakos X, Alten RH, Burmester GR, Grasedyck K, Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W, Gomor B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomized controlled trial. Ann. Rheum. Dis. 65: 1147-1153 (2006). *
Braun-Moscovici Y, Markovits D, Zinder O, Schapira D, Rozin A, Ehrenburg M, Dain L, Hoffer E, Nahir AM, Balbir-Gurman A. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis. J. Rheumatol. 33: 497-500 (2006).
Bravo E, Napolitano M, Lopez-Soldado I, Valeri M, Botham KM, Stefanutti C. Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil. Eur. J. Clin. Invest. 36: 788-795 (2006). *
Braybrook C. Are patients with rheumatoid arthritis prone to accelerated atherosclerosis? Nat. Clin. Pract. Cardiovasc. Med. 3: 296-297 (2006).
Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, Macek M Jr, Bartunkova J, Lauschmann H. Differential cytokine profile in children with cystic fibrosis. Clin. Immunol. 115: 210-215 (2006). *
Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin. Immunol. 121: 350-357 (2006). *
Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development. Horm. Res. 65 Suppl. 3: 98-104 (2006).
Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R. The genetics of spondyloarthropathies. Joint Bone Spine 73: 355-362 (2006). *
Bregenzer N, Hartmann A, Strauch U, Scholmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm. Bowel Dis. 12: 53-56 (2006). *
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease. Exp. Clin. Endocrinol. Diabetes 114: 1-5 (2006).
Breij EC, Heijnen P, van der Goes A, Teunissen CE, Polman CH, Dijkstra CD. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients. J. Neuroimmunol. 176: 106-114 (2006).
Breitwieser GE. Calcium sensing receptors and calcium oscillations: calcium as a first messenger. Curr. Top. Dev. Biol. 73: 85-114 (2006).
Brellou GD, Kleinschmidt S, Meneses F, Nolte I, Hewicker-Trautwein M. Eosinophilic granulomatous gastroenterocolitis and hepatitis in a 1-year-old male Siberian husky. Vet. Pathol. 43: 1022-1025 (2006).
Bremner AR, Griffiths M, Argent JD, Fairhurst JJ, Beattie RM. Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study. Pediatr. Radiol. 36: 947-953 (2006). *
Brennan PA, Kendrick KM. Mammalian social odours: attraction and individual recognition. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361: 2061-2078 (2006). *
Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M. Does a negative screening colonoscopy ever need to be repeated? Gut 55: 1145-1150 (2006). *
Brenner M, Laragione T, Yarlett NC, Li W, Mello A, Gulko PS. Cia27 is a novel non-MHC arthritis severity locus on rat chromosome 10 syntenic to the rheumatoid arthritis 17q22-q25 locus. Genes Immun. 7: 335-341 (2006). *
Breslow JL. n-3 Fatty acids and cardiovascular disease. Am. J. Clin. Nutr. 83: 1477S-1482S (2006). *
Bresnihan B. Synovial biomarkers in the spondylarthropathies. Curr. Opin. Rheumatol. 18: 359-363 (2006).
Bressan E, De Queiroz Cunha F, Tonussi CR. Contribution of TNFalpha, IL-1beta and CINC-1 for articular incapacitation, edema and cell migration in a model of LPS-induced reactive arthritis. Cytokine 36: 83-89 (2006).
Bressler B. Another tool in the epidemiologist's toolbox. Inflamm. Bowel Dis. 12: 245-246 (2006). *
Bressler B. The role of endoscopy in the management of postoperative patients with Crohn's disease. Can. J. Gastroenterol. 20: 631-632 (2006). *
Bressler B, Sands BE. Review article: medical therapy for fistulizing Crohn's disease. Aliment. Pharmacol. Ther. 24: 1283-1293 (2006). *
Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116: 1371-1381 (2006). *
Breuer GS, Baer A, Dahan D, Nesher G. Lupus-associated pancreatitis. Autoimmun. Rev. 5: 314-318 (2006).
Breuhahn K, Baeuerle PA, Peters M, Prang N, Tox U, Kohne-Volland R, Dries V, Schirmacher P, Leo E. Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma. Hepatol. Res. 34: 50-56 (2006).
Brewer GJ, Dick R, Zeng C, Hou G. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model. J. Inorg. Biochem. 100: 927-930 (2006). *
Brewer M, Kirkpatrick ND, Wharton JT, Wang J, Hatch K, Auersperg N, Utzinger U, Gershenson D, Bast R, Zou C. 4-HPR modulates gene expression in ovarian cells. Int. J. Cancer 119: 1005-1013 (2006). *
Breza TS Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J. Cutan. Pathol. 33: 512-515 (2006). *
Brezinschek HP, Brickmann K, Yazdani-Biuki B, Dorner T, Graninger WB, Brezinschek RI. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes. Wien. Med. Wochenschr. 156: 61-67 (2006).
Briani C, Doria A, Marcolongo R, Tognon S, Ruggero S, Toffanin E, Ermani M, Ghirardello A, Zampieri S, Semenzato G. Increased titres of IgM anti-heparan sulfate antibody in Behcet's disease. Clin. Exp. Rheumatol. 24: S104-S107 (2006).
Brickner AG. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms. Immunol. Res. 36: 33-42 (2006). *
Bridges CC, Zalups RK. System B0,+ and the transport of thiol-S-conjugates of methylmercury. J. Pharmacol. Exp. Ther. 319: 948-956 (2006). *
Bridges CC, Zalups RK. Molecular mimicry as a mechanism for the uptake of cysteine S-conjugates of methylmercury and inorganic mercury. Chem. Res. Toxicol. 19: 1117-1118 (2006). *
Brigman C, Feranchak A. Liver involvement in cystic fibrosis. Curr. Treat. Options Gastroenterol. 9: 484-496 (2006).
Brik R, Livnat G, Pollack S, Catz R, Nagler R. Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: novel observation in oligoarticular-type patients. J. Rheumatol. 33: 2532-2537 (2006).
Brinar VV, Petelin Z, Brinar M, Djakovic V, Zadro I, Vranjes D. CNS demyelination in autoimmune diseases. Clin. Neurol. Neurosurg. 108: 318-326 (2006).
Bringer MA, Glasser AL, Tung CH, Meresse S, Darfeuille-Michaud A. The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell. Microbiol. 8: 471-484 (2006). *
Brinza D, He J, Zelikovsky A. Combinatorial search methods for multi-SNP disease association. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1: 5802-5805 (2006).
Brisebois M, Zehntner SP, Estrada J, Owens T, Fournier S. A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease. J. Immunol. 177: 2403-2411 (2006). *
Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV, Tarkowski A. Phenotypic and functional characterization of human CD25 B cells. Immunology 117: 548-557 (2006). *
Briz O, Macias RI, Perez MJ, Serrano MA, Marin JJ. Excretion of fetal biliverdin by the rat placenta-maternal liver tandem. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R749-R756 (2006). *
Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, Marin JJ. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? J. Biol. Chem. 281: 30326-30335 (2006). *
Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13: 2487-2502 (2006).
Brockhausen I. The role of galactosyltransferases in cell surface functions and in the immune system. Drug News Perspect. 19: 401-409 (2006).
Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control 17: 1005-1016 (2006). *
Brod SA, Nguyen M, Hood Z, Shipley GL. Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis. J. Interferon Cytokine Res. 26: 150-155 (2006).
Brode S, Raine T, Zaccone P, Cooke A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177: 6603-6612 (2006). *
Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 7: 407-419 (2006).
Brodtkorb E. Autoimmune epilepsy. Tidsskr. Nor. Laegeforen. 126: 782 (2006).
Broekaert IJ, Walker WA. Probiotics and chronic disease. J. Clin. Gastroenterol. 40: 270-274 (2006).
Broer S. The SLC6 orphans are forming a family of amino acid transporters. Neurochem. Int. 48: 559-567 (2006).
Broersen K, Brink DV, Fraser G, Goedert M, Davletov B. alpha-Synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 45: 15610-15616 (2006). *
Brogan PA, Malik M, Shah N, Kilday JP, Ramsay A, Shah V, Murch SH, Thomson MA, Walker-Smith JA, Lindley KJ, Milla PJ, Dillon MJ. Systemic vasculitis: a cause of indeterminate intestinal inflammation. J. Pediatr. Gastroenterol. Nutr. 42: 405-415 (2006). *
Bromberg JS, LeRoith D. Diabetes cure - is the glass half full? N. Engl. J. Med. 355: 1372-1374 (2006). *
Bromberg ME. Immune thrombocytopenic purpura - the changing therapeutic landscape. N. Engl. J. Med. 355: 1643-1645 (2006). *
Bronner MP. Biomarkers, surveillance strategies, chromoendoscopy medication-induced malignancies and chemoprevention (present). Inflamm. Bowel Dis. 12 Suppl. 3: S11-S12 (2006).
Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60: 1053-1061 (2006). *
Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C. A modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55: 1449-1460 (2006). *
Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55: 505-509 (2006). *
Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309 (2006). *
Brooks PM. The burden of musculoskeletal disease - a global perspective. Clin. Rheumatol. 25: 778-781 (2006). *
Broom OJ, Massoumi R, Sjolander A. alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. J. Cell. Physiol. 209: 950-958 (2006). *
Broome U. Primary sclerosing cholangitis could have been the cause of Beethoven's death. Lakartidningen 103: 2494-2496 (2006).
Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin. Liver Dis. 26: 31-41 (2006). *
Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'Morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun. 7: 19-26 (2006). *
Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J. Nutr. 136: 1636S-1640S (2006). *
Brosnan JT, da Silva R, Brosnan ME. Amino acids and the regulation of methyl balance in humans. Curr. Opin. Clin. Nutr. Metab. Care 10: 52-57 (2006).
Broughman JR, Sun L, Umar S, Sellin JH, Morris AP. Chronic PKCbeta activation in HT-29 Cl.19A colonocytes (2) prevents cAMP-mediated ion secretion by inhibiting apical membrane CFTR targeting. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G331-G344 (2006). *
Brousil JA, Roberts RJ, Schlein AL. Cladribine: an investigational immunomodulatory agent for multiple sclerosis (CE). Ann. Pharmacother. 40: 1814-1821 (2006).
Brouwer IA, Geelen A, Katan MB. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease. Prog. Lipid Res. 45: 357-367 (2006). *
Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am. Heart J. 151: 857-862 (2006). *
Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295: 2613-2619 (2006). *
Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54: 3761-3773 (2006). *
Brown GD. Macrophage receptors and innate immunity: insights from dectin-1. Novartis Found. Symp. 279: 114-123 (2006).
Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6: 33-43 (2006). *
Brown HJ, Lock HR, Sacks SH, Robson MG. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J. Immunol. 177: 1925-1931 (2006). *
Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch. Pathol. Lab. Med. 130: 1020-1025 (2006).
Brown KK. Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidence-based clinical practice guidelines. Chest 129: 132S-137S (2006). *
Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression. CMAJ 175: 42-46 (2006). *
Brown MA. Non-major-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract. Res. Clin. Rheumatol. 20: 611-621 (2006).
Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br. J. Cancer 94: 842-853 (2006). *
Brown N, Nagarkatti M, Nagarkatti PS. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery. Toxicol. Appl. Pharmacol. 212: 119-126 (2006). *
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: Part I. Important features. Mult. Scler. 12: 453-464 (2006).
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships. Mult. Scler. 12: 465-475 (2006).
Brown RS Jr. Asymptomatic liver mass. Gastroenterology 131: 619-623 (2006). *
Brown SJ. The role of vitamin D in multiple sclerosis. Ann. Pharmacother. 40: 1158-1161 (2006).
Brown V, Brown RA, Ozinsky A, Hesselberth JR, Fields S. Binding specificity of Toll-like receptor cytoplasmic domains. Eur. J. Immunol. 36: 742-753 (2006). *
Brown WM. Anti-CD3 antibody MacroGenics Inc. Curr. Opin. Investig. Drugs 7: 381-388 (2006).
Browning BL, Satsangi J, Noble C, Arnott ID, Russell RK, Nimmo ER. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population * Authors' reply. Gut 55: 1050 (2006). *
Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 44: 466-471 (2006). *
Browning JD, Davis J, Saboorian MH, Burgess SC. A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content. Hepatology 44: 487-488 (2006). *
Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat. Rev. Drug Discov. 5: 564-576 (2006). *
Browning SR. Multilocus association mapping using variable-length Markov chains. Am. J. Hum. Genet. 78: 903-913 (2006). *
Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, Thompson SJ. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum. 54: 854-863 (2006). *
Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Mauri F, Palmieri G, Spodick DH. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 98: 267-271 (2006). *
Bruckner HW, Hrehorovich VR, Sawhney HS, Meeus SI, Coopeman AM. Chemotherapeutic management of small bowel adenocarcinoma associated with Crohn's disease. J. Chemother. 18: 545-548 (2006).
Brueck M, Runde T, Rauber K, Kramer W. Portal and mesenteric venous thrombosis in inflammatory bowel disease treated by fibrinogen-guided thrombolysis with urokinase. Dtsch. Med. Wochenschr. 131: 84-88 (2006).
Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann. N. Y. Acad. Sci. 1072: 242-252 (2006). *
Bruining DH, Loftus EV. Evolving diagnostic strategies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 8: 478-485 (2006).
Brulhart L, Ciurea A, Finckh A, Notter A, Waldburger JM, Kyburz D, Gabay C. Efficacy of B-cell depletion in rheumatoid arthritis patients refractory to anti-tumour necrosis factor (TNF)- a agents: an open label observational study. Ann. Rheum. Dis. 65: 1255-1257 (2006). *
Brumeanu TD, Goldstein R, Casares S. Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors. Clin. Immunol. 119: 1-12 (2006). *
Brummel R, Roberts TL, Stacey KJ, Lenert P. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice. Eur. J. Immunol. 36: 1951-1962 (2006). *
Brun P, Castagliuolo I, Floreani AR, Buda A, Blasone L, Palu G, Martines D. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 55: 1212 (2006). *
Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am. J. Psychiatry 163: 2148-2156 (2006).
Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116: 1052-1062 (2006). *
Brunham LR, Kruit JK, Pape TD, Parks JS, Kuipers F, Hayden MR. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ. Res. 99: 672-674 (2006). *
Bruni R, Serino FM, Galluzzo S, Coppolino G, Cacciapaglia F, Vadacca M, Nilo S, Terminio N, Afeltra A. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels. Ann. N. Y. Acad. Sci. 1069: 208-211 (2006). *
Brunmair B, Staniek K, Dorig J, Szocs Z, Stadlbauer K, Marian V, Gras F, Anderwald C, Nohl H, Waldhausl W, Furnsinn C. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 49: 2713-2722 (2006). *
Brunn GJ, Wijdicks MF, Platt JL. Toward a modern concept of sepsis: new answers to ancient questions. Discov. Med. 6: 11-17 (2006).
Brunner E. Oily fish and omega 3 fat supplements. BMJ 332: 739-740 (2006). *
Brunner J, Sergi C, Muller T, Gassner I, Prufer F, Zimmerhackl LB. Juvenile sarcoidosis presenting as Crohn's disease. Eur. J. Pediatr. 165: 398-401 (2006). *
Brunner J, Sitzmann FC. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. Clin. Exp. Rheumatol. 24: 449-451 (2006).
Brunner JK, Sitzmann FC. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Mod. Rheumatol. 16: 372-375 (2006). *
Brunner M, Lackner E, Exler PS, Fluiter HC, Kletter K, Tschurlovits M, Dudczak R, Eichler HG, Muller M. 5-Aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers. Aliment. Pharmacol. Ther. 23: 137-144 (2006). *
Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S. Effect of high-dose cortisol on memory functions. Ann. N. Y. Acad. Sci. 1071: 434-437 (2006). *
Bruno MA, Cuello AC. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U.S.A. 103: 6735-6740 (2006). *
Bruscia EM, Price JE, Cheng EC, Weiner S, Caputo C, Ferreira EC, Egan ME, Krause DS. Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation. Proc. Natl. Acad. Sci. U.S.A. 103: 2965-2970 (2006). *
Bruscia EM, Ziegler EC, Price JE, Weiner S, Egan ME, Krause DS. Engraftment of donor derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 24: 2299-2308 (2006). *
Brustolim D, Ribeiro-Dos-Santos R, Kast RE, Altschuler EL, Soares MB. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol. 6: 903-907 (2006).
Brutkiewicz RR. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177: 769-775 (2006). *
Bry L, Brigl M, Brenner MB. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect. Immun. 74: 673-681 (2006). *
Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Inwards DJ, Yasenchak CA, Kumar SK, Gertz MA. Response to rituximab in patients with type II cryoglobulinemia. Clin. Lymphoma Myeloma 7: 140-144 (2006).
Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214: 73-91 (2006). *
Brydges S, Kastner DL. The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr. Top. Microbiol. Immunol. 305: 127-160 (2006).
Bryhn M, Hansteen H, Schanche T, Aakre SE. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins Leukot. Essent. Fatty Acids 75: 19-24 (2006). *
Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53: 688-695 (2006).
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res. Treat. 99: 257-265 (2006). *
Bu HZ. A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment. Curr. Drug Metab. 7: 231-249 (2006).
Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr. Regul. 40: 1-6 (2006). *
Bucci P, Carile F, Sangianantoni A, D'Angio F, Santarelli A, Lo Muzio L. Oral aphthous ulcers and dental enamel defects in children with coeliac disease. Acta Paediatr. 95: 203-207 (2006).
Bucciarelli S, Cervera R, Espinosa G, Gomez-Puerta JA, Ramos-Casals M, Font J. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun. Rev. 6: 72-75 (2006).
Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramos-Casals M, Ingelmo M, Font J. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann. Rheum. Dis. 65: 81-86 (2006). *
Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gomez-Puerta JA, Ramos-Casals M, Font J, Asherson RA. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 54: 2568-2576 (2006). *
Buch T, Waisman A. Protection from autoimmunity by DNA vaccination against T-cell receptor. Methods Mol. Med. 127: 269-280 (2006).
Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 103: 1492-1497 (2006). *
Buchli R, Vangundy RS, Giberson CF, Hildebrand WH. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. J. Immunol. Methods 314: 38-53 (2006). *
Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology 130: S5-S15 (2006). *
Buchman AL, Babbo AM, Gieser RG. Central retinal vein thrombosis in a patient with ulcerative colitis. Dig. Dis. Sci. 51: 1847-1849 (2006). *
Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 43: 9-19 (2006). *
Buchwald P, Juhasz A, Bell C, Patfalusi M, Kovacs P, Hochhaus G, Howes J, Bodor N. Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants. Pharmazie 61: 125-134 (2006).
Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H. Analysis of the C/T(-1)) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68: 335-338 (2006). *
Buckley JL, Chastain MA, Rietschel RL. Improvement of cystic fibrosis during treatment with isotretinoin. Skinmed. 5: 252-255 (2006).
Buckley RH. Primary immunodeficiency or not? Making the correct diagnosis. J. Allergy Clin. Immunol. 117: 756-758 (2006). *
Buckova D, Holla LI, Znojil V, Vasku A. Polymorphisms of the CD14 gene and atopic phenotypes in Czech patients with IgE-mediated allergy. J. Hum. Genet. 51: 977-983 (2006). *
Bucuvalas J, Yazigi N, Squires Jr RH. Acute liver failure in children. Clin. Liver Dis. 10: 149-168 (2006).
Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-280 (2006).
Budancamanak M, Kanter M, Demirel A, Ocakci A, Uysal H, Karakaya C. Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis. Arch. Toxicol. 80: 768-776 (2006). *
Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6: 196-204 (2006). *
Buell JF, Alloway RR, Steve Woodle E. How can donors with a previous malignancy be evaluated? J. Hepatol. 45: 503-507 (2006). *
Buelta-Gonzalez C, Fernandez-Salazar L, Martin-Merino M, Aller de la Fuente R, Cuello Garcia R. Ulcerative colitis and autoimmune hemolytic anemia. Gastroenterol. Hepatol. 29: 110 (2006).
Buendia MA. Liver cancer. Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 20-21 (2006). *
Bueso MB, Caballero R, Castro HJ, Barakat A, Bellanti JA. Recurrent infections and joint pain. Allergy Asthma Proc. 27: 164-171 (2006).
Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36: 485-501 (2006). *
Bugeja MJ, Booth D, Bennetts B, Heard R, Rubio J, Stewart G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med. Genet. 7: 64 (2006). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Mult. Scler. 12: 710-722 (2006).
Buhler OT, Wiedig CA, Schmid Y, Grassl GA, Bohn E, Autenrieth IB. The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect. Immun. 74: 4322-4329 (2006). *
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn�s disease: role of CARD15 3020insC mutation? Gut 55: 342-347 (2006). *
Bui HH, Schiewe AJ, von Grafenstein H, Haworth IS. Structural prediction of peptides binding to MHC class I molecules. Proteins 63: 43-52 (2006). *
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7: 153 (2006). *
Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J. Hepatobiliary Pancreat. Surg. 13: 517-524 (2006). *
Bukharin OV, Gritsenko VA, Tret'iakov AA, Chernikov DA. Taxonomic spectrum and antibiotic resistance of Enterobacteriaceae isolated from bile of patients with cholangitis. Antibiot. Khimioter. 51: 7-12 (2006).
Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes. J. Virol. 80: 5854-5861 (2006). *
Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations. J. Eur. Acad. Dermatol. Venereol. 20: 829-833 (2006). *
Bulhak AA, Sjoquist PO, Xu CB, Edvinsson L, Pernow J. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Basic Res. Cardiol. 101: 244-252 (2006).
Bullano MF, McNeeley BJ, Yu YF, Quimbo R, Burawski LP, Yu EB, Woolley JM. Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis. Manag. Care Interface 19: 47-53 (2006).
Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7: 135 (2006). *
Bultink IE, Hamann D, Seelen MA, Hart MH, Dijkmans BA, Daha MR, Voskuyl AE. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus (SLE). Arthritis Res. Ther. 8: R183 (2006). *
Bulut K, Pennartz C, Felderbauer P, Ansorge N, Banasch M, Schmitz F, Schmidt WE, Hoffmann P. Vascular endothelial growth factor (VEGF(164)) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-beta release from epithelial cells. Scand. J. Gastroenterol. 41: 687-692 (2006). *
Bulut M, Turkmen N, Fedakar R, Aydin SA. A case report of fatal oral ingestion of resorcinol. Mt. Sinai J. Med. 73: 1049-1051 (2006). *
Bulwin GC, Heinemann T, Bugge V, Winter M, Lohan A, Schlawinsky M, Schulze A, Walter S, Sabat R, Schulein R, Wiesner B, Veh RW, Lohler J, Blumberg RS, Volk HD, Utku N. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression. J. Immunol. 177: 6833-6841 (2006). *
Bunce J, Achila D, Hetrick E, Lesley L, Huffman DL. Copper transfer studies between the N-terminal copper binding domains one and four of human Wilson protein. Biochim. Biophys. Acta 1760: 907-912 (2006). *
Buning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H. DLG5 variants in inflammatory bowel disease. Am. J. Gastroenterol. 101: 786-792 (2006). *
Buning C, Lochs H. Conventional therapy for Crohn's disease. World J. Gastroenterol. 12: 4794-4806 (2006). *
Buning J, Hundorfean G, Schmitz M, Zimmer KP, Strobel S, Gebert A, Ludwig D. Antigen targeting to MHC class II-enriched late endosomes in colonic epithelial cells: trafficking of luminal antigens studied in vivo in Crohn's colitis patients. FASEB J. 20: 359-361 (2006). *
Bunk R, Dittrich AM, Schulze I, Horn J, Schmolke K, Volk HD, Wahn V, Hoflich C. Rapid whole blood flow cytometric test to detect ICOS deficiency in patients with common variable immunodeficiency. Int. Arch. Allergy Immunol. 140: 342-344 (2006).
Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R. A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm. Bowel Dis. 12: 558-565 (2006). *
Burch LH, Picher M. E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signal. 2: 399-408 (2006). *
Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, Casciotti L, Maganti V, Reddy PS, Strahs A, Immermann F, Spinelli W, Schwertschlag U, Slager AM, Cotreau MM, Dorner AJ. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J. Mol. Diagn. 8: 51-61 (2006). *
Burd RM. Psoriasis: a general overview. Br. J. Hosp. Med. (Lond.) 67: 259-262 (2006).
Burdge GC. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 75: 161-168 (2006). *
Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract. Res. Clin. Rheumatol. 20: 879-896 (2006).
Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Marki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1 alpha (PGC1alpha), prevents triglyceride accumulation and potentiates insulin signaling in vitro. Mol. Endocrinol. 20: 809-830 (2006). *
Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J. Immunol. 176: 1490-1497 (2006). *
Burgmann T, Clara I, Graff L, Walker J, Lix L, Rawsthorne P, McPhail C, Rogala L, Miller N, Bernstein CN. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis - how much is irritable bowel syndrome? Clin. Gastroenterol. Hepatol. 4: 614-620 (2006).
Burgos JS, Serrano-Saiz E, Sastre I, Valdivieso F. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. J. Neurovirol. 12: 420-427 (2006).
Burja AM, Radianingtyas H, Windust A, Barrow CJ. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production. Appl. Microbiol. Biotechnol. 72: 1161-1169 (2006). *
Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT. Association of asthma with a functional promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol. 117: 86-91 (2006). *
Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease. Clin. Dermatol. 24: 247-255 (2006).
Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader JP, Gonvers JJ, The Epage Study Group. Use, appropriateness, and diagnostic yield of screening colonoscopy: an international observational study (EPAGE). Gastrointest. Endosc. 63: 1018-1026 (2006).
Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in vitamin D receptor knockout mice. Brain Res. Bull. 69: 74-78 (2006).
Burnett JR, Huff MW. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia. Expert Opin. Investig. Drugs 15: 1337-1351 (2006).
Burnevich EZ, Lopatkina TN. System manifestations of primary biliary cirrhosis. Klin. Med. (Mosk.) 84: 42-46 (2006).
Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, Rebeck GW. The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. J. Neurochem. 98: 792-800 (2006). *
Burra P, Porte RJ. Should donors and recipients be matched in liver transplantation? J. Hepatol. 45: 488-494 (2006). *
Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11: 529-543 (2006).
Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D, Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M, Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, et al. 3-Month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 367: 225-232 (2006). *
Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol. 27: 11-16 (2006). *
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 54: 3750-3760 (2006). *
Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295: 527-535 (2006). *
Burton DR, Dwek RA. Immunology. Sugar determines antibody activity. Science 313: 627-628 (2006). *
Burton S, Lloyd M. An overview of rheumatoid arthritis. Nurs. Stand. 20: 46-49 (2006).
Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 66: 1373-1383 (2006).
Busche A, Goldmann T, Naumann U, Steinle A, Brandau S. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A. Hum. Gene Ther. 17: 135-146 (2006).
Buscher R, Grasemann H. Disease modifying genes in cystic fibrosis: therapeutic option or one-way road? Naunyn. Schmiedebergs. Arch. Pharmacol. 374: 65-77 (2006). *
Buschhausen L, Kruis W, Aymaz S, Weber M, Krakamp B. Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates. Med. Klin. (Munich) 101: 791-795 (2006).
Bush WS, Dudek SM, Ritchie MD. Parallel multifactor dimensionality reduction: a tool for the large scale analysis of gene-gene interactions. Bioinformatics 22: 2173-2174 (2006). *
Bushinsky DA, Laplante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int. 69: 1586-1592 (2006). *
Busquets-Perez N, Narvaez J, Valverde-Garcia J. Interstitial granulomatous dermatitis with arthritis (Ackerman syndrome). J. Rheumatol. 33: 1207-1209 (2006).
Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N. Engl. J. Med. 355: 1672-1681 (2006). *
Bussey H, Andrews B, Boone C. From worm genetic networks to complex human diseases. Nat. Genet. 38: 862-863 (2006). *
Busteed S, Bennett MW, Molloy C, Houston A, Stone MA, Shanahan F, Molloy MG, O'Connell J. Bcl-x(L) expression in vivo in rheumatoid synovium. Clin. Rheumatol. 25: 789-793 (2006). *
Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N. Autoantibodies in Argentine women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 55: 201-207 (2006). *
Butchar JP, Parsa KV, Marsh CB, Tridandapani S. Negative regulators of Toll-like receptor 4-mediated macrophage inflammatory response. Curr. Pharm. Des. 12: 4143-4153 (2006).
Butler M, Ng CY, van Heel DA, Lombardi G, Lechler R, Playford RJ, Ghosh S. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur. J. Immunol. 36: 864-874 (2006). *
Butovich IA, Lukyanova SM, Bachmann C. Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure and inhibition of human 5-lipoxygenase. J. Lipid Res. 47: 2462-2474 (2006). *
Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 116: 905-915 (2006). *
Butrimiene I, Ranceva J, Griskevicius A. Potential triggering infections of reactive arthritis. Scand. J. Rheumatol. 35: 459-462 (2006).
Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60: 24-29 (2006). *
Butt AM. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54: 666-675 (2006).
Butt C, Gladman D, Rahman P. PPAR-gamma gene polymorphisms and psoriatic arthritis. J. Rheumatol. 33: 1631-1633 (2006). *
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res. Ther. 8: R27-R30 (2006). *
Butterworth JR. Another important function for an old friend! The role of iron in colorectal carcinogenesis. Gut 55: 1384-1386 (2006). *
Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pohlau D, Rivera V, Trojano M, Verheul F, Malkowski JP. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult. Scler. 12: 769-774 (2006).
Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG. Novel model of antigen-specific induction of bile duct injury. Gastroenterology 131: 1899-1906 (2006). *
Buydens-Branchey L, Branchey M. n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J. Clin. Psychopharmacol. 26: 661-665 (2006).
Buyse F, Hou YX, Vigano C, Zhao Q, Ruysschaert JM, Chang XB. Substitution of the positive-charged Walker A lysine with a hydrophobic leucine and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis. Biochem. J. 397: 121-130 (2006). *
Buzas EI, Gyorgy B, Pasztoi M, Jelinek I, Falus A, Gabius HJ. Carbohydrate recognition systems in autoimmunity. Autoimmunity 39: 691-704 (2006).
Buzkova H, Pechandova K, Slanar O, Perlik F. Genetic polymorphism of cytochrome P450 and methods for its determination. Prague Med. Rep. 107: 383-393 (2006).
Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH. Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell. Microbiol. 8: 535-544 (2006). *
Buzza MS, Bird PI. Extracellular granzymes: current perspectives. Biol. Chem. 387: 827-837 (2006).
Bybel B, Brunken RC, Shah SN, Wu G, Turbiner E, Neumann DR. PET and PET/CT imaging: what clinicians need to know. Cleve. Clin. J. Med. 73: 1075-1087 (2006). *
Bylaite M, Moussali H, Marciukaitiene I, Ruzicka T, Walz M. Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases. Exp. Dermatol. 15: 110-118 (2006). *
Byrn JC, Wang JL, Divino CM, Nguyen SQ, Warner RR. Management of goblet cell carcinoid. J. Surg. Oncol. 94: 396-402 (2006).
Byrne FR, Viney JL. Mouse models of inflammatory bowel disease. Curr. Opin. Drug Discov. Devel. 9: 207-217 (2006).
Byrne JA, Strautnieks SS, Ihrke G, Knisely AS, Jirsa M, Cebecauerova D, Linton KJ, Higgins CF, Mieli-Vergani G, Thompson RJ. Investigation of the disease mechanisms associated with missense mutations in the bile salt export pump, BSEP. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 61 (2006). *
Byrnes V, Afdhal N, Challies T, Greenstein PE. Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis. Ann. Hepatol. 5: 56-59 (2006). *
Cabana MD, Shane AL, Chao C, Oliva-Hemker M. Probiotics in primary care pediatrics. Clin. Pediatr. (Phila.) 45: 405-410 (2006). *
Cabanillas M, Perez-Perez L, Sanchez-Aguilar D, Toribio J. Generalized pustular psoriasis and cytolytic hepatitis associated with neutrophilic cholangitis. Actas. Dermosifiliogr. 97: 330-333 (2006).
Cabello GM, Cabello PH, Llerena JC Jr, Fernandes O. Polymorphic markers suggest a gene flow of CFTR gene from sub-Saharan/Arabian and Mediterranean to Brazilian population. J. Hered. 97: 313-317 (2006). *
Cabranes A, Pryce G, Baker D, Fernandez-Ruiz J. Changes in CB(1) receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice. Brain Res. 1107: 199-205 (2006).
Cabriada J, Domenech E, Gomollon F, Gonzalez-Carro P, Gonzalez-Lara V, Hinojosa J, Jimenez-Lopez C, Nos P, Obrador A, Panes J, Saro C, Varea V, Lafuente R, Guilera M. Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease. Gastroenterol. Hepatol. 29: 85-91 (2006).
Cadavid D, Sondey M, Garcia E, Lawson CL. Residual brain infection in relapsing-Fever borreliosis. J. Infect. Dis. 193: 1451-1458 (2006). *
Caddy GR, Ardill JE, Fillmore D, Caldwell CM, McKibben BM, Gardiner KR, Watson PR. Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease. Eur. J. Gastroenterol. Hepatol. 18: 195-202 (2006).
Caddy GR, Tham TC. Gallstone disease: symptoms, diagnosis and endoscopic management of common bile duct stones. Best Pract. Res. Clin. Gastroenterol. 20: 1085-1101 (2006).
Cadle RM, Mansouri MD, Darouiche RO. Vancomycin-induced elevation of liver enzyme levels. Ann. Pharmacother. 40: 1186-1189 (2006).
Cadoni G, Boccia S, Scipione S, Arzani D, Cianfagna F, Ricciardi G, Paludetti G, Agostino S. Glutathione S-transferase gene polymorphisms in Italian patients with sudden sensorineural hearing loss. Otol. Neurotol. 27: 1166-1169 (2006).
Cadoni G, Cianfoni A, Agostino S, Scipione S, Tartaglione T, Galli J, Colosimo C. Magnetic resonance imaging findings in sudden sensorineural hearing loss. J. Otolaryngol. 35: 310-316 (2006).
Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 55: 547-553 (2006). *
Cahoon Jr WD, Kockler DR. Mycophenolate mofetil treatment of myasthenia gravis. Ann. Pharmacother. 40: 295-298 (2006).
Cai J, Kohanof S, Terasaki PI. HLA-DR antibody epitopes. Clin. Transpl. 2006: 103-114 (2006).
Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic. Biol. Med. 41: 851-861 (2006).
Cai SS, Syage JA. Comparison of atmospheric pressure photoionization, atmospheric pressure chemical ionization, and electrospray ionization mass spectrometry for analysis of lipids. Anal. Chem. 78: 1191-1199 (2006). *
Cai SY, Boyer JL. FXR: a target for cholestatic syndromes? Expert Opin. Ther. Targets 10: 409-421 (2006).
Cai W, Wu J, Hong L, Xu Y, Tang Q, Shi C. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction. J. Pediatr. Surg. 41: 1663-1668 (2006).
Cai X, Wong YF, Zhou H, Liu ZQ, Xie Y, Jiang ZH, Bian ZX, Xu HX, Liu L. Manipulation of the induction of adjuvant arthritis in Sprague-Dawley rats. Inflamm. Res. 55: 368-377 (2006). *
Cai X, Wong YF, Zhou H, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn. Schmiedebergs. Arch. Pharmacol. 373: 140-147 (2006). *
Cai Z, Taddei A, Sheppard DN. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. J. Biol. Chem. 281: 1970-1977 (2006). *
Caillat-Zucman S. How NKG2D ligands trigger autoimmunity? Hum. Immunol. 67: 204-207 (2006).
Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA. Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J. Trauma 61: 293-299 (2006).
Cakir E, Uyan ZS, Ersu RH, Karadag B, Karakoc F, Dagli E. Mucoid impaction: an unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. Pediatr. Pulmonol. 41: 1103-1107 (2006).
Calabrese L. The yin and yang of tumor necrosis factor inhibitors. Cleve. Clin. J. Med. 73: 251-256 (2006). *
Calander AM, Starckx S, Opdenakker G, Bergin P, Quiding-Jarbrink M, Tarkowski A. Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect. 8: 1434-1439 (2006). *
Calano SJ, Shih PA, Liu CC, Kao AH, Navratil JS, Manzi S, Ahearn JM. Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers. Adv. Exp. Med. Biol. 586: 381-390 (2006).
Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 1069: 62-76 (2006). *
Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV. Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Mol. Pharm. 3: 87-93 (2006).
Caldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, Balatsinou C, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M. Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am. J. Gastroenterol. 101: 2782-2789 (2006). *
Caldari-Torres C, Rodriguez-Sallaberry C, Greene ES, Badinga L. Differential effects of n-3 and n-6 fatty acids on prostaglandin F2alpha production by bovine endometrial cells. J. Dairy Sci. 89: 971-977 (2006). *
Caldas C, Luna E, Spadafora-Ferreira M, Porto G, Iwai LK, Oshiro SE, Monteiro SM, Fonseca JA, Lemos F, Hammer J, Ho PL, Kalil J, Coelho V. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses. Clin. Exp. Immunol. 146: 66-75 (2006). *
Calder CJ, Nicholson LB, Dick AD. Mechanisms for inducing nasal mucosal tolerance in experimental autoimmune uveoretinitis. Methods 38: 69-76 (2006). *
Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot. Essent. Fatty Acids 75: 197-202 (2006). *
Calder PC. Branched-chain amino acids and immunity. J. Nutr. 136: 288S-293S (2006). *
Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83: 1505S-1519S (2006). *
Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc. Nutr. Soc. 65: 264-277 (2006). *
Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, Heinrich J, Garn H, Koletzko S, Lack G, Mattelio G, Renz H, Sangild PT, Schrezenmeir J, Stulnig TM, Thymann T, Wold AE, Koletzko B. Early nutrition and immunity - progress and perspectives. Br. J. Nutr. 96: 774-790 (2006). *
Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177: 27-39 (2006).
Calderoni DR, Andrade Tdos S, Grotto HZ. Haptoglobin phenotype appears to affect the pathogenesis of American trypanosomiasis. Ann. Trop. Med. Parasitol. 100: 213-221 (2006).
Caldwell SH, Argo CK, Al-Osaimi AM. Therapy of NAFLD: insulin sensitizing agents. J. Clin. Gastroenterol. 40 Suppl. 1: S61-S66 (2006).
Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44: 1039-1046 (2006). *
Calguneri OM, Ozturk MA, Kiraz S, Ertenli I, Onat AM, Ureten K, Ozbalkan Z, Haznedaroglu IC. Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism. Joint Bone Spine 73: 334-336 (2006). *
Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-alpha and gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol. Dial. Transplant. 21: 2399-2405 (2006).
Callaghan R, Ford RC, Kerr ID. The translocation mechanism of P-glycoprotein. FEBS Lett. 580: 1056-1063 (2006). *
Callegari PE, Schaible TF, Boscia JA. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. JAMA 296: 2202 (2006). *
Calleja C, Messaddeq N, Chapellier B, Yang H, Krezel W, Li M, Metzger D, Mascrez B, Ohta K, Kagechika H, Endo Y, Mark M, Ghyselinck NB, Chambon P. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev. 20: 1525-1538 (2006). *
Callejas JL, Sabio JM, Haro MD, Camps M, Ramon ED, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45: 1044-1046 (2006). *
Callejas-Rubio JL, Lopez-Nevot MA, Martin-Ibanez J, Ortego-Centeno N. Takayasus's arteritis associated with ulcerative colitis. Med. Clin. (Barc.) 126: 518 (2006).
Calsbeek H, Rijken M, Bekkers MJ, Dekker J, Henegouwen GP. School and leisure activities in adolescents and young adults with chronic digestive disorders: impact of burden of disease. Int. J. Behav. Med. 13: 121-130 (2006).
Calsbeek H, Rijken M, Dekker J, van Berge Henegouwen GP. Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders. Eur. J. Gastroenterol. Hepatol. 18: 203-209 (2006).
Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha(2) integrin C807T gene polymorphism in type 2 diabetes. Platelets 17: 78-83 (2006).
Calvet X, Gallardo O, Coronas R, Casellas F, Montserrat A, Torrejon A, Vergara M, Campo R, Brullet E. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease. Inflamm. Bowel Dis. 12: 692-696 (2006). *
Calvete JJ, Revert F, Blanco M, Cervera J, Tarrega C, Sanz L, Revert-Ros F, Granero F, Perez-Paya E, Hudson BG, Saus J. Conformational diversity of the Goodpasture antigen, the noncollagenous-1 domain of the alpha3 chain of collagen IV. Proteomics 6 Suppl. 1: S237-S244 (2006). *
Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130: 1117-1128 (2006). *
Calvo N, Iversen E, Munck LK. Intestinal side effects of COX-2 inhibitors. Ugeskr. Laeger. 168: 1343-1344 (2006).
Calvo-Alen J, Alarcon GS, Tew MB, Tan FK, McGwin G Jr, Fessler BJ, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 54: 1940-1945 (2006). *
Calvopina M, Barroso PA, Marco JD, Korenaga M, Cooper PJ, Nonaka S, Hashiguchi Y. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Vaccine 24: 5645-5652 (2006). *
Camacho JA, Mardach R, Rioseco-Camacho N, Ruiz-Pesini E, Derbeneva O, Andrade D, Zaldivar F, Qu Y, Cederbaum SD. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Pediatr. Res. 60: 423-429 (2006). *
Camateros P, Moisan J, Henault J, De Sanctis J, Skamene E, Radzioch D. Toll-like receptors, cytokines and the immunotherapeutics of asthma. Curr. Pharm. Des. 12: 2365-2374 (2006).
Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum. 54: 723-732 (2006). *
Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, Wright AL, Halonen M, Klimecki WT, Vercelli D. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J. Immunol. 177: 8633-8642 (2006). *
Camilleri M. Is there a role for probiotics in irritable bowel syndrome? Dig. Liver Dis. 38 Suppl. 2: S266-S269 (2006).
Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J. Clin. Gastroenterol. 40: 264-269 (2006).
Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin. Gastroenterol. Hepatol. 4: 1428-1433 (2006).
Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science 311: 1113-1116 (2006). *
Cammarota G, Cesaro P, Martino A, Zuccala G, Cianci R, Nista E, Larocca LM, Vecchio FM, Gasbarrini A, Gasbarrini G. High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. Aliment. Pharmacol. Ther. 23: 61-69 (2006). *
Cammelli D. Extra-articular manifestations of seronegative spondyloarthritis. Recenti Prog. Med. 97: 280-289 (2006).
Camp RD. Updates from the Fourth International Congress 'Psoriasis: from Gene to Clinic', The Royal College of Physicians, London, U.K., 1-3 December 2005. Br. J. Dermatol. 155: 1124-1130 (2006). *
Campagnoli MF, Garbarini L, Quarello P, Garelli E, Carando A, Baravalle V, Doria A, Biava A, Chiocchetti A, Rosolen A, Dufour C, Dianzani U, Ramenghi U. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica 91: 538-541 (2006). *
Campagnoli MF, Pucci A, Garelli E, Carando A, Defilippi C, Lala R, Ingrosso G, Dianzani I, Forni M, Ramenghi U. Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J. Clin. Pathol. 59: 440-442 (2006). *
Campard D, Vasse M, Rose-John S, Poyer F, Lamacz M, Vannier JP. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells. Stem Cells 24: 1302-1314 (2006). *
Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. U.S.A. 103: 16834-16839 (2006). *
Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 52: 77-92 (2006). *
Campbell MJ, Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin. Ther. Targets 10: 735-748 (2006).
Campbell PJ, Green AR. The myeloproliferative disorders. N. Engl. J. Med. 355: 2452-2466 (2006). *
Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J. Immunol. 176: 1889-1898 (2006). *
Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins. Br. J. Cancer 95: 520-524 (2006). *
Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-de-Moraes M, Askenase PW. Invariant NKT cells rapidly activated via immunization with diverse contact antigens collaborate in vitro with B-1 cells to initiate contact sensitivity. J. Immunol. 177: 3686-3694 (2006). *
Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, Xaus J, Zarzuelo A, Galvez J. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin. Nutr. 25: 466-476 (2006).
Canales P, Mery VP, Larrondo FJ, Bravo FL, Godoy J. Epilepsy and celiac disease: favorable outcome with a gluten-free diet in a patient refractory to antiepileptic drugs. Neurologist 12: 318-321 (2006).
Canaple L, Rambaud J, Dkhissi-Benyahya O, Rayet B, Tan NS, Michalik L, Delaunay F, Wahli W, Laudet V. Reciprocal regulation of BMAL1 and PPARalpha defines a novel positive feedback loop in the rodent liver circadian clock. Mol. Endocrinol. 20: 1715-1727 (2006). *
Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment. Pharmacol. Ther. 23: 377-385 (2006). *
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment. Pharmacol. Ther. 23: 1097-1104 (2006). *
Canbay A, Bechmann LP, Best J, Jochum C, Treichel U, Gerken G. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. Z. Gastroenterol. 44: 245-248 (2006).
Cancado EL, Medeiros DM, Deguti MM, Dos Santos MS, de Mello ES, Vendramini MB, Carrilho FJ. Celiac disease associated with nodular regenerative hyperplasia, pulmonary abnormalities, and IgA anticardiolipin antibodies. J. Clin. Gastroenterol. 40: 135-139 (2006).
Candia L, Cuellar ML, Marlowe SM, Marquez J, Iglesias A, Espinoza LR. Charcot-like arthropathy: a newly-recognized subset of psoriatic arthritis. Clin. Exp. Rheumatol. 24: 172-175 (2006).
Candia L, Marquez J, Gonzalez C, Santos AM, Londono J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J. Clin. Rheumatol. 12: 226-229 (2006).
Candon S, Mosca A, Ruemmele F, Goulet O, Chatenoud L, Cezard JP. Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease. Clin. Immunol. 118: 11-19 (2006). *
Candore G, Aquino A, Balistreri CR, Bulati M, Di Carlo D, Grimaldi MP, Listi F, Orlando V, Vasto S, Caruso M, Colonna-Romano G, Lio D, Caruso C. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann. N. Y. Acad. Sci. 1067: 282-287 (2006). *
Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, DI-Carlo D, Grimaldi MP, Orlando V, Piazza G, Vasto S, Lio D, Caruso C. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis. Ann. N. Y. Acad. Sci. 1089: 509-515 (2006). *
Caniato RN, Alvarenga ME, Garcia-Alcaraz MA. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine. Aust. N. Z. J. Psychiatry 40: 691-697 (2006). *
Cankurtaran M, Ulger Z, Dogan S, Balam Yavuz B, Halil M, Gullu I, Gedikoglu G, Aniogul S. Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient. Aging Clin. Exp. Res. 18: 75-77 (2006).
Canny G, Cario E, Lennartsson A, Gullberg U, Brennan C, Levy O, Colgan SP. Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G557-G567 (2006). *
Canny G, Swidsinski A, McCormick BA. Interactions of intestinal epithelial cells with bacteria and immune cells: methods to characterize microflora and functional consequences. Methods Mol. Biol. 341: 17-35 (2006).
Canny GO, Trifonova RT, Kindelberger DW, Colgan SP, Fichorova RN. Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells. J. Infect. Dis. 194: 498-502 (2006). *
Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 131: 1856-1869 (2006). *
Cano Vargas-Machuca E, Mondejar-Marin B, Navarro-Munoz S, Perez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A. Recurrent aseptic meningitis secondary to taking ibuprofen and ketorolac. Rev. Neurol. 42: 217-219 (2006).
Canovic P, Gajovic O, Todorovic Z, Mijailovic Z. Epstein-Barr virus hepatitis associated with icterus - a case report. Med. Pregl. 59: 179-182 (2006).
Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Citrullinated proteins in rheumatoid arthritis: crucial ... but not sufficient! Arthritis Rheum. 54: 3381-3389 (2006). *
Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 44: 446-457 (2006). *
Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Clin. Invest. Med. 29: 159-165 (2006).
Cantin AM, Berthiaume Y, Cloutier D, Martel M. Prolastin aerosol therapy and sputum taurine in cystic fibrosis. Clin. Invest. Med. 29: 201-207 (2006).
Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am. J. Physiol. Cell. Physiol. 290: C262-C270 (2006). *
Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am. J. Respir. Crit. Care Med. 173: 1139-1144 (2006). *
Canto E, Ricart E, Monfort D, Gonzalez-Juan D, Balanzo J, Rodriguez-Sanchez JL, Vidal S. TNFalpha production to TLR2 ligands in active IBD patients. Clin. Immunol. 119: 156-165 (2006). *
Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92: 60-64 (2006). *
Cantwell MM, Flynn MA, Gibney MJ. Acute postprandial effect of hydrogenated fish oil, palm oil and lard on plasma cholesterol, triacylglycerol and non-esterified fatty acid metabolism in normocholesterolaemic males. Br. J. Nutr. 95: 787-794 (2006). *
Cao H, Kabaroff LC, You Q, Rodriguez A, Boermans HJ, Karrow NA. Characterization of ovine hepatic gene expression profiles in response to Escherichia coli lipopolysaccharide using a bovine cDNA microarray. BMC Vet. Res. 2: 34 (2006). *
Cao J, Li JL, Li D, Tobin JF, Gimeno RE. Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis. Proc. Natl. Acad. Sci. U.S.A. 103: 19695-19700 (2006). *
Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin. Chem. 52: 2265-2272 (2006). *
Cao P, Zhang S, Gong Z, Tang X, Cao M, Hu Y. Development of a compact anti-BAFF antibody in Escherichia coli. Appl. Microbiol. Biotechnol. 73: 151-157 (2006). *
Cao Q, Shen XL, Zhou W, Wang JG. The relationship of nature killer cell 2D gene polymorphisms and ulcerative colitis in the Chinese. Zhonghua Nei Ke Za Zhi 45: 824-826 (2006).
Cao Q, Zhu Q, Wu ML, Hu WL, Gao M, Si JM. Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms. Chin. Med. J. (Engl.) 119: 1198-1203 (2006). *
Cao W, Harnett KM, Pricolo VE. NK2 receptor-mediated spontaneous phasic contractions in normal and ulcerative colitis human sigmoid colon. J. Pharmacol. Exp. Ther. 317: 1349-1355 (2006). *
Capasso M, Di Muzio A, Comar M, Robuffo I, Gambi A, Crovella S, Pizzigallo E, Campello C, Uncini A. The association of chronic hepatitis B and myopathy. Neurology 67: 1467-1469 (2006).
Caplan JP. All-trans retinoic acid (ATRA) syndrome can mimic panic disorder. Psychosomatics 47: 450-451 (2006). *
Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Eur. Cytokine Netw. 17: 167-174 (2006).
Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A. Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 177: 112-118 (2006).
Capoulade-Metay C, Ayouba A, Kfutwah A, Lole K, Petres S, Dudoit Y, Deterre P, Menu E, Barre-Sinoussi F, Debre P, Theodorou I. A natural CCL5/RANTES variant antagonist for CCR1 and CCR3. Immunogenetics 58: 533-541 (2006). *
Cappell MS. The effect of Nazism on medical progress in gastroenterology: the inefficiency of evil. Dig. Dis. Sci. 51: 1137-1158 (2006). *
Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 Suppl. 1: i36-i58 (2006). *
Caprioli F, Losco A, Vigano C, Conte D, Biondetti P, Forzenigo LV, Basilisco G. Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease. Am. J. Gastroenterol. 101: 1551-1558 (2006). *
Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br. J. Dermatol. 154: 319-324 (2006). *
Caputo M, Brizzolara R, Schiavo M, Salmaso C, Pesce G, Bagnasco M. Occurrence of overt celiac disease in the elderly following total thyroidectomy. J. Endocrinol. Invest. 29: 831-833 (2006).
Caputo R, Marzano AV, Tourlaki A, Marchini M. Reticular erythematous mucinosis occurring in a brother and sister. Dermatology 212: 385-387 (2006).
Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol. Int. 26: 209-214 (2006). *
Caramori G, Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Curr. Opin. Allergy Clin. Immunol. 6: 323-328 (2006).
Carayol N, Chen J, Yang F, Jin T, Jin L, States D, Wang CY. A dominant function of IKK/NF-kappaB signaling in global lipopolysaccharide-induced gene expression. J. Biol. Chem. 281: 31142-31151 (2006). *
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E. Systemic autoimmune disease in patients with uveitis. Arch. Soc. Esp. Oftalmol. 81: 193-198 (2006).
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Molina J, Fernandez-Cruz E. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings. Allergol. Immunopathol. (Madr.) 34: 131-135 (2006).
Card TR, Solaymani-Dodaran M, Hubbard R, Logan RF, West J. Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J. Epidemiol. Community Health 60: 819-821 (2006).
Cardaba B, Pozo VD, Gallardo S, Palomino P, Posada M, Lahoz C. Genetic approaches in the understanding of toxic oil syndrome. Toxicol. Lett. 161: 83-88 (2006). *
Cardell SL. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 143: 194-202 (2006). *
Cardon LR. Genetics. Delivering new disease genes. Science 314: 1403-1405 (2006). *
Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, Weber CJ, Pearson TC, Rajotte RV, Larsen CP. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 12: 304-306 (2006). *
Cardoso E, Fukuda T, Pereira J, Seixas J, Miranda R, Rodrigues B, Saback T, Andrade R, Cardoso G, Martinez R, Avena J, Melo A. Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil. Arq. Neuropsiquiatr. 64: 727-730 (2006). *
Cardoso H, Nunes AC, Carneiro F, Veloso FT. Successful infliximab therapy for oral Crohn's disease. Inflamm. Bowel Dis. 12: 337-338 (2006). *
Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA. Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49: 1000-1007 (2006). *
Carini R, Alchera E, De Cesaris MG, Splendore R, Piranda D, Baldanzi G, Albano E. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia. J. Hepatol. 45: 236-245 (2006). *
Cario E. Toll-like receptors in IBD. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 27 (2006). *
Cario E, Golenbock DT, Visintin A, Runzi M, Gerken G, Podolsky DK. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance. J. Immunol. 176: 4258-4266 (2006). *
Cario E, Podolsky DK. Toll-like receptor signaling and its relevance to intestinal inflammation. Ann. N. Y. Acad. Sci. 1072: 332-338 (2006). *
Cariou B, Staels B. The expanding role of the bile acid receptor FXR in the small intestine. J. Hepatol. 44: 1213-1215 (2006). *
Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J. Biol. Chem. 281: 11039-11049 (2006). *
Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 26: 2637-2645 (2006).
Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling in physiological control and disease. Crit. Rev. Eukaryot. Gene Expr. 16: 1-22 (2006).
Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr. Top. Med. Chem. 6: 1243-1253 (2006).
Carlo JT, Demarco D, Smith BA, Livingston S, Wiser K, Kuhn JA, Lamont JP. The utility of capsule endoscopy and its role for diagnosing pathology in the gastrointestinal tract. Am. J. Surg. 190: 886-890 (2006). *
Carlsen HS, Yamanaka T, Scott H, Rugtveit J, Brandtzaeg P. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria. Inflamm. Bowel Dis. 12: 1013-1024 (2006). *
Carlsen M, Cilio CM. Normal T cell development in the absence of thymic insulin expression. Ann. N. Y. Acad. Sci. 1079: 205-212 (2006). *
Carlson BA, Kingston JD. Docosahexaenoic acid, the aquatic diet, and hominin encephalization: difficulties in establishing evolutionary links. Am. J. Hum. Biol. 19: 132-141 (2006).
Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442: 299-302 (2006). *
Carlson EJ, Pitonzo D, Skach WR. p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation. EMBO J. 25: 4557-4566 (2006). *
Carlsson A, Agardh D, Borulf S, Grodzinsky E, Axelsson I, Ivarsson SA. Prevalence of celiac disease: before and after a national change in feeding recommendations. Scand. J. Gastroenterol. 41: 553-558 (2006). *
Carlton VE, Ireland JS, Useche F, Faham M. Functional single nucleotide polymorphism-based association studies. Hum. Genomics 2: 391-402 (2006).
Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 7: 375-386 (2006).
Carmelo E, Zurita AI, Martinez E, Valladares B. The sera from individuals suffering from cutaneous leishmaniasis due to Leishmania brazilensis present antibodies against parasitic conserved proteins, but not their human counterparts. Parasite 13: 231-236 (2006).
Carmichael SL, Shaw GM, Iovannisci DM, Yang W, Finnell RH, Cheng S, Lammer EJ. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am. J. Med. Genet. A. 140: 2433-2440 (2006).
Carol M, Borruel N, Antolin M, Llopis M, Casellas F, Guarner F, Malagelada JR. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J. Leukoc. Biol. 79: 917-922 (2006). *
Caroli E, Salvati M, Ferrante L. Tumor-like multiple sclerosis: report of four cases and literature review. Tumori. 92: 559-562 (2006).
Caron P, Trottier J, Verreault M, Belanger J, Kaeding J, Barbier O. Enzymatic production of bile acid glucuronides used as analytical standards for liquid chromatography-mass spectrometry analyses. Mol. Pharm. 3: 293-302 (2006). *
Carotenuto A, D'Ursi AM, Mulinacci B, Paolini I, Lolli F, Papini AM, Novellino E, Rovero P. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. J. Med. Chem. 49: 5072-5079 (2006). *
Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev. Environ. Health 21: 1-23 (2006).
Carpentier YA, Hacquebard M. Intravenous lipid emulsions to deliver omega 3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 75: 145-148 (2006). *
Carpentier YA, Portois L, Malaisse WJ. n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 83: 1499S-1504S (2006). *
Carr-Locke DL. Cholelithiasis plus choledocholithiasis: ERCP first, what next? Gastroenterology 130: 270-272 (2006). *
Carrell DT, De Jonge C, Lamb DJ. The genetics of male infertility: a field of study whose time is now. Arch. Androl. 52: 269-274 (2006).
Carrera D, Domenech A, Mora J, Ballester R, Roca M, Jimenez RI, Verdura B, Baliellas C, Guardiola J, Martin-Comin J. Prognostic utility of scintigraphy with 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease. Rev. Esp. Med. Nucl. 25: 380-386 (2006).
Carrero JJ, Grimble RF. Does nutrition have a role in peripheral vascular disease? Br. J. Nutr. 95: 217-229 (2006). *
Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, Blackshear PJ. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J. Autoimmun. 26: 182-196 (2006).
Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298: 225-257 (2006).
Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalu AB. Anti-TNF (infliximab) treatment in Crohn disease: safety profile. Recenti Prog. Med. 97: 108-112 (2006).
Carroccio A, Di Prima L, Pirrone G, Scalici C, Florena AM, Gasparin M, Tolazzi G, Gucciardi A, Sciume C, Iacono G. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin. Chem. 52: 1175-1180 (2006). *
Carroccio A, Di Prima L, Scalici C, Soresi M, Cefalu AB, Noto D, Averna MR, Montalto G, Iacono G. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease. Clin. Gastroenterol. Hepatol. 4: 455-459 (2006).
Carroll L, Hannawi S, Marwick T, Thomas R. Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products. Wien. Med. Wochenschr. 156: 42-52 (2006).
Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213: 48-65 (2006). *
Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 139: 1163-1172 (2006). *
Carter JD. Tumour necrosis factor inhibition causing psoriasis? A more plausible explanation exists. Ann. Rheum. Dis. 65: 1680 (2006). *
Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J. Rheumatol. 33: 1014-1017 (2006).
Carter PJ. Potent antibody therapeutics by design. Nat. Rev. Immunol. 6: 343-357 (2006). *
Carter RH. B cells in health and disease. Mayo Clin. Proc. 81: 377-384 (2006). *
Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7: 1074-1081 (2006). *
Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P. Gender, fatty liver and GGT. Hepatology 44: 278-279 (2006). *
Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm. Bowel Dis. 12: 258-262 (2006). *
Casais P, Meschengieser SS, Gennari LC, Alberto MF, Sanchez-Luceros A, Blanco AN, Lazzari MA. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease. Thromb. Haemost. 96: 19-23 (2006).
Casale TB, Kessler J, Romero FA. Safety of the intranasal Toll-like receptor 4 agonist CRX-675 in allergic rhinitis. Ann. Allergy Asthma Immunol. 97: 454-456 (2006).
Casartelli N, Giolo G, Neri F, Haller C, Potesta M, Rossi P, Fackler OT, Doria M. The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner. J. Gen. Virol. 87: 2291-2296 (2006). *
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935 (2006). *
Case S, Adams PC. Celiac disease - hidden and dangerous. Can. J. Gastroenterol. 20: 571-573 (2006).
Casella G, De Marco E, Monti C, Baldini V. The therapeutic role of thalidomide in inflammatory bowel disease. Minerva Gastroenterol. Dietol. 52: 293-301 (2006).
Casellas F, Lopez Vivancos J, Malagelada JR. Current epidemiology and accessibility to diet compliance in adult celiac disease. Rev. Esp. Enferm. Dig. 98: 408-419 (2006).
Casellas I Jorda F. Celiac disease. Med. Clin. (Barc.) 126: 137-142 (2006).
Casey J. Successful treatment of inflammatory bowel disease with budesonide in clinical practice. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 185 (2006). *
Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-1130 (2006). *
Cash HL, Whitham CV, Hooper LV. Refolding, purification, and characterization of human and murine RegIII proteins expressed in Escherichia coli. Protein Expr. Purif. 48: 151-159 (2006). *
Casola S, Rajewsky K. B cell recruitment and selection in mouse GALT germinal centers. Curr. Top. Microbiol. Immunol. 308: 155-171 (2006).
Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum. 55: 53-56 (2006). *
Caspi RR. Ocular autoimmunity: the price of privilege? Immunol. Rev. 213: 23-35 (2006). *
Cassan C, Piaggio E, Zappulla JP, Mars LT, Couturier N, Bucciarelli F, Desbois S, Bauer J, Gonzalez-Dunia D, Liblau RS. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J. Immunol. 177: 1552-1560 (2006). *
Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int. J. Immunopathol. Pharmacol. 19: 237-240 (2006).
Cassano N, Loconsole F, Galluccio A, Miracapillo A, Pezza M, Vena GA. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study). Int. J. Immunopathol. Pharmacol. 19: 225-229 (2006).
Cassatella MA. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J. Leukoc. Biol. 79: 1140-1149 (2006). *
Cassater D, Gambaro G, Fabris A, Cena C, Calabria S, Capelluto S, Lupo A. Henoch-Schonlein purpura and Crohn's disease in a family. J. Nephrol. 19: 387-390 (2006).
Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review. J. Rheumatol. 33: 1452-1456 (2006).
Cassiani-Ingoni R, Cabral ES, Lunemann JD, Garza Z, Magnus T, Gelderblom H, Munson PJ, Marques A, Martin R. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J. Neuropathol. Exp. Neurol. 65: 540-548 (2006).
Castaldo G, Tomaiuolo R, Vanacore B, Ferrara P, Del Vecchio S, Carnovale V, Abete P, Rengo F, Salvatore F. Phenotypic discordance in three siblings affected by atypical cystic fibrosis with the F508del/D614G genotype. J. Cyst. Fibros. 5: 193-195 (2006).
Castano G, Etchart C, Sookoian S. Vitamin A toxicity in a physical culturist patient: a case report and review of the literature. Ann. Hepatol. 5: 293-295 (2006). *
Castell JV, Castell M. Allergic hepatitis induced by drugs. Curr. Opin. Allergy Clin. Immunol. 6: 258-265 (2006).